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Background: The routine measurement of gastric residual volume to guide the initiation and delivery
of enteral feeding is widespread in paediatric intensive care and neonatal units, but has little
underlying evidence to support it.
Objective: To answer the question: is a trial of no gastric residual volume measurement feasible in UK
paediatric intensive care units and neonatal units?
Design: A mixed-methods study involving five linked work packages in two parallel arms: neonatal units
and paediatric intensive care units. Work package 1: a survey of units to establish current UK practice.
Work package 2: qualitative interviews with health-care professionals and caregivers of children admitted
to either setting. Work package 3: a modified two-round e-Delphi survey to investigate health-care
professionals’ opinions on trial design issues and to obtain consensus on outcomes. Work package 4:
examination of national databases to determine the potential eligible populations. Work package 5: two
consensus meetings of health-care professionals and parents to review the data and agree consensus on
outcomes that had not reached consensus in the e-Delphi study.
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Participants and setting: Parents of children with experience of ventilation and tube feeding in both
neonatal units and paediatric intensive care units, and health-care professionals working in neonatal
units and paediatric intensive care units.
Results: Baseline surveys showed that the practice of gastric residual volume measurement was very
common (96% in paediatric intensive care units and 65% in neonatal units). Ninety per cent of parents
from both neonatal units and paediatric intensive care units supported a future trial, while highlighting
concerns around possible delays in detecting complications. Health-care professionals also indicated
that a trial was feasible, with 84% of staff willing to participate in a trial. Concerns expressed by junior
nurses about the intervention arm of not measuring gastric residual volumes were addressed by
developing a simple flow chart and education package. The trial design survey and e-Delphi study
gained consensus on 12 paediatric intensive care unit and nine neonatal unit outcome measures,
and identified acceptable inclusion and exclusion criteria. Given the differences in physiology, disease
processes, environments, staffing and outcomes of interest, two different trials are required in the
two settings. Database analyses subsequently showed that trials were feasible in both settings in
terms of patient numbers. Of 16,222 children who met the inclusion criteria in paediatric intensive
care units, 12,629 stayed for > 3 days. In neonatal units, 15,375 neonates < 32 weeks of age met
the inclusion criteria. Finally, the two consensus meetings demonstrated ‘buy-in’ from the wider UK
neonatal communities and paediatric intensive care units, and enabled us to discuss and vote on the
outcomes that did not achieve consensus in the e-Delphi study.
Conclusions and future work: Two separate UK trials (one in neonatal units and one in paediatric
intensive care units) are feasible to conduct, but they cannot be combined as a result of differences
in outcome measures and treatment protocols, reflecting the distinctness of the two specialties.
Trial registration: Current Controlled Trials ISRCTN42110505.
Funding: This project was funded by the National Institute for Health Research (NIHR) Health
Technology Assessment programme and will be published in full in Health Technology Assessment;
Vol. 24, No. 23. See the NIHR Journals Library website for further project information.
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Plain English summary
Nurses looking after babies and children on intensive care units in the UK usually pass a tube andaspirate whatever food or fluid is in the baby’s stomach before they give a feed. The idea is to
ensure that the stomach is not overdistended with food and prevent the baby vomiting or, worse,
aspirating food into the lungs. However, there is little justification for this practice. It is rarely done in
many other countries. It may not be pleasant for the child and perhaps is unnecessary.
Some experts have suggested that the policy should be evaluated in a randomised controlled trial.
This would mean allocating a large number of children at random to either have the stomach aspirated
before feeds, or not. Such a trial would be a major undertaking and we are unsure if parents or staff
would be willing to allow children to participate.
The aim of this study was to see if it is possible to conduct such a large trial in the UK. Two surveys
(of 119 units) showed us that regularly measuring the stomach contents when starting and increasing
feeds is common practice for both newborn and older children in UK intensive care units. However,
in some countries, such as France, this practice is rarely done.
We asked 31 parents and 51 health-care professionals about a future study. Overall, parents were
supportive of a trial if it was explained to them well by a knowledgeable and caring professional,
and if they were approached at the right time. Some concerns were expressed about not picking up
complications early if gastric residual volume was not measured.
Health-care professionals were also mainly positive about a future trial, but mentioned similar
concerns about not picking up complications early and the difficulty of changing a long-standing
routine practice. Parents suggested study outcomes that were important to them. These, along with
other outcomes, were voted on in a further survey of 106 professionals and at face-to-face meetings
involving 41 participants. Overall, our findings suggest that a trial is feasible to perform and acceptable
to parents.
However, because of differences in both treatments and important outcomes between children’s
intensive care units and newborn baby intensive care units, two trials would be needed, one in each
type of intensive care unit.
These two trials will test whether or not the benefits of not measuring gastric residual volume
(e.g. improved calorie intake) outweigh the potential harms (e.g. delayed diagnosis of complications).
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Scientific summary
Background
What is gastric residual volume?
Gastric residual volume is a measurement taken to estimate the volume of fluid present in a child’s
stomach at a given point in time.
Intervention
Gastric residual volume measurement is the practice by which nurses try to aspirate (suck out) the
whole of the child or infant’s stomach contents every few hours to assess the volume and appearance
of the stomach contents. This is then used to guide the progression of feeding. However, there is a
lack of evidence to support routine gastric residual monitoring as part of enteral feeding protocols in
both infants and children, and increasing evidence to suggest this practice may delay the achievement
of full enteral feeds in neonatal units and prevent the achievement of required energy targets in
paediatric intensive care units. Therefore, it is important to determine whether or not this practice
can have an impact on these outcomes, and if it is possible to conduct a trial of routine gastric residual
measurement compared with no gastric residual volume measurement in critically ill infants and
children in the UK.
Study objectives
l To describe ‘usual care practices’ around enteral feeding and gastric residual volume measurement
in UK paediatric intensive care units and neonatal units.
l To explore both paediatric intensive care unit and neonatal unit parents’ or carers’ and health-care
professionals’ views around gastric residual volume measurement, acceptability of not measuring
gastric residual volume, willingness to agree or randomise to a future trial, barriers to recruitment,
perceived information needs of parents, training needs for staff, and inclusion and exclusion criteria.
l To explore future trial design issues and gain consensus on primary and secondary
outcome measures.
l To determine trial feasibility based on potentially eligible patients (from routine national data sets)
to inform sample size calculations for a future trial.
l To develop a standard (control) arm (with routine gastric residual volume measurement) and an
intervention arm (no routine gastric residual volume measurement) for a future trial.
l To integrate all the data and determine if a trial of no gastric residual volume measurement is
feasible in UK paediatric intensive care units and neonatal units.
Methods
A mixed-methods study with five interlinked work packages.
Work package 1: survey of current practice
An electronic survey was sent via national research networks to all UK paediatric intensive care unit
and neonatal units to establish ‘usual care practices’ around enteral feeding and gastric residual
volume measurement.
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Work package 2: interviews and focus groups involving parents and
health-care professionals
Qualitative semistructured interviews with parents of children who have experience of mechanical
ventilation and tube feeding in paediatric intensive care units and neonatal units, and semistructured
interviews and focus groups with health-care professionals.
Work package 3: trial design survey, including e-Delphi
A survey and a modified two-round e-Delphi survey were sent to paediatric intensive care unit and
neonatal unit health-care professionals. The survey sought views on trial design issues, including
willingness to randomise and eligibility criteria. The e-Delphi survey sought consensus on outcomes for
a future trial in both settings.
Work package 4: analysis of national data sets for trial feasibility
The National Neonatal Research Database and Paediatric Intensive Care Audit Network were analysed
to determine potential patient population numbers based on the inclusion and exclusion criteria
identified in work package 3. In addition, summary statistics for any outcome potentially relevant to a
future trial were collected from each database.
Work package 5: consensus and trial design meetings
Face-to-face consensus meetings brought together key stakeholders to provide feedback on
preliminary results and assess the ‘acceptability’ of a future trial. Meetings also sought consensus on
any ‘no-consensus’ items from work package 3.
Results
Surveys of current practice
Two survey instruments were developed and tested by the study team: a 51-item instrument for
paediatric intensive care units and a 19-item neonatal unit survey instrument around three domains
(general enteral feeding and nutrition practices in the respondents’ unit, the gastric residual volume
measurement technique used in the respondents’ unit and clinical management in response to gastric
residual volume).
Eighty-nine per cent (24/27) and 52% (95/184) of surveys of current practice were returned from
paediatric intensive care units and neonatal units, respectively. These surveys showed that the practice
of gastric residual volume measurement to guide feeding was prevalent across the UK, with almost all
of paediatric intensive care units (23/24, 96%) and 66% (59/90) of neonatal units measuring gastric
residual volume routinely.
Current paediatric intensive care unit practice
Most paediatric intensive care units (15/24, 63%) used the Schofield equation to predict energy
requirements and aimed to achieve these energy targets within 48–72 hours by enteral nutrition. Most
paediatric intensive care units (18/24, 75%) defined feed intolerance in their guidance and, of these
definitions, all included gastric residual volume (18/18, 100%), along with other signs [vomiting (12/18,
67%), diarrhoea (9/18, 50%) and abdominal appearance (8/18, 44%)]. The frequency of gastric residual
volume measurement was most commonly reported as 4-hourly (18/24, 75%). Almost all (21/24, 88%)
responding units reported that gastric residual volume was the main indicator to withhold enteral
feeding. The decision to withhold feeds was determined most frequently by a maximum volume in body
weight (ml/kg) (11/21, 52%).
Current neonatal unit practice
When units were asked about how frequently gastric residual volume is measured, 20 out of 90 (22%)
measured aspirates before every feed, 26 (29%) measured when it was felt to be clinically indicated
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and 39 (43%) measured gastric residual volume at regular intervals [most commonly 4- to 6-hourly
(35/39, 90%)]. One unit had no guidelines on this and four (4.4%) units reported that they did not
measure gastric residual volume. The bedside nurse most commonly made decisions in relation to
gastric residual volume results (56/90, 62%), followed by middle-grade doctors (41/90, 46%) and
the senior nurse in charge of the shift (26/90, 29%). Responding units had mixed views on how useful
the volume of the aspirate was for guiding feeding decisions, with 13 out of 90 (14%) units reporting
that volume affected clinical decision-making ‘very much’ and the most frequent response was
an intermediate score. The colour of the aspirate was felt to be more important, with 37 out of
90 (41%) units reporting that colour influenced clinical decisions ‘very much’ and this was the most
frequent response. These data have enabled us to propose ‘best fit’ control arms for a future trial
based on current practice.
Interviews and focus groups involving parents and health-care professionals
Thirty-one parents with experience of tube feeding (17 parents with experience of neonatal units,
seven parents with experience of paediatric intensive care units, and seven parents with experience of
both neonatal units and paediatric intensive care units) were interviewed, and their views regarding a
future trial were very positive. Most parents (28/31, 90%) said that they would hypothetically agree to
their child’s participation in a trial if they were approached at an appropriate time and by an individual
who was caring and knowledgeable about the trial. Parents did, however, have some concerns about
potential delays to recognising adverse events, such as necrotising enterocolitis or ventilator-acquired
pneumonia, by not measuring gastric residual volume. Fifty-one paediatric intensive care unit and
neonatal unit health-care professionals (nurses, physicians, dietitians and surgeons) participated in
focus groups and interviews, and most (84%) were supportive of a future trial. Junior nurses had the
most concerns about not being able to measure gastric residual volume. Health-care professionals
expressed concerns about not identifying adverse events (necrotising enterocolitis and ventilator-
acquired pneumonia) earlier. There was also concern about lack of knowledge of how to assess feed
intolerance without gastric residual volume, with many health-care professionals expressing their
concerns about the difficulty of changing an historical, embedded practice.
Trial design survey including e-Delphi study
The trial design survey (included at the beginning of round 1 of the e-Delphi study) was completed
by 30 paediatric intensive care unit and 76 neonatal unit health-care professionals. Importantly, almost
all health-care professionals [97% (29/30) of paediatric intensive care units and 91% (69/76) of
neonatal units] were prepared to randomise a child into a future ‘no gastric residual volume’ trial.
Preferred inclusion criteria by paediatric intensive care unit health-care professionals were all children
aged > 37 weeks (term) to 17 years (27/30, 90%) and cardiac surgical patients (24/30, 80%). However,
despite the commissioning brief, 22 out of 30 (73%) respondents believed that all tube-fed children,
including those on non-invasive ventilation, should be included in a trial. Preferred exclusions included
children with a surgical bowel problem causing admission or active gastrointestinal bleeding (21/30, 70%),
with some preference to exclude patients likely to stay < 24 hours (17/30, 57%).
The inclusion age that health-care professionals preferred for neonatal units was neonates < 32 weeks
of gestational age (72/76, 95%), but there was a range of responses. The only exclusion criterion
considered important by at least half of respondents was ‘any infant with suspected necrotising
enterocolitis’ (58/76, 76%).
Following a review of prior studies and trials involving gastric residual volume (in other populations),
we developed a list of outcomes. From this list, the qualitative work generated several outcomes
considered important by parents, which were incorporated into the e-Delphi survey.
Twenty-two paediatric intensive care unit and 61 neonatal unit health-care professionals participated
in round 2 of the e-Delphi survey to vote on trial outcomes. For paediatric intensive care units,
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22 outcomes were voted on in round 2. Of these, four items achieved ‘consensus in’, no items achieved
‘consensus out’ and 18 items were neither ‘consensus in’ nor ‘consensus out’. The most preferred (8/22,
36%) primary outcome measure was time to achieve the child’s estimated energy targets. For neonatal
units, 26 outcomes were voted on in round 2. Of these, five outcomes achieved ‘consensus in’, no items
were voted ‘consensus out’ and 21 items were neither ‘consensus in’ nor ‘consensus out’. The most
preferred (24/61, 39%) primary outcome measure was incidence of necrotising enterocolitis.
Analysis of national data sets
For paediatric intensive care units, the Paediatric Intensive Care Audit Network database showed
that in 2016 and 2017 a total of 16,122 children admitted to paediatric intensive care units met
the inclusion criterion of being aged > 37 weeks (term) to 17 years and who were also mechanically
ventilated (excluding those admitted with a gastrointestinal surgical diagnosis and those who did not
stay in paediatric intensive care units for > 24 hours). Among this group of children, 12,629 (78%)
stayed in paediatric intensive care units for ≥ 3 days and 10,341 (64%) were intubated for ≥ 3 days.
Surgical admissions for children aged > 1 month old were intubated for a shorter length of time
(median of 2 days).
For neonatal units, the National Neonatal Research Database showed that in 2017 and 2018 a total of
129,155 babies were admitted to a neonatal unit, 15,375 (12%) were born at < 32 weeks of gestational
age, 23,868 (18%) were mechanically ventilated and 82,555 (64%) received gastric tube feeds. Median
length of neonatal unit stay was 5, 50, 24 and 11 days, respectively, for these groups, and median time
from birth to establishing feeds at 150 ml/kg/day was 5, 12, 11 and 6 days, respectively, for these
groups of infants.
The analysis of these national neonatal unit and paediatric intensive care unit data sets showed that
trials in paediatric intensive care units and neonatal units are feasible in terms of patient numbers
when using the proposed inclusion and exclusion criteria in work package 3.
Consensus and trial design meetings
Two consensus meetings were held in April 2019: one paediatric intensive care unit meeting and one
neonatal unit meeting. Twenty individuals (two parents, seven nurses, one paediatric and neonatal
general surgeon, two dietitians, five physicians, one neonatal charity representative and two triallists)
attended the neonatal unit meeting on 1 April 2019. Twenty-two paediatric intensive care unit health-
care professionals (three paediatric dietitians, seven paediatric doctors, 11 paediatric nurses and one
paediatric general surgeon) attended the paediatric intensive care unit meeting on 2 April 2019. Some,
but not all, of the professionals who attended had been involved in the e-Delphi study. None of the
parents attending had been involved in the interviews. Voting took place on items that did not reach
consensus in the e-Delphi study. For paediatric intensive care units, 18 outcome items were voted on
after discussion and debate and from these, eight additional items achieved ‘consensus in’ and six were
voted ‘consensus out’, leaving only four items not reaching consensus. For neonatal units, 21 outcome
items were voted on. Four achieved ‘consensus in’ and four were voted ‘consensus out’, leaving 13
items failing to reach consensus in or out.
Conclusions
This feasibility study has collected and synthesised evidence from different stakeholders using mixed
methods, but without randomising patients, to determine the feasibility of conducting a future trial of
no routine gastric residual volume measurement in UK paediatric intensive care units and neonatal
units. Synthesising these results has identified several barriers to delivering definitive GASTRIC
trials in both settings, but has also provided information about how these barriers can be overcome.
A combined trial of both populations (paediatric intensive care units and neonatal units) cannot be
conducted owing to the fundamental differences in these patient populations. However, our feasibility
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work has shown that two separate trials, one in paediatric intensive care unit settings and one in
neonatal unit settings, are feasible to conduct in the UK. Owing to a limitation of the commissioning
brief, which precluded testing a trial protocol and randomising patients, an inbuilt pilot phase and clear
progression criteria are required in both trials.
Recommendations for future research
l A definitive GASTRIC trial is feasible to conduct in the paediatric intensive care unit setting with an
inbuilt pilot phase for progression to a full trial.
l A definitive GASTRIC trial is feasible to conduct in the neonatal unit setting with an inbuilt pilot
phase for progression to a full trial.
l Progression criteria for the pilot phase that should be assessed include parental consent rate, staff
compliance with study protocol, rate of crossover, and parent and health-care professional ‘acceptability’.
In addition, the pilot phase should aim to confirm the distribution of the primary outcome measure and
determine the feasibility of collecting secondary outcome measures.
Ethics approval
Ethics approval for the study was received on 18 April 2018 by the University of the West of England
(reference HAS.18.04.144) and Health Research Authority approval (reference 244006) was received
for the conduct of the focus groups on NHS sites.
Study Oversight Committee
A Study Oversight Committee was recruited to oversee the study processes and results.
Trial registration
This trial is registered as ISRCTN42110505.
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This project was funded by the National Institute for Health Research (NIHR) Health Technology
Assessment programme and will be published in full in Health Technology Assessment; Vol. 24, No. 23.
See the NIHR Journals Library website for further project information.
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Chapter 1 Surveys to establish
standard practice
Introduction
Work package (WP) 1 involved an electronic survey for all UK paediatric intensive care units (PICUs)
and neonatal units (NNUs), to describe ‘standard care practices’ around enteral feeding and gastric
residual volume (GRV) measurement.
Study management
This WP was led by LNT (for PICU) and JD (for NNUs). The Study Management Group (SMG) was
responsible for providing input into the survey questions and design, with the SMG statistician (BA)
analysing the descriptive results, LNT and JD summarising the guidelines, and members of the
qualitative SMG (KW and ED) undertaking qualitative analysis of the free-text responses.
Aims and objectives
To describe current unit (PICU and NNU) practices around the measurement of GRV.
Methods
Two separate cross-sectional surveys were developed by the study team, one for PICUs and one for
NNUs, in REDCap,1 an online electronic data-capture tool. The surveys were tested for clarity and face
validity on clinicians who did not go on to respond to the final surveys. Minor wording adjustments
were made to improve clarity, then the surveys were tested again within the study team. Ethics
approval for the surveys was provided by the University of the West of England (reference HAS.18.04.144).
The Paediatric Intensive Care Society (PICS) Study Group also reviewed and endorsed the PICU
survey, as did the Neonatal Nutrition Network.
All UK PICUs (n= 27) and NNUs (n= 184) were invited to complete a survey. Between May and July 2018,
each unit was contacted via professional networks and e-mailed an invitation link. Units were asked
to complete the survey as a team consisting of a senior clinical nurse, a consultant and a dietitian
(or equivalent leads in these three areas of expertise). They were also asked to upload any written
guidance that their unit had around enteral feeding. The target response rate was > 70%. This was
maximised by sending out three reminders, 1 week apart. Data were summarised using descriptive
statistics for quantitative data and content analysis for qualitative free-text data.2 The unit guidelines
were reviewed and summarised.
The paediatric intensive care unit survey
The PICU survey [see project web page: www.journalslibrary.nihr.ac.uk/programmes/hta/169402/#/
documentation (accessed 13 February 2020)] consisted of 31 closed questions (tick-box responses,
with room for free-text responses whenever a tick-box response ‘other’ was chosen), a ranking
question and 19 open-ended questions. It was piloted on 10 PICU clinicians (a mix of doctors, dietitians
and nurses). The survey focused on three domains: (1) general enteral feeding and nutrition practices
in the respondents’ unit, (2) the GRV measurement technique used in the respondents’ unit and
(3) clinical management in response to GRV. Twenty-seven UK PICUs were approached: these were
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units that admit children for at least 24 hours of intensive care and that are part of the national
research network (PICS Study Group).
The neonatal unit survey
The NNU survey [see project web page: www.journalslibrary.nihr.ac.uk/programmes/hta/169402/
#/documentation (accessed 13 February 2020)] consisted of 10 closed questions (tick-box responses,
with room for free-text responses whenever a tick-box response ‘other’ was chosen) and nine open-
ended questions. It was piloted on 10 NNU staff (doctors, dietitians and nurses). The survey focused on
three domains: (1) general enteral feeding and nutrition practices in the respondent’s unit, (2) the GRV
measurement technique used in the respondent’s unit and (3) clinical management in response to GRV.
One hundred and eighty-four UK NNUs [special care baby units (SCBUs), local neonatal units (LNUs)
and neonatal intensive care units (NICUs) who looked after both medical and surgical babies] were
approached. These are NHS units that admit babies for at least 24 hours of neonatal care.
Results
Paediatric intensive care unit
Twenty-four of 27 (89%) UK PICUs completed the survey. These were a mixture of general PICUs
(13/24, 54%), mixed cardiac surgical and general PICUs (7/24, 29%) and standalone cardiac intensive
care units (ICUs) (4/24, 17%). Collective unit responses were completed by senior doctors (22/24, 92%),
nurses (23/24, 96%) and dietitians (23/24, 96%). Almost all (23/24, 96%) responding PICUs reported
written guidance regarding enteral feeding and most of these (19/23, 83%) were uploaded for review.
All responding PICUs undertook some nutritional assessment at PICU admission (Table 1).
The first part of the PICU survey consisted of questions regarding general nutrition practices in units.
Most PICUs (15/24, 63%) used the Schofield Equation to predict energy requirements and aimed to
achieve full energy targets within 48–72 hours. Over half (14/24, 58%) of PICUs had a target time
to initiate enteral feeding, and for half (7/14, 50%) of these this was within 6 hours of admission
(total range 2–24 hours). Continuous feeding was delivered in the majority of PICUs (15/24, 63%),
and 34% (9/24) used intermittent bolus via the gastric route. Continuous feeding was mostly delivered
TABLE 1 Nutritional assessment routinely undertaken at PICU admission (e-survey)
Nutritional parameter assesseda Number (%) assessed (n= 24)
Actual weight 20 (83)
Estimated weight 14 (58)
Height or length 13 (54)
z-score/weight 4 (17)
Centile chart 15 (62)
Weight for age 4 (17)
Nutritional assessment score 9 (37)
STAMP 3/9 (33)
PYMS 5/9 (56)
BCH 1/9 (11)
BCH, Birmingham Children’s Hospital Score; PYMS, Paediatric Yorkhill Malnutrition Score; STAMP, Screening Tool for
the Assessment of Malnutrition in Paediatrics.
a Respondents ticked all that applied.
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over 24 hours a day (10/15, 66.6%) or over 20 hours a day (5/15, 33%). When feeding was by
intermittent bolus, this was predominantly every 2 hours (6/9, 67%). Most units (15/24, 63%) reported
using standard rigid gastric tubes, with eight units (33%) using soft silicone tubes as their standard
feeding tube. Most PICUs (18/24, 75%) defined feed tolerance or intolerance in their guidance and,
of these, definitions included GRV (18/18, 100%), vomiting (12/18, 67%), diarrhoea (9/18, 50%) and
abdominal appearance (8/18, 44%). (See Report Supplementary Material 1 for a table of results and the
full qualitative analysis of the text responses.)
The rest of the survey asked questions about GRV technique and management in units. Table 2 presents
the key findings and further results are given in Report Supplementary Material 1. Table 3 is a summary
of the 19 guidelines that were received.
TABLE 2 Summary of PICU GRV practices (e-survey)
Practice Frequency (N= 24), n (%)
GRV is routinely measured 23 (96)
There is an agreed feed intolerance definition 18 (75)
The feed intolerance definition includes GRV 18/18 (100)
Frequency of GRV measurement
Before every bolus feed 2 (8)
4-hourly 18 (75)
5-hourly or 6-hourly 3 (12)
Only when child is vomiting 1 (4)
Guidance is in place for GRV measurement technique 8 (33)
The syringe size is specified 17 (70)
Size of syringea
20 ml 5/17 (29)
50 ml or 60ml 10/17 (59)
Size varies according to circumstance 2/17 (12)
GRV is used to define maximum threshold 21 (88)
Type of threshold
Maximum volume in ml/kg body weight 11/21 (52)
Maximum volume percentage of administered feed 6/21 (29)
Other 4/21 (19)
GRV maximal threshold to define ‘intolerance’a
5 ml/kg 12 (50)
Other: ml/kg threshold (up to 10ml/kg/other) 2 (8)
Gastric aspirate > 2 hours/4 hours/6 hours 4 (17)
> 50% of previous 4 hours of feed 3 (13)
Reason for discarding GRVa
Abnormal colour 17 (70)
a Themes derived from free-text responses.
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TABLE 3 Summary of PICU enteral feeding guidelines
PICU number
and type
Default feeding
method and route
GRV check
frequency
Threshold for
stopping feeds
Actions if threshold
exceeded
Actions if still not tolerating
feeds
Feeding defined by
risk level: low- vs.
high-risk abdomen
Mixed general
and cardiac PICU
Bolus gastric 3-hourly 5 ml/kg Return GRV, stop feeds at
3 hours and recheck GRV
Consider continuous feeding,
post-pyloric feeding, PN or
prokinetics
No
Mixed general
and cardiac PICU
Continuous gastric 4-hourly 5 ml/kg Return GRV, stop feeds at
2 hours and recheck GRV
Change to post-pyloric
feeding
Yes
Mixed general
and cardiac PICU
Bolus gastric 4-hourly > 4 hours of feed
volume given
Replace GRV, continue
feeding at same rate,
recheck GRV at 4 hours
Stop feeds and review by
doctor and dietitian
No
Mixed general
and cardiac PICU
Continuous gastric,
but also uses bolus
4-hourly > 4 hours of feed
volume given or
200 ml
Return GRV, stop feeds at
2 hours and recheck GRV,
restart feed at 0.5–1ml/hour
Change to post-pyloric
feeding
Yes
Mixed general
and cardiac PICU
Bolus gastric 2- to 6-hourly to first
determine the child’s
gastric emptying time
and prior to every
bolus feed
> 50% of last bolus
feed volume
Return GRV, stop feeds at
2 hours and recheck GRV
If GET delayed > 6 hours
start post-pyloric feeding
No
Mixed general
and cardiac PICU
Continuous gastric 4-hourly 5 ml/kg or 200 ml Return GRV, stop feeds at
2 hours and recheck GRV
Withhold and discuss
regarding post-pyloric
feeding
No
Mixed general
and cardiac PICU
Bolus gastric Minimum 8-hourly,
but done before
every 2-hour feed
5 ml/kg or 300 ml Return GRV, stop feeds at
2 hours and recheck GRV
Change to continuous feeds,
add oral prokinetic or
consider post pyloric feeding
No
Mixed general
and cardiac PICU
Continuous gastric 4-hourly 5 ml/kg Return GRV, stop feeds at
2 hours and recheck GRV
If in first 48 hours stop feeds,
after 48 hours change to
post-pyloric feeding
Yes
Cardiac ICU Continuous gastric 4-hourly 5 ml/kg Return GRV, stop feeds at
2 hours and r-check GRV
Discuss with doctor and
dietitian
Yes
Cardiac ICU Continuous gastric
with somatic NIRS
monitoring
4-hourly > 4 hours of feed
volume given
Replace half GRV, stop feeds
at 2 hours and recheck GRV
Consider post-pyloric feeding Yes
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PICU number
and type
Default feeding
method and route
GRV check
frequency
Threshold for
stopping feeds
Actions if threshold
exceeded
Actions if still not tolerating
feeds
Feeding defined by
risk level: low- vs.
high-risk abdomen
General PICU Continuous gastric 4-hourly > 4 hours of feed
volume given
Return GRV, stop feeds at
1 hour and recheck GRV
No mention No
General PICU Continuous gastric 4-hourly 5 ml/kg or 200 ml Return GRV and maintain
rate of feed
Consider alternative feed,
post-pyloric feeding or PN
No
General PICU Continuous gastric,
but do use bolus
4-hourly 5 ml/kg or 200 ml Return GRV, stop feeds
2 hours and recheck GRV
Consider post-pyloric feeding No
General PICU Continuous gastric 4-hourly 5 ml/kg or 200 ml Change to non-fibre feed
then return to half GRV
and continue same rate for
4 hours
Consider post-pyloric feeding
and prokinetics
No
General PICU Bolus gastric 4-hourly > 50% of the feed
volume given in last
4 hours
Discard GRV and give the
previous amount of feed
again, recheck GRV
If still > 50%, change to
continuous feeding. If still not
tolerating, use IV prokinetic
and by 72 hours start
post-pyloric feeding
No
General PICU Continuous gastric 4-hourly 5 ml/kg Return GRV, stop feeds at
1 hour and recheck GRV
Start prokinetics and
post-pyloric feeding
No
General PICU Continuous or
bolus feeds
4-hourly 5 ml/kg or 250 ml Return GRV, stop feeds at
2 hours and recheck GRV
Consider prokinetics, rule out
constipation and consider
post-pyloric feeding
Yes
General PICU Continuous gastric 4-hourly > 50% of the feed
given in last 4 hours
Notify medical professional/
dietitian, stop feed or reduce
rate and recheck GRV
Consider post-pyloric feeding
if not tolerating by 24 hours
No
General PICU Continuous gastric 6-hourly > 6 hours of feed given Return GRV, stops feeds at
1 hour and recheck GRV
Does not specify No
GET, gastric emptying time; IV, invasive ventilation; NIRS, near-infrared spectroscopy; PN, parenteral nutrition.
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All but one (23/24, 96%) responding PICU measured GRV routinely as part of their standard practice,
and none reported that the policy was different for invasively ventilated compared with non-ventilated
children. The frequency of GRV measurement was most commonly reported as 4-hourly (18/24, 75%)
in the survey and (15/19, 79%) in the unit guidelines. However, most PICUs (16/24, 67%) reported little
guidance around the technique of measuring GRV. Only 71% (17/24) of responding units indicated a
specific syringe size to use with GRV measurement (but this was rarely written in their guidelines). When
this was specified, this was most commonly (10/17, 59%) a 50- to 60-ml syringe. Most units (15/24, 63%)
reported that the feeding method (continuous or intermittent) did not influence the frequency of GRV
measurement. Half of responding units (12/24, 50%) reported that the size of the child (i.e. > 40–50 kg)
did not affect the frequency of GRV measurement.
Almost all (21/24, 88%) responding units reported that GRV was the main indicator to withhold enteral
feeding. The decision to withhold feeds was determined most frequently by a maximum volume in ml/kg
body weight (11/21, 52%). Twenty-nine per cent (6/21) of units reported using a maximum percentage
of volume of feed given, but this was higher (8/19, 42%) in the unit guidelines. The volume above
which feeds were withheld was reported as 5 ml/kg by 52% (11/21) of units in the survey and by 58%
(11/19) of guidelines. In the seven units whose guidelines stipulated an upper absolute level (for children
> 40–50 kg), this was most frequently 200 ml (5/7, 71%). Of the six guidelines that used a percentage
of volume of feed given in previous hours to determine whether or not to withhold feeds, this varied
from > 50% of feed given in the previous 4 hours to 100% of the feed given in the previous 2–6 hours.
A percentage of the volume of the previous 4 hours of feed given was used in 5 out of 19 (26%)
guidelines. More than half (14/24, 58%) of responding units reported that they did not vary the
threshold according to the size of the child.
Both volume and/or colour of aspirates affected decisions to stop feeds. Figure 1 shows that most units
rated both volume (14/24, 58%) and colour (15/24, 63%) as fairly important.
Guideline analysis and free-text responses all cited abnormal colour aspirates being green (bilious),
red (bloody) or brown (faecal) in appearance and, even if the volume was not large, aspirates of this
appearance would be discarded and indicate the withholding of feeds. Most (15/24, 63%) units reported
returning GRV. None reported that GRVs were routinely discarded, but that this was dependent on
individual patient factors and aspirate appearance. However, most guidelines (16/19, 84%) required to
return the GRV in all patients unless it was abnormal in appearance. In response to obtaining ‘high’ GRVs,
PICUs reported their actions by free text and then actions were ranked by frequency in the survey.
Qualitative responses indicated that for the majority of PICUs, in the first instance, enteral feeds would
be withheld for a period of time (commonly 2 hours) and GRV reassessed. After this, actions ranked by
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FIGURE 1 How much does aspirate volume and aspirate colour affect your decision to stop feeds? (n = 24 paediatric
intensive care units.)
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order of priority were most commonly (1) changing the feeding method from bolus to continuous feeds,
(2) changing to post-pyloric feeding and/or changing the feed formula, (3) adding prokinetics and
persisting with gastric feeding and, lastly, (4) stopping enteral feeds and commencing parenteral nutrition.
For 79% of units (15/19), the initial action in response to a large GRV was to stop feeds for a period of time
and recheck the GRV. From the guideline review (see Table 3), six units had defined levels of abdominal risk
for enteral feeding of children. Five out of these six units admitted cardiac surgical neonates (83%) and
defined low- and high-risk abdomens in their protocols based on the patient profile. Defining features
of a high-risk abdomen included infants with hypoplastic left heart syndrome, aortic arch abnormalities,
shunts and duct-dependent circulations, gut concerns, including confirmed necrotising enterocolitis
(NEC) in the last 4 weeks, high vasopressor support, high lactate concentrations, low somatic near-
infrared spectroscopy, and after cardiac arrest and extracorporeal life support. In all situations, even
when different feeding regimes were specified in relation to risk, both protocols (for low and high risk)
still used routine GRV measurement, but the rate of feed delivery and the speed of advancement was
much slower in the high-risk patients.
Neonatal units
Ninety-five of 184 (52%) NNUs in the UK, excluding Northern Ireland, completed the survey. These
consisted of 40 NICUs, 42 LNUs and 13 SCBUs,3 giving response rates of 71%, 47% and 33%,
respectively. Seventeen of a possible 18 NICUs that routinely care for both immediate postoperative
surgical and medical patients responded, as did 23 NICUs that routinely care for only medical cases.
LNUs and SCBUs do not provide early postoperative care in the UK.4,5 Survey responses were received
from senior doctors (81/95, 85%), nurses (51/95, 54%) and dietitians (9/95, 10%). Table 4 gives a
summary of general feeding practices. Most (81/95, 85%) responding units reported written enteral
feeding guidance and 28 unit or local neonatal network guidelines were sent to the authors. Enteral
feeding was typically delivered intermittently (90/95, 95%), rather than continuously (5/95, 5%).
Forty-two out of 95 units (44%) reported having written guidance for measurement and interpretation
of GRVs.
Ninety units answered questions about the management of non-surgical babies (Table 5). When asked
about how often GRV is measured, 20 out of 90 units (22%) measured aspirates before every feed,
26 (29%) units measured aspirates when it was felt to be clinically indicated and 39 (43%) units
measured GRV at regular time intervals [most commonly 4- to 6-hourly, 35/39 (90%), but all more
frequently than once per day]. One unit had no guidelines on this and four (4%) reported that they did
not measure GRV. Among units that reported having written GRV measurement guidance, 13 out of
39 (33%) indicated that the guidance was ‘always’ followed and 17 (39%) indicated that the guidance
was ‘usually’ followed; however, free-text responses suggested that practice was ‘very variable
depending on the nurse looking after the baby’ (unit 3, surgical and medical unit). The bedside nurse
most commonly made decisions in relation to GRV results (56/90, 62%), followed by middle grade
doctors (41/90, 46%) and the senior nurse in charge of the shift (26/90, 29%).
TABLE 4 Neonatal unit general feeding practices for all babies (e-survey)
Practice Frequency (N= 95), n (%)
Units had written feeding guidelines/protocol 81 (85)
Standard gastric feeds were intermittent bolus (not continuous) 90 (95)
There was specific guidance about how GRV should be measured and interpreted
(e.g. a protocol or guideline)
42 (44)
NICUs that care for surgical and medical babies (n = 17)
GRV measurement differs between the medical and surgical babies 5/17 (29)
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Responding units had mixed views on how useful the volume of the aspirate was for guiding feeding
decisions (Figure 2), with 13 out of 90 (14%) units reporting that volume affected clinical decision-
making ‘very much’ and the most frequent response was an intermediate score. The colour of the
aspirate was felt to be more important, with 37 out of 90 (41%) units reporting that colour influenced
clinical decisions ‘very much’ and this was the most frequent response. More detail was obtained from
74 open-text responses to this question. A large volume of aspirate was commonly described as a
concern, which would often lead to a clinical review of a baby’s condition and subsequent consideration
of how much milk the baby is receiving. The threshold for prompting a feeding review was reported to
vary. Some units stated that aspirates > 50% of the feed would ‘prompt a review’ (unit 8, NICU surgical
and medical), whereas others stated ‘> 25% of the feed given in previous 6 hours’ (unit 18, NICU
medical only), if exceeds ‘25% of the previous 4 hours’ feed volume’ (unit 22, NICU medical only) or
‘if > 25% of the feed volume given since the last assessment was made’ (unit 25, NICU medical only).
Almost half (44/90, 49%) routinely returned aspirates to the stomach. Seventy-two nurses gave
reasons for seeking medical advice, with 55 (76%) citing increased or large GRVs and 52 (72%) citing
bilious colour of the residual or a change in colour. Other reasons were blood-stained aspirates (16/72,
22%), concerns about the condition of the baby, such as arterial oxygen desaturations (16/72, 22%),
abdominal distension (11/72, 15%) and vomiting (5/72, 7%). In free-text responses, units stated that
TABLE 5 Neonatal unit GRV practices specific to the management of medical babies (e-survey)
Practice Frequency (N= 90), n (%)
Frequency that staff in your unit measure GRV
Once a day 0 (0)
Before every feed 20 (22)
Only when clinically indicated 26 (29)
At regular intervals 39 (43)
At least every 3, 4 or 6 hours 35/39 (90)
GRV is not measured 4 (4)
How often is specific guidance for GRV measurement followed and undertaken as per protocol [asked only of units
with specific guidance for GRV measurement (n= 39)]?
Always 13 (43)
Usually 17 (39)
Often 4 (10)
Rarely/never 5 (13)
Who usually decides what to do with concerning GRV aspirates in the first instance (more than one response allowed)?
Senior doctor (consultant) 13 (14)
Middle-grade doctor (specialist registrar) 41 (46)
Junior-grade doctor (senior house officer) 18 (20)
Bedside nurse 56 (62)
Nurse in charge of shift (senior nurse) 26 (29)
What is usually done with obtained GRV?
Returned 44 (49)
Discarded 7 (8)
Other 39 (43)
SURVEYS TO ESTABLISH STANDARD PRACTICE
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that a dark or bilious colour would ‘trigger medical review [by a] middle grade or consultant’ (unit 22,
NICU medical only), whereas some described how feeds would be stopped, ‘green aspirate – assess
baby and feeds withheld’ (unit 60, LNU). Full summaries of qualitative analyses are presented in
Report Supplementary Material 1.
The 28 guidelines received are summarised in Table 6. This shows that 19 out of 28 (68%) guidelines
specified a volume of aspirate at which to consider stopping feeds, using a defined proportion of the
previous feed. Six guidelines specified this threshold as ≥ 25% of the previous feed, eight guidelines
specified ≥ 50% of the previous feed, whereas five guidelines used a level between these. Fourteen
guidelines mentioned the bilious green colouring of GRV being an indication to stop enteral feeds,
whereas five mentioned blood staining as being important. Vomiting and abdominal distension were also
considered important for guiding management, being mentioned by 13 and 12 guidelines, respectively.
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FIGURE 2 How much does aspirate volume and aspirate colour affect your decision to stop feeds? (n = 90 NNUs.)
TABLE 6 Detailed summary of UK NNU enteral feeding written guidelines
NNU number
and levela
Default feeding
method GRV checking Threshold for stopping feeds
1. NICU Bolus feeds Routinely measured, but no
mention of frequency or
technique
Aspirate > 50% feed volume in previous 6 hours
or bilious aspirates
2. NICU Bolus feeds Measured, but no mention
of frequency or how
Aspirates > 50% or > 1 ml if aspirate contains
blood or bile: discard GRV, stop feeds, wait
2 hours and reassess
3. NICU Bolus feeds No mention of frequency or
technique
Consider stopping if pre-feed aspirate > 4ml/kg,
heavily bile-stained aspirates or two vomits after
consecutive feeds
4. NICU No mention No mention No mention
5. NICU Bolus feeds and
advanced as per
SIFT
Check GRV no more than
6-hourly unless concerns
Withhold feeds for 6–12 hours if GRV > 40% of
feed given, 2 ml or 3 ml (dependent on infant
weight) heavily bile/blood stained or abdominal
distension
6. NICU Bolus feeds Not stated GRV > 50% volume of feeds over last 6 hours
or vomit of this size
continued
DOI: 10.3310/hta24230 Health Technology Assessment 2020 Vol. 24 No. 23
© Queen’s Printer and Controller of HMSO 2020. This work was produced by Tume et al. under the terms of a commissioning contract issued by the Secretary of State for
Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in
professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial
reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House,
University of Southampton Science Park, Southampton SO16 7NS, UK.
9
TABLE 6 Detailed summary of UK NNU enteral feeding written guidelines (continued )
NNU number
and levela
Default feeding
method GRV checking Threshold for stopping feeds
7. NICU 2-hourly bolus
feeds advanced
as per SIFT
4- to 6-hourly Action with gastric residuals, if:
l aspirates 25–50% of total, replace the
volume, omit the feed and do not increment
l aspirates > 50% of total, stop feeds and
medical review
l dark bilious rather than lightly bile stained,
stop feeds and medical review
8. NICU Bolus feeds,
two risk levels,
advanced as
per SIFT
Routine measurement of full
gastric residuals should be
avoided. This should only be
done, with discussion, as a
part of a full medical review
by a doctor or ANNP
Signs of feed intolerance may include clinical
observations, such as desaturation and
bradycardia events, and increased work of
breathing, vomiting, abdominal distension and
discolouration
9. NICU Bolus feeds Not specified Medical babies: 2 ml/kg of milky gastric residual
is not important and should simply be replaced.
When the gastric residual at higher volumes is
equivalent to 100% of the bolus feeds, then the
feeds should be stopped and a clinical review
should be undertaken
Surgical babies: aspirate less than half feed
volume since last aspirate, replace the aspirate
itself and continue feeding. If aspirate is greater
than half feed volume but less than whole feed
volume, replace half of the aspirate and discard
the rest. If aspirate is greater than whole feed
volume since previous aspirate, do not replace
the aspirate, stop feeding and obtain senior
medical and surgical review
10. NICU Bolus feeds 4- to 6-hourly Examine and assess the baby if vomiting, GRV
is > 25% of the previous 4 hours total feed
volume, residuals are persisting or increasing
Small milky/yellow aspirates up to 2–3ml are
frequently normal. They can be replaced and
feeds continued
11. NICU Bolus feeds 4- to 6-hourly When babies are on any enteral feeds, only
aspirate the stomach contents via a gastric tube
every 4–6 hours, to check the residual volume.
The assessment of the baby should include any
abdominal distension, dark green (bilious)
aspirates and bowel opening
If < 50% of the previous 4- to 6-hour total feed
volume is aspirated, then replace the aspirate
and continue enteral feeding, provided the baby
is otherwise clinically stable
If > 50% of the previous 4- to 6-hour total feed
volume is aspirated, then discuss with medical
staff; often reasonable to replace the aspirate
and omit the feed. If necessary, stop the feeds
for 4–6 hours and a senior member of the
medical/nursing team should then review
12. NICU Bolus feeds 6-hourly until infant is
fully fed
Signs of intolerance: vomiting, gastric residuals
> 25% of previous 6 hours feed volume,
persistent or increasing, abdominal distension/
increasing abdominal girth, increase in stool
frequency
SURVEYS TO ESTABLISH STANDARD PRACTICE
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TABLE 6 Detailed summary of UK NNU enteral feeding written guidelines (continued )
NNU number
and levela
Default feeding
method GRV checking Threshold for stopping feeds
13. NICU Bolus feeds Not specified Large-volume aspirates or dark-green bile-
stained aspirates, particularly in association with
abdominal distension and/or tenderness are a
cause for concern. Small milky/yellow aspirates
up to 2–3ml are frequently normal. They can be
replaced and feeds continued
14. NICU Bolus feeds No more than 4- to
6-hourly
If vomit or GRV exceeds 33% of the last feed
volume or 3.5 ml in a single aspirate, then
examine baby. Small residuals normal
15. NICU Bolus feeds Not specified Isolated large GRV in the absence of other
clinical signs and symptoms should not prevent
continued feeding
Signs of intolerance: vomiting, GRV > 30% of
previous 5 hours feed, abdominal distension,
unwell baby
16. LNU Bolus feeds with
advancement
strategy as per
SIFT
Not specified Aspirate > 50% feed volume or green aspirates
17. LNU Bolus feeds with
advancement as
per SIFT
GRV aspirated 4-hourly GRV > 25% feeds in previous 4 hours combined
with abdominal distension and/or vomiting
18. LNU Not stated Not specified 4-hourly NG aspirates are < 25% of total
infused in the preceding 4 hours. No significant
abdominal distension. No significant vomiting.
No bile-stained aspirates
19. LNU Bolus feeds Not specified Aspirates up to 2–3 ml or 50% of the previous
4 hours, feed can be normal if the baby is well
Aspirates > 50% of the previous 4 hours feed or
2–3 ml (whichever is greater) discard aspirate,
hold feed and try again in 2 hours
If aspirate contains blood or bile then stop feeds
20. LNU Bolus feeds Not specified If the aspirates are non-bilious and less than
half the volume of previous feed then they
can be replaced and feeding continued while
observing the infant closely
If the aspirates are bilious or > 50% of the
previous feed volume, consider withholding the
feeds on that occasion and assess for any signs
of NEC
21. LNU Bolus feeds Not specified No mention
22. LNU Bolus feeds 4- to 6-hourly If GRV is 25–50% of total, replace the hourly
amount, omit the feed and do not increase
If GRV is > 50% of total, stop feeds and medical
review
23. SCU Bolus feeds Not specified GRV > 2-hourly amount, vomiting or abdominal
distension
continued
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Summary of findings to inform the GASTRIC trial
Paediatric intensive care unit current practice
The routine and frequent measurement of GRV is embedded into enteral feeding practice and
guidelines in UK PICUs, yet little specific guidance is provided about the technique. This is despite
a lack of evidence and questionable accuracy of this parameter. For most units, GRV is the main
defining assessment of feed tolerance or intolerance and the most commonly used threshold is a GRV
≥ 5 ml/kg. Colour was as important as volume in the decision-making regarding whether to return or
TABLE 6 Detailed summary of UK NNU enteral feeding written guidelines (continued )
NNU number
and levela
Default feeding
method GRV checking Threshold for stopping feeds
24. Mixed
network
Bolus feeds Not specified GRV > 25% (some > 50%) in previous 4 hours
in combination with vomiting and abdominal
distension plus bilious aspirates
25. Mixed
network
Bolus feeds 4-hourly Stop feeds if GRV heavily blood or bile stained.
No mention of volume
26. Mixed
network
Bolus feeds Not specified GRV should not be used in isolation to
determine feed tolerance
Intolerance: vomiting plus GRV > 50% in the
last 4 hours (especially if increasing) plus
abdominal distension
27. Mixed
network
Bolus feeds
advanced as per
SIFT
Not specified Infants ‘feed tolerance’ assessed with each set
of cares (high risk), assess twice daily (moderate
risk) and before making changes in feed
volumes (standard risk)
Assessing tolerance: undigested gastric residuals
using a colour chart, GRV not used in isolation
If vomiting, GRV > 25% of feed volume in
last 4 hours + bloody or bilious residuals +
abdominal distension
28. Mixed
network
Bolus feeds Assess GRV 4- to 6-hourly
depending on cares
If GRV > 50% of total, stop feeds and medical
review
If GRV 25–50% of total, replace the hourly
amount, omit the feed and do not increase
An appropriate GRV is < 25% of preceding
volume since last replacement of GRV
Replace GRV in full
A GRV > 25% but < 1.5 ml is unlikely to be
problematic
A GRV of 25–50% is high, but acceptable if well,
replace only normal hourly volume and continue
feeds but do not increase
A GRV > 50% is excessive, perform a clinical
exam and if acceptable hourly volume can be
replaced, but with feed withheld
ANNP, advanced neonatal nurse practitioner; NG, nasogastric (tube); SCU, special care unit; SIFT, Speed of Increasing
Feeds Trial.5
a NNU level determined by the National Neonatal Audit Programme – 2017 Annual Report on 2016 Data.4
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discard GRV and to withhold feeds. This survey has established current practice around GRV
measurement in UK PICUs, which enabled us to develop a ‘control’ arm of a future trial of not
routinely measuring GRV in critically ill children (see Appendix 1 for flow chart). These results have
been published.6
Neonatal unit current practice
Neonatal units show a more mixed practice for both measuring GRV and in how GRV is used to make
decisions about enteral feeding. However, around half of UK NNUs still routinely use GRV as a parameter
to guide enteral feeding advancement. Health professionals’ views around the importance of the volume
compared with colour of the GRV were inconsistent, and importance was defined at different thresholds.
Aspirate colour was often cited as more important than volume; however, the importance placed on this
was inconsistent. Some unit guidelines specified actions based on bilious or blood staining of the secretions,
whereas others did not.
Understanding current practice in both settings has enabled us to construct a ‘control arm’ for a future
trial in both settings, which reflects the most prevalent practices across the units (see Appendices 1
and 2).
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Chapter 2 Interviews and focus groups
involving parents and health-care
professionals
Study design
Work package 2 was a mixed-method study involving interviews with parents with relevant PICU or
NNU experience, as well as focus groups and interviews with NNU and PICU health-care professionals
(HCPs), including nurses, doctors, surgeons and dietitians.
Objectives
To explore the views of parents with NNU and PICU experience on:
l the acceptability of the proposed trial
l potential barriers to recruitment
l participant information
l whether or not they would be happy to consent to their child’s participation in the trial
l potential parent-centred outcome measures.
To explore HCPs’ views on:
l the acceptability of the trial, including the proposed inclusion and exclusion criteria and equipoise
l the acceptability of not measuring GRV and other measures used to assess feeding tolerance
l the willingness to randomise to a future trial, including potential barriers to recruitment consent
l associated training needs.
Study management
The WP 2 team was led by co-investigator (KW). Two experienced research associates (LR and ED)
were employed to organise, conduct and analyse interviews and focus groups. The SMG was
responsible for overseeing day-to-day management of the entire GASTRIC feasibility study, including
the WP 2 qualitative work.
Design and development of the protocol
The design and development of the protocol, including sample estimation, recruitment strategy,
information sheets [see project web page: www.journalslibrary.nihr.ac.uk/programmes/hta/169402/
#/documentation (accessed 13 February 2020)] and interview topic guide [see project web page:
www.journalslibrary.nihr.ac.uk/programmes/hta/169402/#/documentation (accessed 13 February 2020)],
were informed by previous research.7–11 A review of previous studies of GRV in different populations
was conducted prior to this study to develop a list of outcomes to inform outcome-related discussions
with parents during interviews. A voting system, using TurningPoint software (Turning Technologies,
Youngstown, OH, USA), was used alongside verbally administered questions in practitioner focus groups.
This involved some of the key questions [see project web page: www.journalslibrary.nihr.ac.uk/programmes/
hta/169402/#/documentation (accessed 13 February 2020)] being presented to the group and each
participant using a wireless handset to select their answer from those shown on the screen. This method
enabled the collection of data from all participants, as well as a means of generating statistical data from
all sites alongside qualitative data from group discussions. The same quantitative questions were verbally
administered during HCP telephone interviews and recorded by the researcher using a questionnaire
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[see project web page: www.journalslibrary.nihr.ac.uk/programmes/hta/169402/#/documentation
(accessed 13 February 2020)], allowing for collation of interview and focus group data.
Recruitment
Participants
Based on our team’s previous relevant studies,7–10 it was anticipated that 20–30 parents (10–15 in each
setting) would be recruited to reach data saturation point. This is when the major themes identified in
new data are recurring from previous participants or transcripts and no new major themes are being
discovered in analysis.12,13 We aimed to hold between two and four focus groups for HCPs [e.g. two
focus groups (one NNU, one PICU) in the north of England and two focus groups (one NNU, one PICU)
in the south of England]. It was expected that each focus group would involve 8–12 practitioners.14 We
anticipated conducting up to 10 telephone interviews with HCPs unable to attend the focus groups.
Eligibility criteria
Inclusion criteria
Parents of children with experience of tube feeding in NNU and/or PICU in the last 3 years and HCPs
with involvement in decisions about feeding (nurses, doctors or dietitians) currently working in NNUs
and PICUs in the UK were included.
Exclusion criteria
Parents who were unable to speak English and HCPs not working in the specialty were excluded.
Recruitment and sampling procedure
Parents
We recruited parents through three routes to maximise the potential sample in the recruitment period
and to encourage sample diversity.
Recruitment route 1: social media or website advertising
An advertisement was posted on Twitter (URL: www.twitter.com; Twitter, Inc., San Francisco, CA, USA)
and Facebook (URL: www.facebook.com; Facebook, Inc., Menlo Park, CA, USA), which invited parents
to register interest in participating in the study. Relevant charities and support groups were asked to
place an advertisement on their website and social media [e.g. Bliss (URL: www.bliss.org.uk), Sepsis
Trust (URL: https://sepsistrust.org), hospital charities, GASTRIC study (URL: www.grvstudy.com) and
Mumsnet (URL: www.mumsnet.com)]. In addition, the study team posted the media advert in relevant
university internal newsletters.
Recruitment route 2: national contacts and existing database
E-mails were sent from the study team to their professional national contacts. In addition, e-mail
invitations were sent to eligible parents from the FEVER feasibility study7 who had given consent to be
contacted about related studies.
Recruitment route 3: national newspaper
To assist recruitment and sample variance, we placed an advertisement in the London Metro
newspaper. This helped to balance the predominantly northern sample that was available at that point
in recruitment (September 2018).
Health-care professionals
Focus groups were held in different geographical locations (north, north-west and south) to encourage
the involvement of HCPs from across the country. We purposively targeted individuals, to include those
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unable to attend a focus group and include all key professional groups (e.g. doctors, nurses, dietitians and
surgeons). We recruited through e-mail invitations and networks known to the co-applicants of the study,
including the PICS and British Dietetic Association. HCPs were invited to participate in a telephone
interview and if no response was made to the researcher, they were not contacted again.
Screening and conduct of interviews and focus groups
Parent interviews
Screening
Parents’ expressions of interest to participate were responded to in sequential order. Once eligibility
was confirmed, an interview date and time was scheduled. A participant information sheet (PIS),
a draft GASTRIC randomised controlled trial (RCT) PIS [see project web page: www.journalslibrary.nihr.
ac.uk/programmes/hta/169402/#/documentation (accessed 13 February 2020)] and list of potential
outcomes (see Appendix 3) were e-mailed to parents to read prior to interview. Screening and interview
conduct stopped when data saturation and sample variation (e.g. recruitment of parents via multiple
recruitment routes) was achieved.
Informed consent
Audio-recorded verbal consent was sought over the telephone before the interview. This involved
reading each aspect of the consent form to parents, including consent for audio-recording and to
receive a copy of the findings when the study was complete.
Conduct of parent interviews
Interviews began with a discussion about the aims of the study, and included an opportunity for
questions and checking that the parent had had enough time to read the information sheet and list of
potential outcomes. Interviews commenced using the interview topic guide to explore:
l experience of having a child with a feeding tube in a NNU or a PICU
l any previous experience of participation in clinical trials
l the length and content of the draft GASTRIC study PIS
l the acceptability of measuring GRV
l the acceptability of not measuring GRV
l potential barriers to participation in the trial and how these could be addressed
l potential facilitators of trial participation
l trial design, including the selection of outcome measures and randomisation method
l whether or not parents would (hypothetically) consent to their child taking part in the proposed
GASTRIC study.
Respondent validation14 was used to add unanticipated topics to the topic guide as interviewing and
analysis progressed. After the interview, participants were sent a copy of the consent form and a thank
you letter, including a £30 Amazon voucher (Amazon.com, Inc., Bellevue, WA, USA), to thank them
for their time. A copy of the consent form was retained by the University of Liverpool. Researchers
(LR and ED) conducted a similar number of parent interviews.
Health-care professional focus groups and interviews
Informed consent
At the start of the focus group or interview the researcher checked that all participants had read
the PIS. The focus group or interview aims and topics to be covered were discussed, followed by an
opportunity for questions. Participants were asked to provide written consent before the focus group
began. Using the same procedure as the parent interviews, audio-recorded verbal consent was sought
over the telephone before the HCP interviews.
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Conduct of health-care professional focus groups and interviews
Three researchers were involved in the focus group facilitation (LR, n = 3; KW, n = 1; ED, n = 2) and
two researchers were involved in conducting interviews (LR, n = 8; ED, n = 2). An ‘ice breaker’ question
was used at the beginning of the focus group to help demonstrate how the voting system would work
alongside verbally administered questions. Staff were then asked to introduce themselves, their role
within the ICU and their experience of recruiting to clinical trials.
Focus group and interviews explored site HCPs’ views and experiences on:
l the current approach to GRV measurement
l the acceptability of measuring GRV
l the acceptability of not measuring GRV
l potential barriers to the trial and how these could be addressed
l potential facilitators of trial participation
l trial design, including randomisation method, inclusion and exclusion criteria
l perceived training needs
l the acceptability of the proposed GASTRIC study.
Transcription
Digital audio-recordings were transcribed verbatim by a professional transcription company
(Voicescript Ltd., Bristol, UK) in accordance with the Data Protection Act 1998.15 Transcripts were
anonymised and checked for accuracy. All identifiable information (e.g. names of patients, family
members or the hospital where their child was admitted) was removed.
Data analysis
Quantitative data from the practitioner-closed interview and focus group questions were entered into
Statistical Product and Service Solutions (SPSS) version 20.0 (IBM Corporation, Armonk, NY, USA)
and examined using descriptive statistics. Qualitative interview and focus group data analysis was
interpretive and iterative.16,17 Utilising a thematic analysis approach18 (Table 7), the aim was to provide
an accurate representation of views on trial design and acceptability. Thematic analysis is a method for
TABLE 7 Approach to qualitative data analysis
Phase Description
1. Familiarising with data ED (parents) and LR (practitioners) read and reread transcripts noting down initial ideas
2. Generating initial codes Initially, two data coding frameworks were developed using a priori codes identified from
the project proposal and the interview topic guide. During the familiarisation stage, LR and
ED identified additional data-driven codes and concepts not previously captured in the
initial coding frame
3. Developing the coding
framework
10% of the transcripts were double coded. LR, ED and KW all reviewed and discussed both
initial coding frames (practitioner and parent), making notes on any new themes identified
and how the framework could be refined
4. Defining and naming
themes
Following review and reconciliation by ED, LR and KW, revised coding frames were
subsequently developed and ordered into themes (nodes) within the NVivo database
5. Completing coding of
transcripts
LR and ED completed coding of all transcripts in preparation for further analysis
6. Producing the report ED, LR and KW developed the manuscript using themes that related back to the study
aims to ensure key findings and recommendations were relevant to the GASRTIC study.
Final discussion and development of selected themes occurred during the write-up phase
7. Participant validation During PPI webinars and consensus meetings, findings were presented back to parents and
practitioners who then had a chance to discuss, validate or disagree with the presented results
PPI, patient and public involvement.
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identifying, analysing and reporting patterns (or themes) within data. Analysis was informed by the
work of Braun and Clarke2 and their guide to thematic analysis. This approach allows for themes to be
identified at a semantic level (i.e. surface meanings or summaries) or at a latent level (i.e. interpretive,
theorising the significance of the patterns and their broader meanings and implications).19 NVivo 10
software (QSR International, Warrington, UK) was used to assist in the organisation and coding of data.
The researchers (ED and LR) led the analysis and 10% of the analysis was second coded by the
qualitative lead (KW).
Outcomes analysis
To rank parents’ prioritised outcome measures, we conducted an additional analysis step involving
content analysis.20 Outcomes identified during the thematic analysis were cross-referenced by participant
and by question and entered into an Excel® version 1908 (Microsoft Corporation, Redmond,WA, USA)
database. The number of times each outcome was prioritised was then counted. A weighted point-based
system was used to combine findings from all outcome questions and determine the top prioritised
outcomes by group. For example, each time an outcome was ranked first it received 6 points, if it was
ranked second it received 5 points and if it was mentioned as an important outcome but subsequently not
included in the ranked list it received 1 point.
Results
Participants: parents
A total of 55 parents registered interest (Figure 3), of whom 41 were screened. Five parents were
deemed ineligible and five parents did not respond to contact. Two PICU parents were interviewed,
but not included in the sample because of recording equipment failure and seven parents were not
interviewed as data saturation had been reached. Our sample of 31 parents included 17 parents with
experience of NNUs and 14 parents with experience of PICUs. Interviews took place between May
and November 2018.
1. Social media
• Response, n = 38
• Screened, n = 26/38 (68%)
• Eligible, n = 22/26 (85%)
• Consented, n = 21/22 (91%)
• NNU, n = 12/21 (57%)
• PICU, n = 9/21 (42%)
Parent recruitment to WP 2
• Took part in an interview, n = 33
• Interview data collected, n = 31
• Mothers, n = 22/31 (71%)
• Fathers, n = 9/31 (29%)
• NNU, n = 17/31 (55%)
• PICU, n = 14/31 (45%)
2. National contacts 
• Response, n = 3
• Screened, n = 3
• Eligible, n = 3/3 (100%)
• Consented, n = 3/3 (100%)
• PICU, n = 3 (100%) 
• NNU, n = 0/3 (0%)
3. National newspaper
• Response, n = 0
Word of mouth
• Response, n = 14
• Screened, n = 12/14 (86%)
• Eligible, n = 11/12 (92%)
• Consented, n = 10/11 (91%)
• NNU, n = 5/10 (50%)
• PICU, n = 5/10 (50%)
FIGURE 3 Parent recruitment to WP 2.
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Most participants were recruited through social media (19/31, 61%) and despite advertising nationally,
a large proportion of expressions of interest came from the North West. This geographical clustering
was reinforced by the WP 2 team’s location in Liverpool and the second most effective recruitment
method was word of mouth (9/31, 29%). Although not originally planned as a recruitment route,
several parents expressed an interest in taking part in the study after hearing about it from friends,
family and other participants. The newspaper advert did not yield any response.
Parent characteristics
The sample included 22 mothers (n = 12, NNU; n = 10, PICU; n = 4, bereaved) and nine fathers (n = 5,
NNU; n = 4, PICU; n = 1, bereaved). Most parents lived in the north-west of England (23/31, 74%) and
the remainder were from across England (Yorkshire and the Humber, n = 3; South East, n = 2; South
West, n = 1; North East, n = 1) and Scotland (n = 1, 3%). The majority (26/31, 84%) of parents did
not have medical backgrounds or related occupations. The five parents with health-care-related
occupations had roles that included ambulance dispatcher, health-care assistant, physiotherapist,
paediatric research nurse and a speech and language specialist.
Neonatal unit parent interviews (n = 17) related to 19 children. Three mothers had twins who were
both admitted to NNU and one set of parents were interviewed separately regarding the same child
(Table 8). PICU parent interviews (n = 14) related to 10 children, with four sets of parents interviewed
separately regarding the same child (see Table 8). Six out of 10 children had also been admitted to
NNU at birth and five children had had multiple PICU admissions.
Collectively, parents had experience of ICU and tube feeding spanning 21 hospitals. This experience
varied from hospital admissions due to short-term acute health conditions to chronic conditions, when
children had been placed on feeding tubes at birth and were still on them at hospital discharge (see
Table 8). Although ventilation was not a separate inclusion criterion, most of the sample (28/31, 90%)
had experience of their child being ventilated. Sixteen parents (50%) had experience of their child
being approached to take part in a clinical trial (NNU n = 10, PICU n = 6). Telephone interviews took
place, on average, 11 months (range 0.8–37 months) from admission to hospital and took a mean of
68 [standard deviation (SD) 12.7] minutes.
TABLE 8 Child characteristics and NNU and PICU admission information based on parent interviews
Characteristic NNU PICU
Child age at hospital
admission (or birth)
Median 29 gestational weeks at birth
(range 24–41 weeks)
Median 8 months (range 3 weeks to 12 years)
Days in unit Median 21 (range 1–140, missing n= 1) Median 8 (range 2–72)
Days in hospital Median 57 (range 7–152) Median 39 (range 3–196)
Days on feeding tube Median 58 (range 2–210) Median 127.5 (range 5–547)
Days on breathing support Median 56 (range 0–370) Median 6 (range 0–168)
Main reason for
admittance
Prematurity (n= 18)
Meconium aspiration syndrome (n= 1)
Heart conditions (e.g. congenital heart defect,
hypoplastic left heart syndrome) (n= 4)
Sepsis (n = 2)
Reconstruction of airway (n = 1)
Complications linked to chronic conditions
(e.g. holoprosencephaly, Noonan syndrome,
prematurity) (n= 3)
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Participants: health-care professionals
Five focus groups were conducted at three UK hospitals: two in NNUs and three in PICUs. Forty-two
HCPs (NNU, n = 16; PICU, n = 26) participated in one of the five focus groups. As most focus group
participants were nursing staff, we purposively contacted doctors (n = 10), surgeons (n = 3) and
dietitians (n = 5) and invited them to take part in a telephone interview. Five additional dietitians
expressed interest in being interviewed after receiving study information through their professional
networks. Of those we directly targeted, 12 out of 21 (57%) did not respond. A total of nine interviews
were conducted. Ten hospitals from across England and Wales were represented in the combined
interview and focus group sample. Focus groups and interviews were conducted between May 2018
and November 2018.
Health-care professional characteristics
Sixty-two per cent (26/42) of focus group participants were nurses. The remainder were research
nurses (5/42, 12%), senior doctors (3/42, 7%) and dietitians (2/42, 5%). Six participants (6/42, 14%)
categorised themselves as ‘other’. Three were student nurses and three did not specify. The interview
sample included three consultant doctors (NNU, n = 2; PICU, n = 1), four dietitians (NNU, n = 1; PICU,
n = 3) and two consultant surgeons (both worked with NNU and PICU patients).
The majority (45/51, 88%) of HCPs were involved in the direct clinical care of children and/or had
experience of conducting paediatric clinical trials (39/51, 76%). Focus groups took, on average,
55 minutes (range 49–68 minutes) and telephone interviews took, on average, 32 minutes (range
26–45 minutes).
Parent perspectives
Prior to interviews, parents were sent copies of the draft PIS for a future RCT and a list of potential
outcome measures to read. At the start of each interview, parents were asked questions about their
experiences of their child’s hospital admission and tube feeding. The interview then moved on to
discussions about the proposed GASTRIC RCT.
Views on feeding
Parents’ views around GRV measurement and the perceived acceptability of a future GASTRIC trial
was intrinsically linked to their views on the importance of feeding in the ICU. The extent to which
parents viewed feeding as a priority appeared to be influenced by their child’s prognosis and
associated comorbidities or complications. For example, parents of children who experienced an
imminently life-threatening condition, such as sepsis, had not considered feeding to be a priority
in the ICU:
Bottom of the pile, yes, you know, the fact is they needed to – well initially we needed to try and get
these feet not being black, erm, erm . . . Well initially obviously they were trying to keep her alive, erm,
but, but, but the next thing was trying to get these feet, erm, to not be black as I, as, so I’ve said and, and
make sure, you know, things like peeing for England, make sure everything was working as it should, and
that the, the, the sepsis had gone.
P24, mother, PICU
Once the immediate threat to life had been addressed, parents described how feeding increased in
importance, as it was a sign that their child was getting better:
But obviously the main concern at that point was getting her better and then, when we went into HDU
[high dependency unit], I was like more worried about like her weight and her getting back to normal.
P21, mother, PICU
By contrast, parents of children with a long-lasting condition, such as prematurity, viewed feeding as
very important from the onset of their experience. Weight gain and calorie consumption were seen to
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have a direct causal relationship with short- and longer-term outcomes. These included reduced length
of time on breathing support, time in the PICU or NNU, number of infections, improved kidney
function, ability to undertake and survive medical procedures, reduced chance of NEC, and overall
health and development:
With our two being premature and being quite small, um, we knew that gaining weight was central to
them going home and we also knew that the greater their weight, the less risk there was of an infection
or something having a serious impact upon them. We knew that once they got up to full feeds the
incidences of NEC reduced greatly as well.
P05, father, NNU
So they just wanted to make sure that she was having enough calories intake in her so that she could
thrive basically and, um, she’d get bigger and stronger and, you know, hopefully the, the heart
would stabilise.
P27, mother, PICU and NNU
Feeding was particularly pertinent to NNU and PICU parents whose children had experienced
difficulties with feeding (e.g. reflux, vomiting, unsafe swallow, aspiration and oral aversion), weight gain
or problems related to the child’s bowels (e.g. suspected NEC, bowel loops, bowel perforations, stoma)
and breathing. Both NNU and PICU parents also described concerns about their children being force
fed or overfed, leading to discomfort, vomiting, aspiration and oral aversion:
He always used to scream after his feeds, and, um, I said, it just feels like I’m force-feeding him; I actually
said that to her, I said I feel like, you know, he’s like foie gras or something . . . he’s obviously in pain.
P02, mother, NNU
Yeah, it was a big, big issue, um, for me, because of him being sick. I felt like I was force feeding my child,
um, to the point of him being sick and because of the pressure put upon us, um, by kind of the dietitians
obviously to get certain amounts . . . of food needed, he needed to be getting his calories, especially as he
had more surgery. It was really difficult for me.
P18, mother, PICU and NNU
In addition to being viewed as medically important, feeding of young children was something that
parents, particularly mothers, felt was a key part of their parental role and responsibilities:
I think as a mother, it just feels like my primary role in a way, I was supposed to provide milk and ensure
he grew.
P19, mother, PICU
During interviews, parents often described how feeding was also one of the few areas of their child’s
care that they felt they could be actively involved in within the ICU:
. . . cause everything’s done for your baby other than like you can change a nappy. A lot of the practical
care you can’t do, which is . . . it’s quite powerless, isn’t it, so it’s nice to be able to have like some
hands-on time so yeah, it was really good.
P16, father, NNU
Children of parents in our NNU sample had a higher proportion of long-lasting illnesses and associated
comorbidities than children of parents in the PICU sample. Consequently, it follows that feeding was
more of a priority for NNU parents than for PICU parents. However, this prioritisation was formed
on experiential knowledge of the importance of feeding gained during their hospital stay. In the first
few days of NNU (which would be the point at which children would be eligible for inclusion in the
proposed GASTRIC trial), parents would not have such experience. As the following quote illustrates,
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parents were initially unaware of how difficult, yet important, establishing feeds was at the beginning
of their NNU stay and would still be in what feels like an acute situation:
I remember them saying, oh, they’ve coped really well with the last feed, and you think, coped really well? How
hard is eating? And they don’t explain to you that it can have a huge a huge impact on their, on their kidneys
and everything, because if they’re so premature, then their insides are immature as well, and so they might not
even be able to filter through the nutrients, and you’re just left there with your mouth open going, what?
P11, mother, NNU
By comparison, over half of the PICU parents had past NNU experience and would therefore have
already developed views on feeding in the early phase of their PICU stay.
Views on gastric residual volume measurement
Twenty-one parents recalled their child’s GRV being measured (NNU, n = 15; PICU, n = 6). Eight
reported watching stomach contents being checked for pH and tube placement, but not GRV
measurement (NNU, n = 3; PICU, n = 5). Three PICU parents stated that they were certain that GRV
measurement had not taken place during the period in which their child was receiving tube feeding in
NNU, PICU or at home. Those who did recall GRV being measured had varying understanding of its
utility. Some were aware of GRV measurement, but had no understanding of its purpose, risks or
benefits, as clinicians had not explained the procedure:
I mean obviously when the procedure was done whilst we were in the NNU, no one really explained why
they were doing it, you know, what the benefits were or, um, I suppose what the negatives were for not
doing it. I don’t think anyone ever discussed it, it was just a procedure that, er, was carried out.
P07, mother, NNU
Most parents had a basic understanding of its function, which they described as to see if their child’s
bowels were working, to check milk tolerance, to guide food volumes or to help detect infections.
Some had developed medicalised knowledge of the process and in some cases had performed GRV
measurement themselves:
I remember a nurse explaining that they were doing it to see how much milk had been digested and that
if all of the milk had been digested it was a good sign that they’re, um, bowels were working normally.
P05, father, NNU
They were, erm, sort of like take it out, erm, and then write it into the computer, erm, and they work it
out but if there was so much, if there was too much left then they wouldn’t do the next one as much.
P21, mother, PICU
Some parents noted that GRV process differed between and within hospitals, in terms of frequency
and execution. Such differences led parents to comment on how GRV measurement was not a
‘scientific’ (P30, mother, bereaved, PICU and NNU) or consistent process:
I would say it differs quite considerably between hospital to hospital, what the actual practice is. So in
[hospital 1] they check the pH of the aspirates. So they take a little aspirate every feed and check the pH,
um, to make sure that actually the tube is still located in the stomach, um, and they will check the, um,
GRV every 4 hours. So if feeding hourly then they’d check it every fourth feed, then when it goes to two
hourly feeds you check it every other feed. So you’re checking the full, um, volume in the stomach at that
point. In [hospital 2] it’s completely the opposite. They rarely check the pH of the aspirate and I would say
they never check the volume of the fluids in the stomach at all. And in [hospital 3] it is kind of a bit hit
and miss. So they would check the pH at every feed, but they only check the volume probably twice a
day, yeah, regardless of what kind of, yeah, feeding regime they’re on.
P13, father, NNU
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Although GRV measurement was holistically viewed as being a low-risk standard practice, performed
for the benefit of the child, some parents also perceived it to be invasive and felt that it had caused
vomiting and discomfort:
I don’t see it as being high, high risk. but, um, my husband was quite, um, he was sort of quite worried
them actually taking and, taking the fluid out, pulling it out . . . because when you’re, when you, you see
your, um, your tiny baby in an incubator, hooked up to tubes and then having it, it, it’s quite invasive
when you see, sort of, medical staff going in again, in the incubator when they’re trying to keep them
warm and regulate the temperature. It’s sort of quite sort of daunting, um, whereas I’m quite, I’m quite,
sort of, matter of fact. If it needs to be done, it needs to be done, and let them crack on.
P03, mother, NNU
Perceived acceptability of the proposed GASTRIC randomised controlled trial
Interviews then explored perceived acceptability of the proposed GASTRIC RCT. Overall, parents
supported the trial, with the majority (28/31, 90%) stating that they would hypothetically provide
consent for their child to take part if they were approached about the trial (Figure 4).
While considering trial acceptability and whether or not they would consent, many parents noted that
they would not have pre-existing knowledge or beliefs about tube feeding or GRV measurement at the
point they would be approached about the study:
I wouldn’t have known anything about feeding, so I wouldn’t have known any different.
P19, mother, PICU
Consequently, they would not have been aware it was a change in practice or, indeed, its
consequences:
A lot of the time you wouldn’t know any different, it was all, all very new to me and if you said, we’re
doing a trial where we’re not measuring it and if the nurse said, you know, we can’t see any effect,
it wouldn’t, it wouldn’t bother me.
P15, father, NNU
Building on this situational equipoise, acceptability appeared to be influenced by a belief that the
proposed study question ‘makes perfect sense’ (P23, father, PICU). NNU and PICU parents described
how not measuring GRV might be beneficial because it would reduce potentially unnecessary
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FIGURE 4 Parents’ views on whether or not they would have consented to the proposed GASTRIC RCT.
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interventions that may cause infections, discomfort and pain. Some also described how not measuring
GRV may improve overall health, due to increased calorie consumption:
I just think that extra intervention, if it’s not actually doing anything positive, then is it really necessary?
It’s, you know, it’s, it’s just another issue that can occur, another point of infection, um, and also another
thing that the nurses are having to deal with on top of everything else.
P18, mother, PICU and NNU
It is a huge thing for them, to get the feeding established and get the calories on board, because that
helps them get better faster as well. So, if you can get them better faster, you’re going to cut down,
possibly that they’re blocking a bed as well. You know, like because if they’re getting calories on board
quicker, they’ll start to feel better quicker . . . so it’ll have a knock-on effect in that respect. But again,
you know, like these wee babies, feeding was one of the issues then that would kind of, I think, have an
all-round effect on the overall condition of the, the baby.
P09, mother, NNU
Conversely, measuring GRV was also seen as acceptable, as their child would be receiving normal or
‘standard’ clinical care, because most units in the UK measure GRV:
Well that’s just the way it is. So would they be, would they be told that they’re in a trial and we’re just
carrying on doing what we’re doing anyway?
P20, mother, PICU
Two parents described how no GRV measurement was acceptable and ‘normal’ care because, ‘if I was
in France, this is what would be happening [not measuring GRV] so I wouldn’t, I wouldn’t worry based
on that’ (P17, mother, NNU).
Some parents viewed GRV measurement or no measurement as of little importance, which was
potentially influenced by the low significance associated with feeding during a critical care situation.
These parents highlighted how, at the beginning of their child’s NNU or PICU stay, their child’s acute
condition was the main priority and how a trial involving measuring or not measuring GRV would be
seen as ‘low risk’ and therefore acceptable:
Obviously if they weren’t measuring the contents, it wouldn’t bother me ‘cause that’s what we do at home
anyway. As I say, I don’t think I’d even be thinking about that at that stage. I don’t think I’d be worried
that they weren’t checking it, um, ‘cause I’d be worried about other different, other things. So, um, I think
that would be the last thing on me mind. So no, it wouldn’t bother me.
P27, mother, PICU and NNU
Despite parents describing their support for the study, many also voiced concerns and stated that their
views on trial acceptability and consent decision-making would be influenced by how such concerns
would be addressed. Parents described how they would not have capacity or desire to be approached
about a trial in the early stages of their child being admitted to PICU or NNU. They referred to their
emotional distress, uncertainty and generally being ‘overwhelmed by everything that’s going on’ (P14,
father, NNU) at that point in time. They believed this incapacity would limit their ability to take on
board study information and reach an informed decision. Some stated that being approached in the
first 24 hours after ICU admission could have led to them to decline consent to a trial, which in
different circumstances they would have consented to. Parents stated that any conversations about
research in this early phase, when their child was still critically ill, ‘would have to be very carefully
approached’ (P15, father, NNU). They also reflected on how the nature of the situation would enhance
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their desire to protect their child from any perceived risk, and that any trial or change from standard
care would be viewed as a risk:
The fear of the impact. I think it’s quite different to ask for that consent for your child than it is like if it
was for yourself. I think I’d be more likely to give that consent than I would be for one of my children. Just
because, I don’t know. Same reason why you walk on the side of the pavement where the cars are, isn’t it?
P31, father, PICU
I don’t, I don’t feel that those, sort of, children who are in intensive care, I think they should be left alone,
you know, because there’s some babies that are being fed by tubes that are absolutely tiny, really, sort of,
you know, ill.
P03, mother, NNU
Some parents had described a preference for the ‘standard’ care arm:
Kind of trusting in older practices if that makes sense, especially in that kind of situation, kind of do what
you’ve always done to make my child better type, er, feeling towards it.
P30, mother, bereaved, PICU and NNU
However, parents’ consideration of risk appeared to be influenced by the draft trial information provided
to parents, which outlined potential risks of GRV measurement (standard care). The PIS raised questions
and concerns about a practice that would not otherwise have been brought to their attention. Parents
felt that this may result in the need for practitioners to fully explain and be prepared to answer questions
on the motivation for both measuring GRV and not measuring GRV:
. . . ’cause it sounds really odd, doesn’t it, sucking up the contents of the stomach. I think it probably
would, probably would have drawn more attention to something they do that’s standard practice; I might
have been quite, a bit disturbed about that thought, and, and . . . questioned around whether it hurts and
so on.
P19, mother, PICU
I suppose in, in general I’m all for, um, no intervention where it’s not necessary and so I think then
learning that there was a study, exploring whether, um, we actually needed to measure in the way that it’s
being done and she was being measured in the traditional way but there was now some question marks
potentially about it because I was made aware of this study. Um, then that, that might make me ask a
few extra questions.
P12, mother, NNU
This information was particularly important to PICU parents whose child had been on a feeding tube
before admission and who had no previous experience of GRV. From their perspective, GRV
measurement was not standard practice, but an additional, invasive and unnecessary procedure:
I would be kind of saying why? He’s never had this done before. This is not something I really want him to
have done just for the sake of doing. It’s not necessary . . . But I possibly would say no unless there was
some specific benefit to him [from GRV measurement] . . . I’m always kind of aware of not creating an
aversion, not doing any more poking and prodding than is strictly necessary because he has plenty
already. So I guess I’m probably just weighing it up on, yeah, was it gonna ’cause him any more, sort of
any unnecessary discomfort, which I would avoid. Um, but in the main, I would be wanting to take part,
I think.
P26, mother, PICU and NNU
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Although situational incapacity, risk aversion and concerns about the impact of study participants may
be applicable to most trials conducted in an ICU, there were three main trial-specific factors that
concerned parents about the proposed GASTRIC trial. First, NNU parents were concerned about the
risk of delayed diagnosis of bowel or stomach problems, or missing signs of an infection. Second, NNU
and PICU parents worried about the risk of vomiting into lungs, which, as well as being potentially
distressing for the child, may cause chest infections and breathing difficulties. Third, both groups of
parents focused on the risk of increased pain or discomfort:
I think you’d just be concerned that, like, infections would go unnoticed or that their tube wasn’t in the
baby’s stomach and it could be pumping milk in somewhere else.
P01, mother, NNU
Interestingly, parent accounts suggested that both measuring and not measuring GRV may lead to
vomiting. Returning stomach contents may cause a child to vomit, ‘9 times out of 10 if they shot it
back in, she was sick’ (P15, NNU, father), whereas not measuring GRV may result in overfeeding and
vomiting. Similarly, not measuring GRV is believed to cause discomfort or pain if the child cannot
be winded, the tube placement is incorrect or increased vomiting, whereas measuring GRV may cause
discomfort and pain. In addition, NNU parents were particularly concerned about the risk of NEC not
being detected because of not measuring GRV. This information was provided in the information sheet:
From nurses in passing that they’d mention NEC it, it seemed to be, you know, it was quite like, you know,
a really, oh god, you don’t want your baby getting NEC and stuff like that, so that spread quite quickly I
think, you know, amongst other parents. It was like, oh god NEC, you know, and stuff like that and it was
something that god forbid that, that your child would get. So I think, if I was getting this, my question
would be, if I hadn’t heard already within those 48 hours, what is NEC and how serious is it?
P14, father, NNU
However, as the previous quote from a father (P14, NNU) helps to illustrate, parents may not be aware
of what NEC is at the time of their child’s hospital admission, as this knowledge is often gained from
discussions with clinical staff during their child’s hospital stay. Therefore, a concern in retrospect may
not influence parents’ views on trial acceptably at the point of consent discussions.
The three PICU parents who were unsure whether or not they would provide consent stated that
there was not enough information about the possible benefits of each trial arm for them to predict
whether or not they would consent. They described how if additional verbal information, such as the
potential benefits of participation, was provided by a trial recruiter then they would potentially
consent. However, based on the details provided in the draft PIS alone, they were uncertain about
their consent decision:
I don’t think there’s anything you can put in your leaflet in that, in that moment that would have made
me sign up to something that effectively felt like a trial or something that is deviating from current
practice. Maybe if the doctor had said, had talked through a potential, potential benefit, in terms of the
actual ability to get better or fight the infection. If that, if that was, if they were saying, you know, if your
child’s taking in those calories he’s going to better fight the infection whatever it is, then maybe I’d have
felt differently but the strength of the wording on that doesn’t, doesn’t sort of lead to a conclusion that
would have sold it to me at the time, I don’t think.
P31, father, PICU
I think it depends how it, hmm, how it’s explained. There are the other questions I want to know. Sorry,
it’s hard to say.
P19, mother, PICU
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The proposed GASTRIC randomised controlled trial participant information sheet and
consent discussion
Overall, NNU and PICU parents considered the draft PIS [see project web page: www.journalslibrary.
nihr.ac.uk/programmes/hta/169402/#/documentation (accessed 13 February 2020)] to be ‘very clear’
(P23, father, PICU), ‘very straightforward’ (P01, mother, NNU) and written in a way that would be
comprehensible to someone with no pre-existing medical knowledge:
No, I think it’s quite self-explanatory to someone that, doesn’t really know anything. I think it was quite,
I think the, the wording and everything, um, was fine. I think, you know, parents would be able to
understand what it’s actually about.
P09, mother, NNU
Parents identified parts of the PIS that would benefit from clarification or change (Box 1). Both NNU
and PICU parents highlighted the need for additional information regarding potential benefits of not
measuring GRV and the adjustment to the wording of potential risks. The majority of NNU parents also
reflected that they would require more information around NEC before they could make an informed
decision about consenting to the trial.
BOX 1 Example suggestions for the improvement of the proposed GASTRIC PIS
NNU and PICU PIS
Additional information, suggested examples:
l the function of GRV
l tubes/interventions increasing the likelihood of hospital-related infections
l reducing procedure-related vomiting and discomfort
l impact of growth on organ functioning
l impact of calorie intake on overall health
l time frame of the study.
Wording of the potential risk section, for example currently it makes the same point twice.
Clarify the difference between GRV, aspirate, tube placement and pH testing.
Discuss other types of monitoring that will be conducted.
Segment larger paragraphs and adjust sentence structures to help clarify content.
Include a glossary of terms (e.g. NG).
NNU PIS only
NEC:
l What is the risk of their child getting NEC?
l How effective is GRV at detecting NEC?
l If NEC is not detected by GRV, how else would you know?
Possible benefits:
l Impact of growth on organ functioning and overall health.
NG, nasogastric (tube).
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Given the emotive situation in which the PIS would be read, many suggested that the draft PIS was too
long. That although ‘I understand obviously you need to get all the information across’ (P30, mother,
bereaved, PICU and NNU), parents would be unlikely to process all the information, possibly resulting
in them either making an uninformed decision or refusing consent owing to situational incapacity.
Therefore, they suggested that all the key information should be summarised on the first page. Parents
felt that this format would provide them with essential information needed at the time of the consent
discussion, with the option to read the rest of the information later. Essential information was perceived
to comprise the purpose of the study, risks and benefits. Therefore, the PISs were amended in response
to parental feedback [see project web page: www.journalslibrary.nihr.ac.uk/programmes/hta/169402/#/
documentation (accessed 13 February 2020)].
When reviewing the PIS, many parents noted that the way they were approached about the trial would
probably have more of an impact on their consent decision than written information:
So I just think it’s quite important how you’re approached. Um, and I definitely think, um, information
sheets are great but actually being able to ask questions is probably quite important.
P29, mother, bereaved, PICU and NNU
There was disparity in views on when an appropriate time would be to approach parents about the
trial; suggestions ranged from 12 to 48 hours from the time of their child’s PICU admission. Views on
how long would be needed to make a consent decision ranged from 5 minutes to 24 hours. Parents
emphasised the importance of personal and situational factors in facilitating the consent discussions.
These included whether or not their child was stable, they were calm, both parents were present,
the researcher was caring, supportive and knowledgeable about the trial, and whether the research
was already known to them or introduced by a member of the clinical team:
This is it, who’s connected to the trial and the reasons why they’re doing it as well, I mean, that’s hugely
beneficial. If someone just comes at you with a form and says, read that, can you sign it and agree to
this? That wouldn’t work at all, you need a personal front.
P11, mother, NNU
Some parents questioned if it would be possible to obtain consent prior to being in the NNU, if the
admission was planned, for example before a caesarean section or surgery:
For our situation and because there is the time beforehand to be able to look at it, consider it and process
it, rather than try and make a decision when you’re in a bit of a crisis really . . . be given it at sort of, with
the information pack about having a caesarean.
P06, father, NNU
Views on the use of cluster randomisation in a GASTRIC randomised controlled trial
A description of individual and cluster approaches to randomisation was read to participants (Box 2).
They were then asked to reflect on how they think they would feel if they were informed that the unit
their child was in was taking part in the GASTRIC trial and all babies or children were or were not
having any routine GRV measurement.
Overall, parents stated that they would find their child’s involvement in a cluster randomised trial
exploring GRV or no GRV measurement acceptable. The main reason provided was that they were
happy with both proposed trial arms, as discussed previously. Additionally, parents cited the trust
that they have in medical staff expertise to make decisions regarding the care of their child, often
concluding that if NNU or PICU HCPs were happy to be part of the trial and not measure GRV,
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then parents would be satisfied that not measuring GRV as part of a cluster design was acceptable, low
risk and therefore perceived to be safe for their child:
The medical staff, they’ve decided that this is something that needs to be done within the unit and they
have made that decision. So they obviously think that it is a low risk, you know, to the babies, otherwise
they wouldn’t be doing it.
P09, mother, NNU
Parents’ views on consent in a GASTRIC cluster trial design
Current guidance recommends that informed consent is sought for cluster RCTs when practically
possible, yet makes provision for research without prior consent in trials that are deemed to be no
more than minimal risk to participants.21–24 We therefore explored parents’ views on approaches to
consent if the proposed GASTRIC RCT used a cluster design.
Interview discussions around trial design indicated that parents’ views of the acceptability of a cluster
trial design were influenced by the proposed approaches to consent. Parents had mixed views about their
child participating in a GASTRIC cluster trial and/or their data being collected without their explicit prior
consent. Most parents stated that they do not think it would be necessary to formally give consent for
their child’s involvement in the proposed cluster trial, but they do feel that a conversation needs to take
place between parents and an informed medical professional about the trial:
Just, yeah, just to be informed, and I think that as, as a parent, whenever you’re on the unit, that’s all that
you want, is information. So, so even about a study, you know, when somebody coming up saying, oh, by
the way, we’re doing this, um, you know, this is what’s happening on the unit, this is the care that [child’s
name] receiving, it’s gonna help us with this study, are you happy with that?
P28, father, bereaved, PICU and NNU
Others described how they ‘would be OK with it [not giving consent], um, as long as I knew that my
child’s identity was protected’ (P18, mother, PICU and NNU). Parents described how they trust staff to
make the decision about their child’s participation, and as GRV measurement is part of usual clinical
BOX 2 Description of randomisation methods read to participants during interview
The information sheet we sent to you describes how each baby/child will be allocated at random to receive
either usual care (regular measurement of GRV every X hours) or no routine GRV measurement. This is
called individual randomisation. What happens is, when a child is identified as eligible to take part in the
study a doctor will log on to a computer system, or open an envelope, which will state which group that
child will take part in. This is completely random, so if the study involved 100 children, the system would
randomly allocate 50 children to the GRV group and 50 to the No GRV group. This is how most clinical
trials randomise patients as it gives a fair test between the two treatments.
Another method is called cluster randomisation, this is when all patients in one grouping (e.g. a whole
PICU) would receive the same treatment. So for the GASTRIC trial, this could mean that children in one
ICU (e.g. Liverpool) all have GRV measurement and all children in another unit (e.g. Manchester) do not
have GRV measurement. We would then compare the study findings between whole units rather than by
individual child. As everyone in a unit will be receiving the same GRV approach, informed consent would
not be sought, instead there would be posters about the study on walls and a doctor or nurse may speak to
parents about the study at some point. You would have the option to ‘opt out’ or withdraw your child’s
information from the study from that point forward.
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care and therefore not something they would normally be asked to provide explicit consent for, ‘it’s
sort of happening anyway isn’t it?’ (P21, mother, PICU):
There’s that many procedures involved in every single bit, you know, and, you know, even from, I dunno,
taking their temperature to, you know, the administration of drugs and things, that I’m guessing that it’s
mainly done on a national basis, isn’t it, every single procedure? Um, I dunno, I mean, I’m not sure how
much you, you’d want to . . . actually need to know a-, you know, ‘cause would you have to, to know about
every single procedure, about what, what’s happening to your child? See what I mean? You know . . .
P22, father, PICU
One father (P31, PICU) stated that, in general, acceptability of his child’s trial participation without
prior consent would depend on whether or not his child had a positive outcome:
I guess if you take the stress out of the situation then, and you look at it logically then, you know, I
wouldn’t, about 2 weeks later if he was absolutely fine, I wouldn’t begrudge you having done it that way.
But if he’d died, that’d be another thing on your mind, thinking, well did that have an impact on it? And
we never got a choice in that.
P31, father, PICU
Others felt that, owing to potential concerns about this trial, such as those described previously, they
would want to make an informed decision about their child’s involvement. Some parents described
how they would query whether or not the trial was appropriate, as their child was very small and
vulnerable:
Just, yeah, like from a, from my sort of controlling me, I can imagine it . . . yeah, whether I would sort of
go oh why, why was I not told about this, you know, should I not have been told on day one and then I
could have decided whether I wanted to be part of that study or not.
P29, mother, bereaved, PICU and NNU
If somebody said to me oh well we’re treating these children, we’re treating all the children like this in the
hospital at the moment, I’d just think oh, but my child’s different, you know. Mine’s only tiny, you know.
P20, mother, PICU
Preferred randomisation method
After discussing the different randomisation approaches, participants were asked ‘which type of
randomisation do you think we should use in the GASTRIC study?’ (Figure 5). Twenty-four parents
thought that the GASTRIC trial should use a cluster randomisation approach (PICU, n = 9; NNU,
n = 15), six preferred individual (PICU, n = 4; NNU, n = 2) and one did not know (PICU).
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FIGURE 5 Parents’ preferred approach to randomisation.
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Overall, parents were in favour of a cluster approach. This preference was underscored by trust in
medical staff and the perceived acceptability of both study arms. They stated that not seeking full and
informed consent would circumvent the previously discussed issues of situational incapacity, timing
issues and prevent any concerns about children receiving different care:
I can see the benefit of, um, in that sort of traumatic period of, you know, my child’s been admitted to
PICU, not having to make the decision, the decision already being made and everybody else is in the
same boat.
P29, mother, bereaved, PICU and NNU
I think I’d be happier knowing that all the babies in the unit were getting the same care, so there’s
potentially no disadvantage between babies.
P02, mother, NNU
Um, in some ways I think it would be good because you wouldn’t get parents kind of saying, oh my child
doesn’t have that done, and the other one saying mine does. You know, people talk, don’t they? Parents
talk particularly in things like that. And I think it would, kind of from an equity point of view, it would just
be easier to have one unit doing one thing and one unit doing the other. The only thing I’m not sure about
is kind of including people in something without their expressed consent.
P26, mother, PICU and NNU
Nevertheless, parents said that they would still be likely to provide consent if the trial used an
individual randomisation approach, although their decision would be dependent on how and when they
were approached about the trial. Parents who preferred an individual randomisation approach did so
because they wished to provide informed consent owing to concerns about the trial. Parents also
stated that they would also be likely to provide consent if the trial used a cluster approach, if the
motivation for the methodology was explained by a HCP.
Outcomes of importance to parents
Appendix 3 includes the list of outcomes and accompanying descriptive text sent to parents prior to
the interview. In this section of the interview, a definition of an outcome was first read to parents,
including an explanation about why it is important to explore parents’ perspectives about important
outcomes (Box 3).
We then asked parents, ‘Thinking about your experience of your child being admitted to the NNU or
PICU, what would you hope the GASTRIC study (e.g. the approach to feed measurement) would do to
help your child?’.
BOX 3 Description of outcome measures given to parents
As we have discussed, in the GASTRIC study we want to find out whether not measuring stomach contents
(GRV) is better than measuring stomach contents (usual care).
To do this, we will collect information on (read through outcome measures list sent prior to interview).
By collecting information on these main things, we hope to find out which approach (to measure or not
measure GRV) should be used in the future. These are called outcome measures.
However, these outcomes have come from research papers and don’t really give us much information on
how children or families feel, or what is important to them. It is important that we include outcome
measures that matter to children and their families.
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In response to this question, most parents focused on increased weight gain or growth, time on a feeding
tube and, in the case of the NNU patients, ‘reduce the chances of getting NEC’ (P05, father, NNU):
As long as they were putting weight on and progressing . . . with the feeds and having less tube feeds
and more breast feeds and bottle feeds. I think that’s definitely one of your biggest concerns, I remember
thinking, I just want them to put on weight, because you felt like they were going to get a little bit better
every time, if they got a little bit bigger they’d be able to fight infections off.
P01, mother, NNU
From our team’s previous work exploring parents’ prioritised outcomes for trials investigating
treatments for sepsis,10,25 we were aware that parents sometimes find this a difficult question to
conceptualise and answer. Therefore, all parents were then asked, ‘In general, what would you be
looking for as an indicator that your child was getting better?’. The most common responses were
breathing support, weight gain, vital signs and time to full feeds:
I don’t know, you sort of know your own child, don’t you? Obviously when she was in intensive care sort
of like the ventilation pressures, erm, her having less temperatures, her oxygen requirements coming down.
Erm, and then when she sort of was waking up, her wanting a cuddle from me, erm, like she wouldn’t off
anybody else. Erm, and just sort of like little sort of indicators that she was feeling a bit better, wanting to
watch Peppa Pig and, you know, just little things.
P21, mother, PICU
As illustrated by the quotation from participant 21, PICU parents also prioritised how quickly their child
looked and/or behaved like more like their normal self. Examples included improved mood, communication
and colour, and being more alert and interested in their surroundings. When directly questioned about the
provided outcomes list, both groups of parents thought that they were comprehensive [‘it was quite a,
a very thorough list’ (P07, mother, NNU) and contained ‘important’ (P24, mother, PICU) outcomes].
The researcher then repeated back the outcome measures identified by the individual throughout the
interview discussion. Parents were then asked to rank their identified outcomes in order of importance
for the proposed GASTRIC trial.
As in previous work,25 not all parents included survival as an outcome in their ranked list. When this
was the case, the researcher then proceeded with a follow-up question to explore if this is because
they did not think it was an appropriate outcome for the GASTRIC trial or if they were other reasons
why they had not prioritised survival. One mother reflected that ‘survival has most definitely been
probably the most important thing in our journey on PICU. So I don’t know why I ignored it’ (P29,
mother, bereaved, PICU and NNU). Some suggested they had not mentioned survival as ‘you don’t
think that survival’s even a question’ (P02, mother, NNU). Others explained that survival was not
mentioned separately, as it is implicit in the list of outcomes they provided:
I suppose I’ve indirectly, indirectly said that survival is one of my most important things, ‘cause whenever you
asked me to identify my top I said, well it’s the ones that’s gonna kill them. So it’s hospital acquired infections
and NEC. Yeah, if, if you were saying, first of all it’s survival, um, minimising the things that’s gonna kill them,
and then minimising the things that’s gonna cause long-term disabilities. So I think that’s my, that would be my
three categories of outcome measures in, um, in, yeah, children in intensive care. So I know infections could kill
them, I know NEC could kill them, I know that brain injury could kill them, do you know, so they, they always
flagged up quite high for me. But I suppose as a parent you don’t want to say, do you think they’re gonna
survive or not, because you don’t want to think, I suppose, that they may not have. So that might be why.
P05, father, NNU
Findings from all outcome questions were then combined to determine the top prioritised outcomes by
ICU group (Table 9). Time on ventilator and breathing support, and weight gain both ranked in the top
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three for both NNU and PICU parents. Prioritised outcome measures did not appear to be condition
dependent (e.g. cardiac parents/non-cardiac parents in the PICU).
Health-care professional perspectives
At the start of focus groups and interviews, HCPs were asked questions about their clinical experience
of GRV measurement. The discussion then moved on to focus on the proposed GASTRIC RCT. Most
HCPs (representing 7 out of 10 hospitals) described how their unit had specific guidelines around the
measurement of GRV. Although the guidelines were in place, it was acknowledged that not all staff
adhered to the guidelines. For example, two units had recently completed an audit of GRV practice and
one found ‘that everyone was doing something different’ (P01, interview, dietitian, PICU). A few of the
participants said that they felt ‘very restricted by the guidelines’ (P02, interview, dietitian, PICU).
When describing GRV practice, the frequency of measurements was similar within and across NNUs
and PICUs. For example, the majority reported that their unit measured GRV every 4 hours or at every
feed. There were differences across units about the amount of volume they would consider ‘too much’
or of concern. Many described how feeds would be discarded if they were large, bilious or green, blood
stained or abnormal. Feeds would be returned if ‘it looked like part-digested milk’ (P01, FG3, senior
nurse, NNU). These findings were similar to the survey of practice reported in Chapter 1.
Multiple reasons for measuring GRV were provided, including as a guide for tolerance of feed; historical
practice, or as a habit; because staff were asked to measure it; clinical judgement reasons; gastric
emptying; if child was vomiting, because painkillers reduce gut motility; to aspirate air; to check for
irregularities; because a child’s abdomen looks distended; for comfort of the child; or to check tube
position. Commonly, practitioners across NNUs and PICUs (including nursing, doctors, dietitians and
surgeons) described how GRV measurement provides them with reassurance that a child is tolerating
feeds, which then informs decisions about subsequent feeding:
I think it’s a reassurance for the ward that the feed is being tolerated.
P02, interview, dietitian, PICU
In neonatal units [. . .] the kind of culture behaviour is, is quite a complex kind of beast and, um, the
nurses clearly feel that it gives them some reassurance about, um, you know, ability to increase feed,
or it maybe gives them some reassurance that the baby is, is tolerating milk.
P06, interview, doctor, PICU
To check that the clinical feed is tolerated.
P09, interview, surgeon
TABLE 9 Parents prioritised outcome measures
NNU parents PICU parents All parents
1. Time on ventilator and
breathing support
1. Weight gain 1. Time on ventilator and
breathing support
2. Hospital-related infections 2. Time on ventilator and
breathing support
2. Weight gain/growth
3. Weight gain 3. Long-term feeding 3. Survival (first when prompted)
4. NEC 4. Back to self 4. Full feeds
5. Time to full feeds 5. Survival (second when prompted) 5. Hospital-related infections
6. Survival (first when prompted) 6. Time to full feeds 6. Time in hospital
7. Time in hospital 7. Time in hospital 7. Long-term feeding
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In contrast, some medical staff and dietitians stated that measuring GRV was, on its own, ‘completely
meaningless’ (P06, interview, doctor, NNU) and that ‘I don’t actually think it really represents anything’
(P01, interview, dietitian, PICU). Some stated that ‘we shouldn’t be measuring it’ (P02, interview,
dietitian, PICU) and that if ‘given half a chance, don’t measure it at all’ (P05, interview, surgeon).
Only two nurses shared this viewpoint. Most nurses described the value of measuring GRV to inform
feeding and their clinical care of children. HCPs reported that parents do not measure GRV in their
unit, but might be involved in measuring the pH levels of the aspirate or help with the feeding of the
child. This was particularly the case in NNUs.
In two focus groups, neonatal nurses and one PICU dietitian stated that NEC was a consideration
when checking GRV and how not measuring GRV may lead to NEC due to increased feeding, or that
signs of NEC may be missed:
There is a real potential of NEC as well if you just keep on feeding and feeding and feeding.
P03, FG4, staff nurse, PICU
You’ll have a baby who you’re not measuring residuals anymore, who will end up with NEC and then
they’ll say, ‘Oh, this would have been picked up earlier if we’d realised it has bilious aspects’.
P05, FG5, consultant neonatologist, NNU
However, during the telephone interviews, half of participants (including dietitians, doctors and
surgeons) described how measuring GRV was not indicative of NEC, ‘babies who are going to develop
an important pathology, never present purely with gastric residuals’ (P06, interview, doctor, NNU), and
how they ‘don’t think that measuring the GRV is going to be a, um, reliable indicator of whether a
baby’s got NEC or is at risk of getting NEC’ (P05, interview, surgeon).
The proposed GASTRIC randomised controlled trial
Perceived benefits and risks of not measuring gastric residual volume
After introducing the proposed trial using the staff PIS [see project web page: www.journalslibrary.nihr.
ac.uk/programmes/hta/169402/#/documentation (accessed 13 February 2020)], the researcher sought
practitioner views on the potential barriers to conducting the trial, including perceived benefits and
risks of not measuring GRV. Perspectives were explored using voting in focus groups, as well as
through discussion in interviews and focus groups.
As shown in Table 10, the majority (87.5%) of HCPs indicated that there were barriers to not
measuring GRV, including concerns about increasing the risk of adverse events (AEs), causing
discomfort and pain, or vomiting. There were also concerns about not being able to identify early signs
of infections, gut obstructions or feed intolerances, lung injury (acute respiratory distress syndrome),
NEC, stenosis of pyloric sphincter or incorrect feeding tube placement. As described previously, not
detecting NEC was a concern associated with not measuring GRV and this influenced views on the
proposed trial. Although this did not concern PICU staff as much as NNU staff, NEC was a concern
discussed by both groups.
TABLE 10 Practitioner views on ‘do you think there will be any barriers to staff not measuring GRV in a proposed trial?’
by role (n = 48)
View
Participants, n (% within threshold)
Senior nurse
(N= 11)
Junior nurse
(N= 15)
Research nurse
(N= 4)
Senior doctor
(N= 7)
Dietitian
(N= 7)
Other
(N= 4)
Yes 9 (82) 14 (93) 4 (100) 5 (72) 6 (86) 4 (100)
No 2 (18) 1 (7) 0 (0) 2 (28) 1 (14) 0 (0)
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Health-care professionals were then asked to consider any potential barriers to measuring and
recording GRV in a set way, in a proposed clinical trial. As shown in Table 11, most staff did not
anticipate any barriers with this arm of a proposed trial. However, six out of eight (75%) junior nurses
did anticipate barriers. A few were process related, such as ‘measuring and the writing down and stuff’
(P07, FG2, research nurse, PICU) or attitudinal [‘I think staff attitude, yeah, rather than a practical
barrier’ (P05, FG2, nurse, PICU)].
Many HCPs discussed the potential benefits of measuring GRV during the focus groups and interviews,
which they perceived included benefits for babies and staff by helping to inform clinical care. Perceived
benefits for children included reduced reliance on intravenous lines, having fewer problems with motility
and reduced risk of infection. HCPs also described how GRV can help babies ‘be more comfortable,
more settled’ (P04, FG1, nurse, NNU), reducing the risk of vomiting and ultimately going home quicker.
The most common benefit of not measuring GRV from HCPs’ perspectives was increased nutritional
value of not removing stomach contents. They highlighted the values of increasing ‘nutritional intake
by not checking [GRV], in the vast majority of patients’ (P02, interview, dietitian, PICU), with one
participant explaining that by not measuring GRV:
. . . well you probably get onto feeds much quicker, because people worry that . . . there are residuals and
then start fretting about them and often end up stopping feeds, um, which . . . it takes longer for babies to
get onto full feeds.
P04, interview, doctor, NNU
A surgeon described how ‘measuring it [GRV] gets in the way or can get in the way of advancing
things, um, because the hesitancy is a baby has a what is felt to be large GRV or a dark green colour to
it, to not feed the baby, um, or child’ (P05, interview, surgeon).
Others described the benefits of not measuring something unnecessarily, particularly when there were
uncertainties about whether or not the calculations currently used to measure GRV were optimal,
owing to lack of evidence to inform practice.
Change in practice
Health-care professionals described how a change in practice, to not measuring GRV, would be a
challenge for the proposed trial. As shown in Table 12, 23 staff described how not measuring GRV
would require HCP behaviour change. Mainly, nurses indeed valued GRV measurement as a useful
practice that informed patient care. Six participants, from a range of clinical backgrounds, described
how they would be uncomfortable about changing a ‘normal’ practice for a trial, without evidence to
support such a change.
TABLE 11 Practitioner views on ‘do you think there will be any barriers to staff measuring GRV in a proposed trial?’
by role (n = 46)
View
Participants, n (% within threshold)
Senior nurse
(N= 11)
Junior nurse
(N= 14)
Primarily research
nurse (N= 4)
Senior doctor
(N= 6)
Dietitian
(N= 7)
Other
(N= 4)
Yes 2 6 1 0 0 1
No 9 8 3 6 7 3
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In contrast, some dietitians reported that they were planning to change their unit practice to not
measure GRV, which meant the proposed trial was less of a concern:
I mean we’re going, we’re planning to update ours, um, in the next couple of months cause it’s due for
revision. So our next protocol is, is not gonna have measuring GRVs in it.
P01, interview, dietitian, PICU
Others commented on the current debate around GRV measurement and how some units were
questioning their practice or were in the process of rewriting their feeding algorithm protocols:
At the moment I’m trying to rewrite our feeding algorithm protocol, there’s some debate on the unit as to
whether it’s right.
P03, interview, dietitian, PICU.
There have been discussions over the years and certainly there’s now a lot of questioning about how
relevant it is . . . it’s not something that I’ve ever tried to influence or, or change really.
P08, interview, dietitian, NNU
There were mixed views on the importance of the clinical question. During focus groups and
interviews, dietitians often commented on the importance of the clinical question and how the
proposed trial ‘could change things quite a lot’ (P03, interview, dietitian, PICU). By contrast, medical
practitioners (four doctors and one surgeon) described how the question of whether to measure GRV
or not was ‘more of an irritant than a, you know, a major uncertainty’ (P04, interview, doctor, NNU).
Some stated that it was not a ‘big issue’ (P06, interview, doctor, NNU) or not important ‘in the grand
scheme of things’ (P07, interview, doctor, PICU).
TABLE 12 Health-care professionals’ concerns relating to changing practice (not measuring GRV) in the proposed
GASTRIC RCT (n = 29)
Behaviour change (n= 23) Clinical concerns (n= 6)
Current GRV practice is
helpful (n= 7)
Wanting evidence first
(n= 6)
Um, it’s probably just,
um, I can imagine there
will be barriers to it
because of it’s just the
way, the way that things
are done and that’s the
way, you know, way it’s
always been
P02, interview,
dietitian, PICU
So it might cause quite
a few people to maybe
ask some questions,
they might not think
it’s the best thing to do,
for whatever reason
P01, FG2, research
nurse, PICU
It’s their safety net for
advancing feeds and, and
changing things around
P05, FG5, neonatal
consultant, NNU
I tend to think if I was a
parent on here . . . I might
be more concerned about
the fact that you’re
changing normal practice
without the evidence. And
I appreciate you’ve got to
get the evidence but . . .
P07, FG2, research
nurse, PICU
You obviously feel
dubious about it because
it’s something new, and
we’re not very good in
health care at change
anyway are we so when
someone comes and says,
we’re gonna do this . . .
Everyone’s gonna say,
well, no, actually I don’t
want to do that
P02, FG4, other, NNU
It would be a nerve
racking to take that away
because we do, as you
say, it’s part of the
whole picture
P02, FG1, junior
nurse, NNU
. . . if it’s a new protocol,
then we’d do it, because
obviously all the research
has been done and proven
that that’s better, so even
if you feel uncomfortable
with it, the research is
there; but if the research
isn’t there, and you’re
just trying something,
like, you’d feel quite
uncomfortable
P06, FG3, senior
nurse, PICU
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Trial acceptability and feasibility
Of the 46 practitioners (95.8%) who answered the question, ‘how acceptable is it to conduct the
proposed trial?’, the majority (39/46, 85%) indicated that it was ‘acceptable’ or ‘very acceptable’.
Only 15% (7/46) said that it was not acceptable or very unacceptable. Of these seven, six were
junior nurses. All practitioners (n = 48) said that the trial was practically possible to conduct and
47 practitioners (98%) said that it was practically possible to not measure GRV.
Health-care professional ‘buy-in’ for the proposed GASTRIC randomised controlled trial
Participants were then asked about whether or not they felt it might be difficult to engage any
particular staff groups in conducting the trial. Participants (nurses, dietitians, consultants and surgeons)
felt, overall, that all professional groups would support the proposed trial. However, they felt that
engaging other staff groups could pose a challenge:
I think some nursing staff would feel deeply uncomfortable about not doing, measuring GRV.
P01, interview, dietitian, PICU
She [doctor] might think it’s, it’s in the baby’s best interest not to follow the protocol but, er, to do what
we normally do, so whether you can class that as a barrier or not.
P05, FG1, research nurse, NNU
During two focus groups and two interviews, participants discussed how general surgeons value GRV
measurements in some situations (e.g. after babies have had gut surgery):
Surgeons, they’ll really like gastric residual volumes.
P01, interview, dietitian, PICU
Whether it’s just on preterm babies but on your post op babies, the surgeons may feel certain babies you
should measure it, and I probably would agree with them. So whether they get enrolled in the trial or
whether they’re opted out, that could cause confusion.
P01, FG5, senior nurse, NNU
Health-care professionals highlighted how it was particularly important for senior doctors and
consultants to support the trial to help facilitate wider staff engagement and trial conduct:
I think with the right leadership at consultant level, cause that’s, that would be the important thing, you
would get a lot of people in the trial.
P06, interview, doctor, NNU
The challenge would be, you know, in a unit with 10 consultants, what’s the dynamic of that unit and,
and, and can the PI [principal investigator] really persuade all his consultants to buy-in.
P06, interview, doctor, NNU
Facilitating health-care professional ‘buy-in’ through training
When asked what could help facilitate HCP ‘buy-in’ for the proposed trial, several suggestions were
made. These included bespoke site training and providing additional information to support the study
rationale, including any evidence to demonstrate why not measuring GRV might be beneficial to patients:
It doesn’t hurt to have an education package.
P02, FG5, junior nurse, NNU
Good data-driven justification to demonstrate why not measuring GRVs would be a sensible thing to do
and in fact might be beneficial.
P05, interview, surgeon
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Health-care professionals highlighted the need to provide information and education around which
clinical parameters would be monitored in the trial when GRV was not being measured, to help inform
clinical care. Suggestions included monitoring bowel movements, including if stools were loose or
bloody, or bowels were loopy, whether the abdomen was distended or hard, and whether the patient
was comfortable was vomiting or had arterial oxygen desaturations.
A few participants were confused about the difference between checking the GRV (by aspirating the entire
stomach contents) and simply confirming the position of the feeding tube (by testing the pH, involving
testing a small amount of fluid). Guidance and education would be needed about this for a future trial.
Many stated that a good training package would help ensure ‘trial compliance, er, protocol compliance’
(P04, interview, doctor, NNU), whereas face-to-face site training was favoured over ‘e-learning’ (P03, FG2,
junior nurse, PICU).
During interviews and focus groups, HCPs described the importance of disseminating training to all
staff, ‘including the night staff’ (P08, interview, dietitian, NNU). Suggestions included embedding
training into study days, away days and research forum groups:
People struggle . . . sometimes you can have the training on a research study weeks and weeks before we
actually start it so by the time you come to start it, then it’s a bit like oh I need a refresher really . . . like
maybe the week or 2 weeks before you’re starting it rather than being a big gap before you start it.
P07, FG1, other, NNU
Trial inclusion and exclusion criteria
Neonatal unit and PICU HCPs suggested that babies and children with bronchiolitis, epilepsy, pneumonia,
no gastric problems and those with no previous experience of ventilation may be suitable for inclusion.
The majority (38/46, 83%) identified some children who should be excluded from a future trial (Table 13).
TABLE 13 Exclusion criteria as suggested by practitioners
Exclusions for both NNU and PICU
Babies or children not being fed
Babies or children with feed intolerance
Babies or children who have or will have surgery
NNU-specific exclusions
Congenital gastrointestinal anomaly babies
Babies with a risk of NEC
Very premature babies
Babies with NG on free drainage
PICU-specific exclusions
Children with brain stem death or awaiting organ donation
Children tube fed at home or well-established feeding regime
Liver patients
Children with oesophageal stenosis
Children with reflux
Children with tracheoesophageal fistulas
Children with tracheal slides
Children with traumatic brain injury
NG, nasogastric (tube).
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Overall, all HCPs stated that the proposed trial was practically possible to conduct (n = 48). However,
many described how flexibility regarding who would be included in the trial was needed and they were
keen to consider ‘the clinical picture [of the child] as well though’ (P01, FG1, senior nurse, NNU):
I think there really does need to be a ‘get-out clause’ so that they can choose to start measuring GRV.
P04, FG2, other, PICU
The same participant said:
. . . if you’re going against the clinical judgement of the medical staff and, you know, the child’s vomiting
or constantly vomiting or . . . I think there needs to be a get out clause which of course will upset your
results completely.
P04, FG2, other, PICU
Potential trial design
Finally, HCPs were provided with a description of individual and cluster randomised trial designs
(similar to the description provided to parents) and asked to consider the most appropriate design
for the proposed trial. We also explored views on the benefits and challenges of each trial design
and approaches to consent. Views on trial design were mixed (Figure 6), with 20 out of 48 (42%)
practitioners preferring an individual randomisation design and 25 out of 48 (52%) preferring a cluster
randomisation design. One person had no preference and for two people these data were missing.
Just over half of nursing staff preferred individual randomisation (14/26, 54%). Three research nurse
participants preferred a cluster design (3/26, 12%). ‘Other’ staff groups also preferred a cluster
randomisation (11/17, 65%).
Health-care professionals understood and had experience of an individual randomisation trial design.
Most were happy with the trial design because of the familiarity of it, but did report some concerns
about protocol adherence due to confusion about which babies were part of the trial:
I mean we all think that we’re excellent at handing over and it would be fine but I think there, there is
that potential, more potential for error.
P04, FG2, other, NNU
I think you could get muddled, yeah.
P07, FG3, nurse, PICU
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FIGURE 6 Proposed trial randomisation method preference by current job role.
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There was also general agreement about the difficulties with an individual randomisation from the
parent perspective, which included unease about change in care:
If they know that their child is being treated differently to the [next] child – even if it’s something really
small which they probably don’t really understand anyway, the fact that they’re being treated differently
. . . [they could be unhappy about it].
P08, FG3, consultant, PICU
Although some stated that ‘there wouldn’t be buy-in at all’ (P06, interview, doctor, NNU) if the whole
unit was involved in the cluster design, many were positive about this approach to randomisation.
Practitioners said that it would ‘be easier’ (P04, FG3, staff nurse, PICU), particularly ‘to implement for
the nurses at the bedside . . . sometimes I think it feels natural; it’s a teaching hospital, and I think
people sort of accept that, they know it’s a teaching hospital and they understand that research gets
done in teaching hospitals’ (P03, FG3, dietitian, PICU).
Health-care professionals appeared to believe that a cluster design would reduce workload compared
with the individual randomisation trial design, particularly in relation to the informed consent process.
One participant stated that ‘the nurse looking after the baby on the shop floor, ’cause they’ve got
enough to do as it is, the least amount of extra work that it causes the better’ (P05, FG1, research
nurse, NNU).
Participants also touched on the perspective of parents and how a cluster design may prevent parental
concerns that their baby was being treated in a different way to others. This concern was spoken
about more commonly in relation to NNUs than PICUs:
The only different thing is I know from trials is that parents talk a lot and when you’ve got a trial, and
you might have two babies in the same room and one of them is not getting the residual volume
measured and one of them is and then something goes wrong, that’s when you’ve got, you’ll end up
with problems.
P06, FG1, research nurse, NNU
Summary of findings to inform the GASTRIC trial
Overall, most parents supported the proposed GASTRIC RCT and would have provided consent for
their child’s participation in the trial if they were approached at an appropriate time, and ideally
not in the initial hours of NNU or PICU admission when their child was critically ill. Although GRV
measurement was viewed as a ‘low risk’ and standard practice, it was also perceived to be invasive.
Therefore, the ‘intervention arm’ (of not measuring GRV) might be seen as non-invasive and potentially
beneficial, thus increasing trial acceptability.
Prior knowledge about GRV measurement was one of the main differences between the NNU and
PICU parents. Parents with no experience of tube feeding or GRV measurement at the point of their
child’s admittance to the NNU or PICU hypothesised that they would have considered the proposed
trial as being low risk, without having any preconceptions about measuring, or not measuring, GRV,
and thus no preference for either trial arm (equipoise).
Both NNU and PICU parents raised concerns about not measuring GRV and increasing the risk of
delayed diagnosis of bowel or stomach problems, vomiting into the lungs and increased pain or
discomfort. Parents were also concerned about their situational incapacity, which would make it
difficult to make an informed consent decision. In addition, some parents were unable to distinguish
between GRV measurement and testing pH and/or tube placement. These concerns could be addressed
by adjusting the participant information and through trial protocol changes to help ensure appropriate
timing of trial recruitment discussion.
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Overall, parents preferred a cluster approach to randomisation, but would probably still consent if the
trial used an individual randomisation. Contrastingly, HCPs were split in their preference for individual
randomisation or a cluster trial dependent on role and experiential knowledge.
Differences between the outcomes prioritised by NNU and PICU parents were observed. Although
both groups ranked time on breathing support and weight gain in the top three outcomes, NNU
parents ranked hospital-related infections and PICU parents ranked long-term feeding issues as the
most important outcomes.
Multiple reasons were cited by HCPs for measuring GRV, the most common being that it provides
reassurance to nurses that a baby or child is tolerating feeds. However, there was also support for not
measuring GRV, with some practitioners describing GRV measurement as meaningless.
Concerns about the acceptability and success of conducting the proposed trial mainly related to
changing routine practice. ‘Buy-in’ from staff was considered critical in facilitating trial success and
some practitioners believed that comprehensive training and defined inclusion and exclusion criteria
could address some of the perceived barriers.10,26 Despite these potential obstacles, most staff felt
that the proposed trial was acceptable and all staff felt that it was practically possible to conduct.
From this qualitative work, we have revised, developed and improved the PISs (both for PICUs
and NNUs) [see project web page: www.journalslibrary.nihr.ac.uk/programmes/hta/169402/#/
documentation (accessed 13 February 2020)], and we have developed HCP training packages
(see Appendices 4 and 5).
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Chapter 3 Trial design survey including
e-Delphi
Introduction
A key aspect of assessing the feasibility for a clinical trial is acceptability of the design among HCPs.
This WP sought to engage with a broader group of HCPs working in PICUs and NNUs across the UK.
Aims and objectives
To investigate PICU and NNU HCPs’ opinions on issues regarding a potential trial of GRV compared
with no GRV measurement, including willingness to randomise and inclusion and exclusion criteria, and
to gain consensus on potential primary and secondary outcome measures.
Study management
This WP was led by LNT (for PICUs) and JD and CG (for NNUs). The SMG was responsible for inputting
into the survey questions and design, as a member of the Clinical Trials Unit (HE) was responsible for
managing the software and collecting responses, and the SMG statistician (BA) analysed the results.
Methods
Survey development
Two separate surveys were developed by the study team: one for PICU clinicians and one for NNU
clinicians. Each tool consisted of a cross-sectional survey and a two-round e-Delphi survey [see project
web page: www.journalslibrary.nihr.ac.uk/programmes/hta/169402/#/documentation (accessed 13
February 2020)]. The cross-sectional surveys were developed to look at trial design issues. Each
included a set of potential inclusion and exclusion criteria, questions on willingness to randomise and
questions on what the primary outcome should be in either PICUs or NNUs.
The list of outcomes for the e-Delphi component of the survey was generated as follows. Phase 1
involved the generation of a list of outcomes used in previous studies of GRV in different populations:
11 for PICUs and 11 different ones for NNUs.27–32 In WP 2, parents generated seven more important
outcomes: (1) length of ventilation, (2) weight gain and growth, (3) time to full feeds, (4) length of hospital
stay, (5) long-term feeding issues (PICU), (6) health-care infections (NNU) and (7) survival (of which some
were duplicates of our generated list). This resulted in 16 PICU outcomes and 22 NNU outcomes (as the
long-term outcomes were broken down into specific outcomes) in round 1. Once developed, both surveys
were tested for face validity on 10 individuals (a mix of nurses, doctors and dietitians) and then tested
again within the study team. The e-Delphi process was conducted and managed by DelphiManager
version 3.0 software (University of Liverpool, Liverpool, UK). The final survey tool can be found at the
project web page [www.journalslibrary.nihr.ac.uk/programmes/hta/169402/#/documentation (accessed
13 February 2020)]. The outcomes were listed alphabetically to avoid potential weighting of outcomes
caused by the order in which they were displayed.
Participants
Key stakeholder groups were identified for the PICU e-Delphi: PICU nurses, PICU doctors, paediatric
surgeons and PICU dietitians. We did not involve parents in this process as we had elicited their views
on important outcomes in the qualitative work and thought that asking them to comment on trial
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design issues, such as inclusion and exclusion criteria (without an understanding of the clinical context),
was not useful. Members of these groups were invited to take part via e-mail through professional
networks (British Dietetic Association, PICS and PICS Study Group). Similarly, stakeholder groups were
identified for the NNU e-Delphi: neonatal nurses, neonatal doctors, paediatric surgeons and neonatal
dietitians. Members of these groups were invited to take part via e-mail, through professional networks
(the UK Neonatal Collaborative and the British Association of Perinatal Medicine). The target number
of respondents was 40 for PICU clinicians and 100 for NNU clinicians, reflecting the respective size
of the specialty. Automated reminders were sent via the survey software.
Data collection
The survey was electronic, with participants allocated a unique identifier (via name and e-mail address) to
allow identification of individuals completing all rounds of the e-Delphi exercise. In round 1, participants
completed the cross-sectional survey and then went on to score each of the outcomes listed using a 9-point
Likert scale based on the degree of importance, as recommended by the Grading of Recommendations
Assessment, Development and Evaluation (GRADE) working group33 (with 1–3 labelled ‘not important’,
4–6 labelled ‘important but not critical’ and 7–9 labelled ‘critical’). Participants were provided with an
option to add additional outcomes in round 1 that they thought were relevant and not listed.
In round 2, participants were presented with a summary of the results of round 1 and asked to rescore
these outcomes based on the group score. They were also asked to score any additional outcomes
suggested in round 1. Finally, they were asked to specify a single primary outcome.
Data analysis
All question responses were summarised using descriptive statistics for quantitative data and line-
listings for qualitative free-text data. For each round of the e-Delphi, the distribution of outcome
ratings was assessed using histograms, by stakeholder group. Response rates, attrition bias and the
number of questions for which scores were changed between rounds 1 and 2 were assessed. (Note,
attrition bias can be incurred if those with specific views are more likely to continue with second or
subsequent rounds of an e-Delphi survey. We assessed potential attrition bias between rounds 1 and
2 by comparing the average round 1 score from those responding in both rounds to those responding
in round 1 only.) The round 2 scores were used to formulate consensus statistics for each outcome
by stakeholder group, and overall by the percentage of respondents who scored 7–9 (outcome rated
critical), the percentage who scored 1–3 (outcome rated unimportant) and by consensus status
(‘consensus in’, ‘consensus out’ or ‘no consensus’) (Table 14).
Results
Paediatric intensive care unit
A total of 45 PICU HCPs across UK PICUs were contacted via e-mail, via the PICS Study Group, in
September 2018. Of these HCPs, 30 (67%) registered for the e-Delphi survey and responded with
views regarding inclusion and exclusion criteria. Twenty eight (62%) of those invited went on to score
TABLE 14 Definition of consensus status
Consensus status Description Definition
Consensus in Consensus that the outcome should be
included in the future study design
≥ 70% of participants scoring as 7–9 and < 15% of
participants scoring as 1–3 in each group
Consensus out Consensus that the outcome should not be
included in the future study design
≥ 70% of participants scoring as 1–3 and < 15% of
participants scoring as 7–9 in each group
No consensus Uncertainty about question Anything else
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16 outcomes in round 1 of the e-Delphi survey and 22 (79%) of those who completed round 1 went
on to respond to round 2 (Table 15). As there was just one paediatric surgeon taking part, the SMG
agreed that a new group should be formed: PICU doctors and one paediatric surgeon. Results are
therefore presented throughout for three stakeholder groups instead of four.
Potential inclusion and exclusion criteria
Wide support across all groups was given for including children admitted to PICU aged from > 37 weeks
(term) to 17 years and all children on the PICU who are being fed [intubated, extubated and on non-
invasive ventilation (NIV)] (Table 16). Nurses and dietitians were strongly in favour of including cardiac
infants and post-surgical patients, but some doctors (5/15, 33%) were not. Mechanical ventilation as a
prerequisite had mixed support.
Most doctors (12/15, 80%) and nurses (8/10, 80%) agreed that excluding any child with a ‘surgical gut’
or active gastrointestinal (GI) bleeding was important, although four out of five (80%) dietitians did not
(see Table 16). Seven out of 10 (70%) nurses wanted to exclude children who were expected to have a
length of stay in PICU of < 24 hours. No other exclusion criteria proposed received strong agreement
from any group.
When ‘other’ was selected, participants could offer their own suggestions (see Table 1 in
Report Supplementary Material 2).
Willingness to randomise
All respondents except one (29/30, 97%) said that they were willing to randomise children in a trial
comparing GRV with no GRV. The one nurse respondent who was not sure elaborated: ‘I struggle to
understand how you assess if a child is tolerating feed without using GRV when bolus feeding. Equally
I think GRV will be very difficult to interpret if continuous feeding’.
e-Delphi round 1
Sixteen outcomes were scored. These are listed in Appendix 5. Fourteen of these outcomes were
scored by 28 respondents and two other outcomes were rated by 27 respondents (one doctor
ticked ‘unable to score’ for these). Feedback was offered for most outcomes (see Table 2 in
Report Supplementary Material 2).
e-Delphi round 2
Six additional non-duplicate outcomes were suggested in the round 1 survey and added to round 2, to
make a total of 22 outcomes to be rated (see Appendix 6). A total of 22 respondents completed round 2.
Importantly, the dietitian group was reduced to only three. Although this group is small, we present
their round 2 results here, to allow potential differences of opinion from dietitians to be considered
(see Table 3 in Report Supplementary Material 2 for summary statistics of the round 2 scores).
TABLE 15 Respondents to each round of the PICU e-Delphi survey
Stakeholder group Total invited, n
Cross-sectional survey,
n (% of those invited)
R1 e-Delphi,
n (% of those invited)
R2 e-Delphi,
n (% of those that
completed R1)
PICU doctors 25 14 (56) 13 (52) 10 (77)
Paediatric surgeons 2 1 (50) 1 (50) 1 (100)
PICU nurses 13 10 (77) 9 (69) 8 (89)
PICU dietitians 5 5 (100) 5 (100) 3 (60)
Total 45 30 (67) 28 (62) 22 (79)
R1, round 1; R2, round 2.
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Attrition bias
Figure 1 in Report Supplementary Material 2 shows that the three doctors, one nurse and two dietitians
who only took part only in round 1 did not have very different views from the 22 HCPs who went on
to respond to round 2. We therefore conclude that there was no evidence of attrition bias.
Score changes from round 1 to round 2
Figure 2 in Supplementary Material 2 shows the number of outcomes for which a respondent changed
their score between rounds 1 and 2. Thirty-six per cent of respondents (8/22) changed their minds for
TABLE 16 Number and percentage of PICU respondents agreeing with potential inclusion and exclusion criteria
(in descending order of overall agreement)
Criterion
PICU doctors/
paediatric surgeon
(N= 15), n (%)
PICU nurses
(N= 10),
n (%)
PICU
dietitians
(N= 5), n (%)
All
(N= 30),
n (%)
Inclusion criteria
Children aged > 37 weeks to 17 years in the
PICU
14 (93) 8 (80) 5 (100) 27 (90)
All children, including cardiac infants and
post-surgical patients
10 (67) 9 (90) 5 (100) 24 (80)
All children on the PICU who are being fed
(intubated, extubated and on NIV)
11 (73) 7 (70) 4 (80) 22 (73)
Only children who are mechanically ventilated
in PICU
6 (40) 7 (70) 3 (60) 16 (53)
Children aged > 1 month (> 44 weeks’ GA to
17 years)
3 (20) 5 (50) 2 (40) 10 (33)
Other 3 (20) 2 (20) 1 (20) 6 (20)
Only children with a medical cause of PICU
admission
1 (7) 0 1 (20) 2 (7)
Exclusion criteria
Any child with a surgical gut or active GI
bleeding
12 (80) 8 (80) 1 (20) 21 (70)
< 24 hours expected PICU admission 7 (47) 7 (70) 3 (60) 17 (57)
Neonates < 37 weeks’ GA (postmenstrual age) 8 (53) 6 (60) 1 (20) 15 (50)
Children on ECMO/ECLS 5 (33) 4 (40) 0 9 (30)
Children on any vasopressor support 5 (33) 1 (10) 0 6 (20)
All neonates up to 44 weeks’ GA 3 (20) 3 (30) 0 6 (20)
Other 2 (13) 2 (20) 2 (40) 6 (20)
Only postoperative cardiac surgical infants
after complex surgery
4 (27) 1 (10) 0 5 (17)
Postoperative cardiac surgical children 3 (20) 1 (10) 0 4 (13)
All pre- and postoperative cardiac children 3 (20) 1 (10) 0 4 (13)
Children on NIV 0 3 (30) 1 (20) 4 (13)
None 1 (7) 0 3 (60) 4 (13)
Children on HFNC 0 2 (20) 0 2 (7)
ECLS, extracorporeal life support; ECMO, extracorporeal membrane oxygenation; GA, gestational age; GI, gastrointestinal;
HFNC, high-flow nasal cannula.
TRIAL DESIGN SURVEY INCLUDING E-DELPHI
NIHR Journals Library www.journalslibrary.nihr.ac.uk
46
one, two or no outcomes, which means that the remaining 64% (14/22) changed their minds for at
least three outcomes. These results suggest that including a second round in the e-Delphi was useful.
Outcome scores
Table 3 in Supplementary Material 2 shows the median rating given at the end of round 2 for each
outcome considered. This shows a little heterogeneity between groups for some outcomes, but also
that some outcomes are rated as important by all. No outcomes had a median rating of < 4 in any
group, showing that, in general, no outcome was considered as ‘unimportant’ by our respondents.
Consensus statistics
Four outcomes were categorised as ‘consensus in’ in all three stakeholder groups: (1) time to achievement
of predicted energy goals, (2) incidence of ventilator-associated pneumonia (VAP), (3) time feed stopped per
24 hours and (4) incidence of GI morbidity (vomiting). No outcomes could be categorised as ‘consensus out’
and the remaining 18 outcomes were categorised ‘no consensus’ (Table 17). If we ignore the stakeholder
groups, two outcomes reached ‘consensus in’ [(1) the length of time invasive ventilation (IV) and (2) the
incidence of NEC]; however, these did not achieve the a priori threshold. Note, our small sample size of
dietitians (n= 3) had undue influence over the ‘consensus in’ threshold: it required only one of the dietitians
to score an outcome < 7, regardless of the opinions of other groups, for the outcome to drop below the
threshold for ‘consensus in’.
TABLE 17 Percentage of participants who scored 7–9, by stakeholder group, for outcomes in PICU round 2
(in descending order)
Outcome
PICU doctors and
paediatric general
surgeon (n= 11), %
PICU
nurses
(n= 8), %
PICU
dietitians
(n= 3), %
All
(n= 22),
%
Consensus
status
Time to achievement of predicted energy
goals (full feeds)
90.9a 87.5a 100.0a 90.9b Consensus in
Incidence of VAP 81.8a 87.5a 100.0a 86.4b Consensus in
Time feed stopped per 24 hours 81.8a 87.5a 100.0a 86.4b Consensus in
Incidence of NEC 90.9a 87.5a 66.7 86.4a No consensus
Incidence of GI morbidity: vomiting 72.7a 87.5a 100.0a 81.8b Consensus in
Length of time: IV 63.6 75.0a 100.0a 72.7a No consensus
Mortality 63.6 62.5 100.0a 68.2 No consensus
Length of stay: PICU 63.6 62.5 66.7 63.6 No consensus
Total length of time respiratory support
(IV +NIV)
63.6 50.0 100.0a 63.6 No consensus
Nursing time spent measuring GRV 54.5 50.0 100.0a 59.1 No consensus
Length of stay: hospital 63.6 37.5 66.7 54.5 No consensus
Administration of parenteral nutrition
secondary to feed intolerance
45.5 37.5 66.7 45.5 No consensus
Post-pyloric feeding (placing a
post-pyloric tube) secondary to feed
intolerance
27.3 50.0 100.0a 45.5 No consensus
Change in weight (growth) between
PICU admission and discharge
27.3 50.0 66.7 40.9 No consensus
continued
DOI: 10.3310/hta24230 Health Technology Assessment 2020 Vol. 24 No. 23
© Queen’s Printer and Controller of HMSO 2020. This work was produced by Tume et al. under the terms of a commissioning contract issued by the Secretary of State for
Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in
professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial
reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House,
University of Southampton Science Park, Southampton SO16 7NS, UK.
47
Primary outcome suggestion responses
In round 2, after rating the 22 outcomes, 20 out of 22 (91%) respondents suggested at least one
primary outcome, although some suggested more than one (Table 18). Overall, 36% chose ‘time to
achievement of predicted energy goals (full feeds)’ and 23% chose ‘incidence of VAP’.
TABLE 17 Percentage of participants who scored 7–9, by stakeholder group, for outcomes in PICU round 2
(in descending order) (continued )
Outcome
PICU doctors and
paediatric general
surgeon (n= 11), %
PICU
nurses
(n= 8), %
PICU
dietitians
(n= 3), %
All
(n= 22),
%
Consensus
status
Long-term feeding issues 27.3 37.5 33.3 31.8 No consensus
GI morbidity: diarrhoea 9.1 37.5 66.7 27.3 No consensus
Long-term outcomes (after hospital
discharge)
36.4 25.0 0 27.3 No consensus
Administration of prokinetic drugs
secondary to feed intolerance
18.2 12.5 66.7 22.7 No consensus
Looking and/or behaving like their
normal self
18.2 25.0 0 18.2 No consensus
Change in length (growth) between PICU
admission and discharge
18.2 12.5 33.3 18.2 No consensus
Change to feed formula type secondary
to feed intolerance
0 25.0 66.7 18.2 No consensus
Parental satisfaction 9.1 0 33.3 9.1 No consensus
a ‘Consensus in’ criteria were met: ≥ 70% scored 7–9 and < 15% scored 1–3.
b ‘Consensus in’ criteria met in all groups.
TABLE 18 Summary statistics for suggested primary outcome
Primary outcome suggesteda
PICU doctors and
one paediatric
general surgeon
(N= 11), n (%)
PICU
nurses
(N= 8),
n (%)
PICU
dietitians
(N= 3),
n (%)
All
(N= 22),
n (%)
Time to achievement of predicted energy goals (full feeds) 5 (46) 3 (38) 0 8 (36)
Incidence of VAP 1 (9) 3 (37.5) 1 (33) 5 (23)
Incidence of GI morbidity: vomiting 1 (9) 1 (13) 1 (33) 3 (14)
Time feed stopped per 24 hours 1 (9) 1 (13) 1 (33) 3 (14)
Change in weight (growth) between PICU admission and
discharge
1 (9) 1 (13) 0 2 (9)
GI morbidity: diarrhoea 0 1 (13) 1 (33) 2 (9)
Length of stay: PICU 0 2 (25) 0 2 (9)
Length of time: IV 1 (9) 0 0 1 (5)
Long-term feeding issues 0 1 (13) 0 1 (5)
Nursing time spent measuring GRV 0 1 (13) 0 1 (5)
No outcome suggested 1 (9) 1 (13) 0 2 (9)
a Some respondents suggested more than one primary outcome.
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Neonatal units
Health-care professionals at all 184 UK NNUs were contacted via e-mail, with a request that the
invitation was forwarded on to relevant individuals. A total of 76 HCPs registered for the survey
(Table 19) and responded with views regarding inclusion and exclusion criteria. Seventy-four HCPs
went on to score 22 outcomes in round 1 of the e-Delphi survey, and 61 (82%) of those who completed
round 1 went on to respond to round 2. After round 1, the SMG agreed to collapse the five stakeholder
group options into three [only two respondents were paediatric surgeons and the five respondents
that selected ‘other’ could all be categorised as nurses (neonatal or paediatric)]. Results are therefore
presented throughout for three stakeholder groups instead of five.
Potential inclusion and exclusion criteria
There was wide support across all groups for including all babies who are mechanically ventilated (78%),
or babies who are being tube fed (regardless of whether or not they are ventilated or on respiratory
support) (79%) and preterm babies aged < 30 weeks’ gestation (99%) (Table 20). Including only babies
with an upper gestational age limit of 32 and 34 weeks’ gestation was also strongly supported. Eighty-five
per cent of nurses and 67% of dietitians were in favour of including babies aged 37–40 weeks’ gestation,
but half of doctors were not. Most respondents (76%) preferred to exclude neonates who were already
suspected of having NEC. No other exclusion criteria proposed received strong agreement from any group
(see Table 20). When ‘other’ was selected, participants could offer their own suggestions (see Table 1 in
Report Supplementary Material 2).
Willingness to randomise
Most respondents (69/76, 91%) said that they would be willing to randomise babies in a trial
comparing GRV with no GRV. One dietitian was not in favour ‘because across our network we do
not routinely measure residuals and this is embedded practice’. Another six dietitians were not sure,
one stated ‘Because I read the article about time to full feeds with not measuring GRV and prefer to
do that. Not sure if would be happy to randomise to the GRV group’, whereas another replied ‘Have
never participated in randomisation before’ and another respondent wrote ‘I would be happy as long as
all the antenatal information was available, i.e. dopplers, etc., and after discussion with the treating
consultant’.
e-Delphi round 1
Following the process described previously (see Chapter 3, Methods), 22 outcomes were included in the
round 1 survey [11 from the literature and seven generated from parents (some were duplicates)];
however, other outcomes were broken down into more specific long-term morbidities. These are listed
in Appendix 7. Seventeen of these outcomes were scored by 74 respondents and five other outcomes
were rated by 73 respondents (one nurse ticked ‘unable to score’ for these). Feedback was offered for
most outcomes (see Table 5 in Report Supplementary Material 2).
TABLE 19 Respondents to each round of the NNU e-Delphi survey
Stakeholder group Cross-sectional survey, n R1 e-Delphi, n
R2 e-Delphi,
n (% of those that
completed R1)
Neonatal/paediatric doctors or paediatric surgeons 44 44 40 (91)
Neonatal/paediatric nurses 26 25 18 (72)
Neonatal dietitians 6 5 3 (60)
Total 76 74 61 (82)
R1, round 1; R2, round 2.
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e-Delphi round 2
Four additional outcomes were suggested in round 1 and added to the round 2 survey, making a total
of 26 outcomes to be rated at round 2 (see Appendix 8). A total of 61 respondents completed round 2.
Importantly, the dietitian group was reduced to only three. Although this group is small, we present
their round 2 results here to allow potential differences of opinion from dietitians to be considered.
Attrition bias
Figure 3 in Report Supplementary Material 2 shows that the four doctors, seven nurses and two dietitians
who took part only in round 1 did not have very different views from the 61 HCPs who went on to
respond in round 2. We therefore conclude that there was no evidence of attrition bias.
TABLE 20 Number and percentage of NNU respondents agreeing with potential inclusion and exclusion criteria
(in descending order of overall agreement)
Criterion
Neonatal and
paediatric doctors/
paediatric surgeons
(N= 44), n (%)
Neonatal and
paediatric
nurses (N= 26),
n (%)
Neonatal
dietitians
(N= 6),
n (%)
All
(N= 76),
n (%)
Inclusion criteria
Preterm babies: < 30 gestational weeks 42 (95) 24 (92) 6 (100) 72 (95)
Preterm babies: < 32 gestational weeks 39 (89) 26 (100) 6 (100) 71 (93)
Preterm babies: < 34 gestational weeks 34 (77) 24 (92) 5 (83) 63 (83)
Preterm babies: < 28 gestational weeks 37 (84) 18 (69) 6 (100) 61 (80)
All babies who are mechanically ventilated 33 (75) 21 (81) 5 (83) 59 (78)
Babies on the NNU who are being tube fed
(regardless of whether or not they are
ventilated or on respiratory support)
28 (64) 25 (96) 6 (100) 59 (78)
Preterm babies: 34–37 gestational weeks 22 (50) 22 (85) 4 (67) 48 (63)
Only babies with no surgical issues 22 (50) 18 (69) 2 (33) 42 (55)
Babies, including cardiac infants and/or
post-surgical patients, so long as being fed
17 (39) 14 (54) 3 (50) 34 (45)
Other 4 (9) 6 (23) 0 10 (13)
Exclusion criteria
Neonates with suspected NEC 31 (70) 22 (85) 5 (83) 58 (76)
Neonates receiving total body hypothermia 21 (48) 12 (46) 2 (33) 35 (46)
Babies with cardiac, neurological, chromosomal
or congenital anomalies
22 (50) 9 (35) 0 31 (41)
Other 13 (30) 5 (19) 1 (17) 19 (25)
Babies with antenatally detected abnormal
Doppler studies
8 (18) 9 (35) 0 17 (22)
Preterm babies: < 34 gestational weeks 6 (14) 2 (8) 1 (17) 9 (12)
Preterm babies: > 32 gestational weeks 7 (16) 1 (4) 1 (17) 9 (12)
Preterm babies: < 28 gestational weeks 7 (16) 3 (12) 0 10 (13)
Neonates with a birthweight below the
10th centile for gestational age
4 (9) 3 (12) 0 7 (9)
Preterm babies: > 30 gestational weeks 4 (9) 2 (8) 0 6 (8)
None 3 (7) 1 (4) 0 4 (5)
Babies not receiving any respiratory support 2 (5) 1 (4) 0 3 (4)
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Score changes from round 1 to round 2
Figure 4 in Report Supplementary Material 2 shows the number of outcomes for which a respondent
changed their score between rounds 1 and 2. Twenty-five per cent of respondents (15/61) changed
their minds for one, two or no outcomes, which means that the remaining 75% changed their minds for
at least three outcomes. These results suggest that including a second round in the e-Delphi was a
useful exercise.
Outcome scores
Table 6 in Report Supplementary Material 2 shows the median rating given at the end of round 2 for
each outcome considered. This shows a little heterogeneity between groups for some outcomes, but
also some outcomes that are rated as important by all. No outcomes had a median rating of < 4 in any
group, showing that, in general, no outcome was considered as ‘unimportant’ by our respondents.
Consensus statistics
Five outcomes were categorised as ‘consensus in’ in all three stakeholder groups (Table 21): (1) days on
parenteral nutrition, (2) incidence of NEC, (3) time feed stopped per 24 hours, (4) time from start of
enteral feeding to achieve full (150 ml/kg/day) enteral feeds and (5) mortality. No outcomes could be
categorised as ‘consensus out’ and the remaining 17 outcomes were categorised as ‘no consensus’.
If we ignore stakeholder groups, four outcomes reached ‘consensus in’: (1) days of central venous line
access, (2) change in weight (growth) between birth and NNU discharge, (3) health-care-associated
infections and (4) incidence of catheter-associated bloodstream infections, but these did not achieve
the a priori threshold. Note, our small sample size for dietitians (n = 3) had undue influence over the
‘consensus in’ threshold: it required only one dietitian to score an outcome < 7, regardless of the
opinions of other groups, for the outcome to drop below the threshold for ‘consensus in’.
TABLE 21 Percentage of participants who scored 7–9, by stakeholder group, for outcomes in NNU round 2
(in descending order)
Outcome
Neonatal and
paediatric
doctors/paediatric
surgeons (n= 40), %
Neonatal and
paediatric nurses
(n= 18), %
Neonatal
dietitians
(n= 3), %
All
(n= 61), %
Consensus
status
Mortality 100a 100.0a 100.0a 100.0b Consensus in
Incidence of NEC 100a 94.4a 100.0a 98.4b Consensus in
Time from start of enteral
feeding to achieve full
(150 ml/kg/day) enteral feeds
92.5a 88.9a 100.0a 91.8b Consensus in
Health-care-associated infections 87.5a 88.9a 66.7 86.9a No consensus
Days on parenteral nutrition 77.5a 94.4a 100.0a 83.6b Consensus in
Incidence of catheter-associated
bloodstream infection
85.0a 70.6a 66.7 80.0a No consensus
Time feed stopped per 24 hours 70.0a 83.3a 100.0a 75.4b Consensus in
Change in weight (growth)
between birth and NNU
discharge
75.0a 77.8a 66.7 75.4a No consensus
Days of central venous line
access
75.0a 72.2a 66.7 73.8a No consensus
Length of stay in hospital 45.0 72.2a 100.0a 55.7 No consensus
continued
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Primary outcome suggestion responses
In round 2, after rating the 26 outcomes, respondents were asked to suggest a primary outcome from
the list of 26. Forty-eight out of 61 respondents (79%) suggested at least one primary outcome,
although some suggested more than one (Table 22). Overall, 39% of HCPs chose ‘incidence of NEC’ and
30% of HCPs chose ‘time from start of enteral feeding to achieve full (150 ml/kg/day) enteral feeds’.
TABLE 21 Percentage of participants who scored 7–9, by stakeholder group, for outcomes in NNU round 2
(in descending order) (continued )
Outcome
Neonatal and
paediatric
doctors/paediatric
surgeons (n= 40), %
Neonatal and
paediatric nurses
(n= 18), %
Neonatal
dietitians
(n= 3), %
All
(n= 61), %
Consensus
status
Incidence of pneumonia due to
milk aspiration
37.5 76.5a 66.7 50.0 No consensus
Length of stay: NNU 35.0 72.2a 66.7 47.5 No consensus
Long-term outcomes: problems
with mobility like cerebral palsy
45 50.0 33.3 45.9 No consensus
Long-term outcomes: problems
with cognition
35.0 38.9 33.3 36.1 No consensus
GI morbidity: vomiting 30.0 61.1 100.0a 42.6 No consensus
Change in head circumference
between birth and NNU
discharge
42.5 23.5 100.0a 40.0 No consensus
Change in length (growth)
between birth and NNU
discharge
42.5 27.8 66.7 39.3 No consensus
Long-term outcomes: problems
with cognition
35.0 38.9 33.3 36.1 No consensus
Long-term outcomes: brain injury
on imaging
25.0 33.3 33.3 27.9 No consensus
Time to oral feeding 27.5 23.5 33.3 26.7 No consensus
Length of time: IV 12.5 50.0 66.7 26.2 No consensus
Long-term outcomes: hearing
loss
15.0 27.8 33.3 19.7 No consensus
Long-term outcomes: problems
with eyesight
15.0 27.8 33.3 19.7 No consensus
Nursing time spent measuring
GRV
5.0 27.8 66.7 14.8 No consensus
GI morbidity: diarrhoea 5.0 27.8 33.3 13.1 No consensus
Total length of time on
respiratory support (IV+NIV)
2.5 27.8 0 9.8 No consensus
Time to nasogastric tube
removal
10.0 5.6 0 8.2 No consensus
a ‘Consensus in’ criteria were met: ≥ 70% scored 7–9 and < 15% scored 1–3.
b ‘Consensus in’ criteria met in all groups.
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Summary of findings to inform the GASTRIC trial
These trial design surveys and the e-Delphi study have allowed us to generate a list of ‘clinician-
acceptable’ inclusion and exclusion criteria for future PICU and NNU trials. This enabled us to request
data from national data sets to determine potential eligible numbers of children for a future trial.
It has also allowed us to gauge clinician’s acceptability on a wider scale, with regard to willingness
to randomise. Most importantly, for both PICUs and NNUs, we have been able to generate a list of
outcomes measures for a future trial, including the preferred primary outcome measure. This enabled
us to conduct final voting (on the non-consensus outcomes) at the face-to-face consensus meeting.
TABLE 22 Summary statistics for suggested primary outcome
Primary outcome suggested
Neonatal and paediatric
doctors/paediatric
surgeons (N= 40), n (%)
Neonatal and
paediatric nurses
(N= 18), n (%)
Neonatal
dietitians
(N= 3), n (%)
All
(N= 61),
n (%)
Incidence of NEC 19 (48) 5 (28) 0 24 (39)
Time from start of enteral feeding
to achieve full (150 ml/kg/day)
enteral feeds
12 (30) 5 (28) 1 (33) 18 (30)
Mortality 8 (20) 0 0 8 (13)
Days of central venous line access 4 (10) 1 (6) 0 5 (8)
Days on parenteral nutrition 2 (5) 1 (6) 1 (33) 4 (7)
Length of stay in hospital 2 (5) 0 0 2 (3)
Length of stay NNU 2 (5) 0 0 2 (3)
Incidence of pneumonia due to milk
aspiration
0 2 (11) 0 2 (3)
Change in weight (growth) between
birth and NNU discharge
1 (3) 0 0 1 (2)
Change in length (growth) between birth
and NNU discharge
1 (3) 0 0 1 (2)
Long-term outcomes: problems with
eyesight
1 (3) 0 0 1 (2)
Long-term outcomes: problems with
cognition
1 (3) 0 0 1 (2)
Long-term outcomes: problems with
mobility (e.g. cerebral palsy)
1 (3) 0 0 1 (2)
Health-care-associated infections 0 1 (6) 0 1 (2)
Time to oral feeding 1 (3) 0 0 1 (2)
No primary outcome suggested 6 (15) 6 (33) 1 (33) 13 (21)
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Chapter 4 Analysis of national data sets
for trial feasibility
Introduction
Work package 4 analysed the data gathered and used two existing national databases, the National
Neonatal Research Database (NNRD) and the Paediatric Intensive Care Audit Network (PICANet),
to explore the size of eligible populations and inform sample sizes for potential future trials of GRV
compared with no GRV in UK PICUs and NNUs.
Aims and objectives
To determine potential patient recruitment numbers based on inclusion and exclusion criteria and,
when these data are collected, to obtain summary statistics for potential primary and secondary
outcomes identified by consensus from WP 3.
Study management
This WP was led by LNT and RP (for PICUs) and CG (for NNUs). The SMG statisticians (BA and APJ)
summarised the analysed data.
Methods
Paediatric Intensive Care Audit Network
Data items
The PICANet collects basic demographic and clinical data on all children admitted to designated
PICUs in the UK and Ireland. Each admission constitutes an episode, and an individual may have
several episodes in the database. Episodes may be aggregated by individual PICUs or by census or
administrative geographies using standard postcode lookup tables (the National Statistics Postcode
Directory). PICANet has permission to collect patient-identifiable data under section 251 of the
National Health Service Act 200634 (originally enacted under section 60 of the Health and Social
Care Act 200135). PICANet collects data on demographics, admission characteristics, presenting
physiology (to allow calculation of the expected probability of mortality for risk adjustment), diagnostic
information, clinical interventions and outcome. A full list of data items and data definitions can be
found at www.picanet.org.uk/documentation.
Data quality
Ensuring quality is part of the PICANet process. At input, internal logical, consistency and range
checks are carried out within the software, with an on-screen summary of outstanding validation
checks on completion of a record for the data entry personnel on the unit. Units can access admission
reports (among many others) that allow them to cross-check against admission books and patient
administration systems. This system of checks provides an ongoing audit of the quality of the PICANet
data. Validation visits are carried out annually to review a sample of records and cross-check that the
data submitted to PICANet correspond with the data held in the patient’s clinical records. Detailed
feedback is sent to the unit following these visits to ensure that any problems with data collection
and abstraction can be dealt with locally.
DOI: 10.3310/hta24230 Health Technology Assessment 2020 Vol. 24 No. 23
© Queen’s Printer and Controller of HMSO 2020. This work was produced by Tume et al. under the terms of a commissioning contract issued by the Secretary of State for
Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in
professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial
reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House,
University of Southampton Science Park, Southampton SO16 7NS, UK.
55
Data snapshot
A data request was formally made to PICANet in December 2018, based on the results of the e-Delphi
survey findings. We received the anonymised data in March 2019.
Inclusion criteria
Admissions to a UK PICU during 2016 and 2017 who were:
l aged > 37 weeks’ gestation to 17 years
l intubated and mechanically ventilated.
Exclusion criteria
l Length of stay in the PICU < 24 hours.
l Extubated, non-invasive or high-flow nasal cannula ventilation.
l Admitted after surgical admission with a GI diagnostic group.
Methods
The total number of children fulfilling the inclusion and exclusion criteria was found and split by
subgroup: age group and whether a surgical or medical admission. Only two ‘consensus in’ outcomes
relevant to the GASTRIC trial are recorded in PICANet: length of stay (categorised as 1 or 2 days, 3–7
days and > 7 days) and length of time intubated [categorised as 1 day, 2 days, 3–7 days and > 7 days,
but also as a continuous measure (number of days)]. Numbers and percentages in each outcome
category were reported, split by subgroup. Median [interquartile range (IQR)] length of time intubated
was reported by subgroup. PICANet also collects mortality data, but as UK PICU mortality is so low
(< 4% consistently)36 we did not request these data specifically.
National Neonatal Research Database
The NNRD holds data from all infants admitted to NHS NNUs in England, Scotland and Wales
(approximately 90,000 infants annually). The NNRD is formed from data extracted from the neonatal
electronic health record system used by HCPs during routine clinical care. Briefly, daily clinical information
on NNU admissions is recorded at the point of care in clinician-entered electronic patient records.
A defined data extract, the Neonatal Data Set (NHS Information Standard SCCI595), is transmitted
quarterly to the Neonatal Data Analysis Unit at Imperial College London and Chelsea and Westminster
Hospital NHS Foundation Trust, where patient episodes across different hospitals are linked and data
are cleaned and entered into the NNRD. Contributing NNUs are known as the UK Neonatal Collaborative.
The NNRD is approved by the National Research Ethics Service (10/H0803/151), Confidentiality Advisory
Group of the Health Research Authority [805(f)/2010], and Caldicott Guardians and lead clinicians of
contributing hospitals.
Data items
The NNRD holds the Neonatal Data Set, approximately 450 data items that form a NHS data
standard.37
Data items include demographic and admission items (e.g. maternal conditions, birthweight), daily items
[entered every day for all infants (e.g. respiratory support, feeding information)], discharge items (e.g.
feeding and weight at discharge) and ad hoc items [entered if they occur (e.g. suspected infection,
ultrasound scan findings, abdominal radiographic findings)].
Data quality
Data extracted from the neonatal electronic patient record are cleaned and records with implausible
data configurations are queried and corrected by the treating clinicians. Cleaning is carried out by the
Neonatal Data Analysis Unit before data are incorporated into the NNRD. The robustness of core
NNRD data (birth weight, sex, length of stay and death) has been previously demonstrated for research
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purposes. Accuracy and completeness of NNRD data were confirmed by comparison with case record
forms from the National Institute for Health Research Health Technology Assessment Probiotics in
Preterms trial, which showed high data completeness and accuracy (> 95%).38 Data held in the NNRD
are used for multiple purposes, including national audit [the Healthcare Quality Improvement
Partnership-funded National Neonatal Audit Programme (NNAP)] and analyses for the Department of
Health and Social Care, NHS England and the Chief Medical Officer.
Data snapshot
Inclusion criteria
Babies admitted to a NNU in England or Wales during 2017 and 2018, who had at least 1 day of care in
which the location was a NNU (NICU, LNU or SCBU). Only days of care when the baby was recorded as
being on the NNU were included.
Methods
The total number of children fulfilling each of three separate inclusion criteria was found:
1. gestational age at birth < 32 weeks
2. mechanically ventilated at any point during NNU stay
3. received gastric tube feeds at any point during NNU stay.
The following outcomes measured by NNRD were summarised with descriptive statistics, split by each
inclusion criterion:
l mortality during NNU stay
l NEC
l central line-associated bloodstream infection
l incidence and duration of central line duration
l incidence and duration of parenteral nutrition
l incidence and duration of mechanical ventilation
l time from birth to achieve full enteral feeds (150 ml/kg/day)
l length of NNU stay.
Outcomes were summarised with descriptive statistics, split by inclusion criteria subgroup. Variable
codes used for searches can be found in Appendix 9.
Results
Paediatric Intensive Care Audit Network
In 2016 and 2017 there were 16,122 children treated in PICUs that satisfy all the inclusion and
exclusion criteria. Table 23 shows the results of the search, split by age group and whether surgical or
medical. Of the children included, 36% were surgical (5813/16,122) and 64% were medical (10,309/
16,122). The age distribution is similar for surgical and medical, skewed to younger years (median age
category 1–12 months, 21% were aged < 1 month and 87% aged < 11 years).
A total of 12,629 (78%) of the children stayed in a PICU for ≥ 3 days. The most common length of stay
was 3–7 days overall (7712/16,122, 48%) and in medical admissions (5022/10,309, 49%), regardless of
age. In surgical admissions, children aged < 1 year were also likely to stay 3–7 days (1707/3306, 52%),
whereas children aged ≥ 1 year were most likely to stay 1 or 2 days (1071/2507, 43%).
A total of 10,341 (65%) of the children were intubated for ≥ 3 days. The most common length of
intubation was 3–7 days overall (7026/16,122, 44%) and in medical admissions (5117/10,309, 50%),
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regardless of age. In surgical admissions, children aged < 1 month were also likely to be intubated for
3–7 days (609/1068, 57%), whereas children aged ≥ 1 month were most likely to be intubated for 1 or
2 days (2896/4745, 61%). The median intubation duration for medical admissions was 4 days for all
age groups except babies aged < 1 month, for whom the median was 5 days. In surgical admissions,
median intubation was shorter (2 days for all age groups except babies aged < 1 month, for whom the
median was 4 days).
Note that no other GASTRIC-trial relevant outcomes are collected by PICANet.
TABLE 23 Paediatric Intensive Care Audit Network summary statistics for outcomes of interest to the GASTRIC trial
Patient population All
Age group
< 1
month
1–12
months
1–4
years
5–10
years
11–14
years
15–17
years
All eligible (surgical and
medical), n (%)
16,122 3401 (21) 5298 (33) 2804 (17) 2514 (16) 1326 (8) 779 (5)
Surgical
Surgical, n (% within age
group)
5813 (36) 1068 (31) 2238 (42) 946 (34) 820 (33) 454 (34) 287 (37)
Length of stay (days), n (% of surgical admissions within age group)
1 or 2 1888 (32) 137 (13) 680 (30) 383 (40) 353 (43) 209 (46) 126 (44)
3–7 2690 (46) 615 (58) 1092 (49) 366 (39) 326 (40) 172 (38) 119 (41)
> 7 1235 (21) 316 (30) 466 (21) 197 (21) 141 (17) 73 (16) 42 (15)
Length of time (days) intubated, n (% of surgical admissions within age group)
1 1339 (23) 46 (4) 432 (19) 300 (32) 317 (39) 147 (32) 97 (34)
2 1800 (31) 197 (18) 772 (34) 304 (32) 245 (30) 178 (39) 104 (36)
3–7 1909 (33) 609 (57) 741 (33) 226 (24) 180 (22) 92 (20) 61 (21)
> 7 765 (13) 216 (20) 293 (13) 116 (12) 78 (10) 37 (8) 25 (9)
Length of time intubated
(days), median (IQR)
4 (4) 2 (3) 2 (3) 2 (2) 2 (2) 2 (2)
Medical
Medical, n (% within age
group)
10,309 (64) 2333 (69) 3060 (58) 1858 (66) 1694 (67) 872 (66) 492 (63)
Length of stay (days), n (% of medical admissions within age group)
1 or 2 1605 (16) 196 (8) 390 (13) 392 (21) 352 (21) 175 (20) 100 (20)
3–7 5022 (49) 1280 (55) 1553 (51) 857 (46) 757 (45) 379 (43) 196 (40)
> 7 3682 (36) 857 (37) 1117 (37) 609 (33) 585 (35) 318 (36) 196 (40)
Length of time intubated (days), n (% of medical admissions within age group)
1 876 (8) 105 (5) 205 (7) 208 (11) 200 (12) 106 (12) 52 (11)
2 1766 (17) 302 (13) 486 (16) 360 (19) 348 (21) 173 (20) 97 (20)
3–7 5117 (50) 1353 (58) 1596 (52) 853 (46) 738 (44) 378 (43) 199 (40)
> 7 2550 (25) 573 (25) 773 (25) 437 (24) 408 (24) 215 (25) 144 (29)
Length of time intubated
(days), median (IQR)
5 (4) 4 (5) 4 (5) 4 (5) 4 (5) 4 (7)
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National Neonatal Research Database
In 2017 and 2018 a total of 129,155 infants were admitted to a NNU in England, Wales or Scotland.
Of these infants, 15,375 (12%) had a recorded gestational age at birth < 32 weeks and 23,868 (18%)
were recorded to have received mechanical ventilation and 82,555 (64%) to have received nasogastric
tube feeds. Further details describing the level of unit of birth (NICU, LNU or SCBU) for these infants
is available in Appendix 10. Summary statistics for outcomes, stratified by different potential study
populations, are shown in Table 24.
Table 24 shows that babies born at < 32 weeks’ gestation have different outcomes from the general
NNU population. The outcomes of mechanically ventilated babies are also different from those of the
general NNU population, but to a lesser extent than babies born at < 32 weeks’ gestation. Infants who
receive gastric tube feeds also have a longer length of stay. All duration outcomes are non-normally
distributed and skewed. Feeding times vary considerably across each group.
Summary of findings to inform the GASTRIC trial
The analysis of both the national PICU and NNU databases reveal that there are sufficient numbers of
potentially eligible patients meeting the inclusion and exclusion criteria to potentially conduct a trial
with individual randomisation of patients.
For PICUs, only three of the outcomes are collected routinely in PICANet: (1) length of ventilation,
(2) PICU length of stay and (3) mortality. As discussed previously, mortality is so low (4%) so, although
collected as part of any trial, would never be a primary outcome. However, few of the data collected by
PICANet are relevant to the GASTRIC trial, limiting the usefulness of PICANet as a source of data in
any future trial.
TABLE 24 National Neonatal Research Database summary statistics for outcomes of interest to the GASTRIC trial
Outcome
Inclusion criterion
All admissions
to NNUs
(N= 129,155)
Born at
< 32 gestational
weeks (N= 15,375)
Mechanically
ventilated
(N= 23,868)
Received
nasogastric
tube feeds
(N= 82,555)
Mortality, n (%) 1290 (8) 1978 (8) 895 (1) 2072 (2)
NEC, n (%) 806 (5) 778 (3) 770 (1) 806 (1)
Catheter-associated bloodstream infection,
n (%)
1004 (7) 1089 (5) 1127 (1) 1180 (1)
Had a central venous line in situ, n (%) 12,517 (81) 17,505 (73) 23,322 (28) 26,332 (20)
Median duration in days (IQR) 9 (4–15) 6 (0–12) 0 (0–3) 0 (0–0)
Received parenteral nutrition, n (%) 12,634 (82) 13,707 (57) 19,396 (23) 20,476 (16)
Median duration in days (IQR) 9 (5–15) 4 (0–11) 0 (0–0) 0 (0–0)
Received mechanical ventilation, n (%) 10,335 (67) 23,868 (100) 20,762 (25) 23,868 (18)
Median duration in days (IQR) 2 (0–6) 2 (1–5) 0 (0–1) 0 (0–0)
Time from start of enteral feeding to achieve
full (150 ml/kg/day) enteral feeds, median
duration in days (IQR)
12 (9–17) 11 (8–16) 6 (4–9) 5 (3–8)
Duration of NNU stay, median duration in
days (IQR)
50 (34–76) 24 (9–59) 11 (4–24) 5 (2–16)
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For NNUs, five of the six ‘consensus in’ items and all three outcomes deemed to be highly important
for two stakeholder groups are routinely extracted and held in the NNRD. This indicates that a data-
enabled approach to any future trial would be potentially feasible using existing neonatal electronic
patient record systems and data held in the NNRD.
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Chapter 5 Consensus and trial design meeting
Introduction
Work package 5 involved separate PICU and NNU face-to-face consensus meetings.
Aims and objectives
To bring together key stakeholders in each specialty, including national societies, parent groups, as well
as HCPs and triallists, to:
l gain stakeholders’ views on the preliminary results from WPs 1–4
l determine the acceptability of a routine GRV (control arm) and a no GRV (intervention arm) to a
wider group of UK HCPs and parents
l discuss and gain consensus on outcome measures that did not reach consensus in WP 3 of a
future trial
l discuss the feasibility of different study designs and randomisation methods of a future trial.
Study management
This WP was led by LNT (for PICUs) and CG (for NNUs). The SMG was responsible for organising the
meeting (HE) and keeping accurate records for the meetings. The whole SMG team attended these
meetings. The independent facilitation of the meeting was carried out by Carrol Gamble (director
and statistician, Liverpool Clinical Trials Centre) and the summary and analysis of the voting on
non-consensus outcomes was done by BA.
Methods
Key stakeholders in both specialties were first identified. These were UK-based NNU and PICU
consultants, nurses, dietitians, general surgeons, parents with experience of having a child in NNUs
or PICUs, triallists and methodologists from trials units, and key individuals who led these specialist
research networks. Individuals were invited to attend a 1-day face-to-face meeting in central London
in April 2019. Potential HCPs were contacted through our national networks via e-mail and we tried
to get attendance from a range of units geographically and from different types of units. Potential
parent participants were invited through our Parent Advisory Group, through our study Twitter
account, through the charities and via our Parent Forum Group. The preliminary results of the WPs
were presented for discussion, to determine the acceptability of a future trial. Proposed ‘no GRV
(intervention) arms’ were presented from two members of the study team who work in a PICU (FVV)
and a NNU (AB) in Lyon, France, where GRV is not routinely measured. Following this, outcomes that
failed to reach consensus in WP 3 were discussed and voted on using TurningPoint software. With
consent from participants, the discussion from the meeting was audio-recorded to ensure no important
points were missed. The discussions were summarised and the results of the voting were used to
classify the final consensus status of each outcome (in/out/no consensus) using the criteria outlined
in Table 14. (Note that all participants were considered as a single group, so results were not split by
stakeholder group.)
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Paediatric intensive care unit meeting report
Participants
The following members of the SMG attended the NNU meeting:
l Barbara Arch
l Frederic Valla (member of the SMG who participated in voting)
l Helen Eccleson
l Jennifer Preston
l Kerry Woolfall
l Louise Roper
l Lynne Latten (member of the SMG who participated in voting)
l Lyvonne Tume (member of the SMG who participated in voting)
l Nazima Pathan (member of the SMG who participated in voting).
Twenty-two HCPs (three paediatric dietitians, seven paediatric doctors, 11 paediatric nurses and one
paediatric general surgeon) attended this meeting, representing 13 of 29 (45%) UK PICUs: Royal Hospital
for Children (Glasgow), Leeds General Infirmary (Leeds), Great North Children’s Hospital (Newcastle),
Manchester University Foundation Trust (Manchester), Alder Hey Children’s Hospital (Liverpool),
Birmingham Children’s Hospital (Birmingham), Nottingham Children’s Hospital (Nottingham), Bristol Royal
Hospital for Children (Bristol), Noah’s Ark Children’s Hospital for Wales (Cardiff), University Hospital
Southampton NHS Foundation Trust (Southampton), Imperial College Healthcare NHS Trust (London),
Evelina London Children’s Hospital (London) and Great Ormond Street Hospital for Children (London).
Discussion areas
Health-care professionals queried whether or not it was important to protocolise the control arm and
this may be problematic if the trial was a cluster design. Dietitians confirmed the Schofield equation
for estimation of energy requirements would be their standard practice, with the exception of one who
expressed concerns that a huge amount of work has been done in their unit with regard to their own
nutritional assessment and a change in assessment may cause confusion when patients step down to
other wards. There was discussion about units being allowed to set their own energy targets, but that
if a predefined energy target was not set, some units may overfeed or underfeed. Further discussion
was that the Schofield equation is the internationally accepted and recommended assessment equation
for PICU and could be used to standardise the assessment. One unit stated that their PICU would
not be willing to increase fluid allowance to achieve targets and thus would not be able to be part
of a future trial.
There was also discussion about cluster randomisation and that if a future trial was a cluster trial, then
local habits could influence the outcome. However, if a future trial was a RCT, then local habits would
be balanced. HCPs queried whether or not the feed volume could be standardised across the control
and intervention arms, as the amount of fluid delivered to a child will differ and may have an impact on
outcomes and may also have an impact on feed tolerance. It was discussed that there are also differences
in feed types, which may have an impact on gastric emptying. It was highlighted that there is variation in
feeding method and formula used between units, and it would be impossible to standardise it all. There
was discussion about how pragmatic a trial could be when minimising crossover between arms. HCPs
discussed that a cluster trial would make the process a lot simpler, as introducing two new practices
in a unit would be difficult.
Many HCPs preferred a cluster design trial and there was lots of discussion around this issue. Many
believed that this would be better accepted among PICU staff, with views that it was an ‘easier option’
when changing practice. Considerable discussion took place about the feasibility of a cluster design
in UK PICUs, especially as unit practices were not the same across the country and the trial results
might be criticised because any differences between the two arms could be due to an imbalance in
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characteristics between the two arms, rather than due to the intervention. It was discussed that cluster
trials can be matched on several important prognostic factors; however, there is such a strong level of
variation in practice that it would diminish the value of the result, and, with only 15–19 ‘research-active’
PICUs in the UK, powering a cluster design would probably not be possible. There was a question about
the possibility of using a stepped-wedge trial design (as in a current UK trial). The team outlined that this
trial was different, in that the intervention was a team-based ‘best-practice’ protocol, which would have
been impossible to do with individual randomisation, and, although the intervention may not be beneficial,
it was ‘best practice’ and thus would be unlikely to cause harm. This cannot be applied to the GASTRIC
trial, as we do not know if not measuring GRV will be beneficial or if it may cause harm. In terms of
parent-proposed outcomes, one participant raised the issue of potential parent bias in the outcomes,
because a proportion (4/10 parents interviewed) were parents of cardiac patients and they have known
problems with feeding issues in the longer term and have a big focus on weight gain.
Dr Frederic Valla (Lyon, France), a SMG member, presented a unit protocol that does not measure GRV
routinely. Unlike French NNUs, there were no before and after data, as they have not undertaken this
practice for nearly 20 years (more detail is presented in Chapter 7).
Paediatric intensive care unit outcomes: consensus results
A total of 22 outcomes were discussed; however, four had previously achieved ‘consensus in’ from the
e-Delphi (see Chapter 3). Therefore, 18 outcomes were voted on at the meeting. Of these, eight were
voted ‘consensus in’, six were voted ‘consensus out’ and four failed to achieve consensus in or out
(Table 25). Full results, including voting statistics, can be found in Table 2 in Report Supplementary
Material 3.
TABLE 25 Final consensus status of outcomes considered during the PICU meeting
Outcome Consensus status
Administration of parenteral nutrition, secondary to feed intolerance Consensus in
Change to feed formula type, secondary to feed intolerance Consensus in
Change in weight (growth) between PICU admission and discharge Consensus in
Incidence of NEC Consensus in
Length of time: IV Consensus in
Length of stay: PICU Consensus in
Mortality Consensus in
Post-pyloric feeding (placing a post-pyloric tube), secondary to feed intolerance Consensus in
Administration of prokinetic drugs, secondary to feed intolerance No consensus
GI morbidity: diarrhoea No consensus
Length of stay: hospital No consensus
Total length of time on respiratory support (IV +NIV) No consensus
Long-term feeding issues Consensus out
Long-term outcomes (after hospital discharge) Consensus out
Looking and/or behaving like their normal self Consensus out
Nursing time spent measuring GRV Consensus out
Change in length (growth) between PICU admission and discharge Consensus out
Parental satisfaction Consensus out
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Neonatal unit meeting report
Participants
The following members of the SMG attended the NNU meeting:
l Anne Beissel (member of the SMG who participated in voting)
l Barbara Arch
l Chris Gale (member of the SMG who participated in voting)
l Helen Eccleson
l Iza Andrzejewska (member of the SMG who participated in voting)
l Jennifer Preston
l Kerry Woolfall
l Louise Roper
l Lyvonne Tume.
Nineteen participants (one neonatal charity representative, one clinical triallist and methodologist, two
neonatal dietitians, five neonatal doctors, seven neonatal nurses, one paediatric general surgeon and
two parents) attended this meeting from 14 out of 184 (8%) UK NNUs, three UK universities and a
neonatal charity: Bliss, Bradford Teaching Hospitals NHS Foundation Trust (Bradford), Chelsea and
Westminster Hospital (London), Great Ormond Street Hospital (London), NHS Greater Glasgow and
Clyde (Glasgow), Lancashire Teaching Hospitals NHS Foundation Trust (Preston), North Bristol NHS
Trust (Bristol), Portsmouth Hospitals NHS Trust (Portsmouth), Sheffield Teaching Hospitals NHS
Foundation Trust (Sheffield), Shrewsbury and Telford Hospital NHS Trust (Shrewsbury), University
Hospitals of Leicester NHS Trust (Leicester), University of Oxford (Oxford), University of Southampton
(Southampton), University of West London (London) and William Harvey Hospital (Ashford).
Discussion areas
There was discussion around specifics of a protocolised control arm or whether or not we allow a
more pragmatic approach and not ‘define’ a control arm. Specifically, issues were raised about defining
a specified time period that feeds would be withheld after large GRVs and what to do with returning
aspirates. One consultant said that they would go with a GRV control arm, even though their unit does
not currently routinely measure GRV. A nurse stated that in their unit they would not be happy going
back to measuring GRV, as this practice stopped many years ago. A good point was raised about not
using the term ‘intervention arm’ and instead using ‘aspirate’ or ‘no aspirate’ arms, to acknowledge that
around 30% of UK NNUs do not measure it routinely. There was further discussion and debate about
a cluster compared with individual randomised trial, with the methodologists, triallists and statisticians
strongly recommending a standard trial. This recommendation was on the basis that cluster trials
usually require larger sample sizes and are therefore more difficult to fund, there needs to be a large
number of units taking part to balance out centre-specific heterogeneity in methods of care and
patient populations, and that a cluster design would necessarily exclude Scottish NNUs. Clinicians and
some parents preferred a cluster randomisation approach, with factors cited including being a ‘whole
unit education and intervention’ being less confusing, easier for practice and fewer problems with
agency nursing staff. Additionally, consent could be obtained at an institutional level, rather than
needing to be sought from families in a moment of distress. The overall view was that most babies
should be included, but any surgical babies and babies with cardiac lesions (awaiting transfer to a
PICU) should be excluded (and these would comprise small numbers estimated at < 10% anyway).
This would also increase ‘buy-in’ from units for a future trial.
Dr Anne Beissel (Lyon, France), a SMG member, presented a no GRV protocol and the impact of this on
their unit after changing in the last 5 years. This NICU had measured the impact of a no GRV protocol
on their outcomes of NEC, time to feeding tube removal and hospital length of stay. They found that
the incidence of NEC in their unit (in infants < 33 weeks’ gestation) was 2.8–3% (comparable to the
2–7% incidence reported in the recent literature39). The median age of feeding tube removal was
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33.8 weeks (or 60 days of life) and the median hospital length of stay was 89.8 days for infants at
< 28 weeks’ gestation, 52.2 days for infants between 28 and 31 weeks’ gestation and 25.5 days for
infants between 31 and 36 weeks’ gestation. This is comparable to that reported in the literature40
and was not affected by not measuring GRV.
Neonatal unit outcomes: consensus results
A total of 26 outcomes were discussed, but five of these were already voted as ‘consensus in’ from the
e-Delphi (see Chapter 3). Voting therefore took place on the remaining 20 no-consensus outcomes. Of
these, four were voted ‘consensus in’, four were voted ‘consensus out’ and 12 outcomes remained as
‘no consensus’ (Table 26). Full results including voting statistics can be found in Table 1 in Report
Supplementary Material 2.
Summary of findings to inform future GASTRIC trials
The consensus meetings were very useful, enabling us to gain consensus on 12 outcomes that should be
measured in a future PICU trial: (1) time to and achievement of predicted energy goals, (2) incidence of
VAP, (3) time feed stopped per 24 hours, (4) incidence of GI morbidity (vomiting), (5) length of time on IV,
(6) length of stay in a PICU, (7) mortality, (8) post-pyloric feeding (placing a post-pyloric feeding tube),
secondary to feed intolerance, (9) administration of parenteral nutrition, secondary to feed intolerance,
(10) change to feed formula type, secondary to feed intolerance, (11) change in weight (growth) between
PICU admission and discharge and (12) incidence of NEC.
TABLE 26 Final consensus status of outcomes considered during the NNU meeting
Outcome Consensus status
Change in weight (growth) between birth and NNU discharge Consensus in
Health-care-associated infections Consensus in
Incidence of catheter-associated bloodstream infection Consensus in
Incidence of pneumonia due to milk aspiration Consensus in
Change in head circumference between birth and NNU discharge No consensus
GI morbidity: vomiting No consensus
Length of stay: hospital No consensus
Length of stay: NNU No consensus
Length of time: IV No consensus
Long-term outcomes: hearing loss No consensus
Long-term outcomes: problems with eyesight No consensus
Long-term outcomes: problems with cognition No consensus
Long-term outcomes: brain injury on imaging No consensus
Long-term outcomes: problems with mobility (e.g. cerebral palsy) No consensus
Time to oral feeding No consensus
Total length of time on respiratory support (IV +NIV) No consensus
Change in length (growth) between birth and NNU discharge Consensus out
GI morbidity: diarrhoea Consensus out
Nursing time spent measuring GRV Consensus out
Time to nasogastric tube removal Consensus out
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We gained consensus on nine outcomes to be measured in a future NNU trial: (1) mortality, (2) the
incidence of NEC, (3) time from start of enteral feeds to achieve full feeds (150 ml/kg/day), (4) days
on parenteral nutrition, (5) time feed stopped per 24 hours, (6) change in weight (growth) between
birth and unit discharge, (7) health-care-associated infections, (8) incidence of catheter-associated
bloodstream infections and (9) incidence of pneumonia due to milk aspiration. Furthermore, they
allowed us to determine wider UK acceptability and ‘buy-in’ for a future trial, beyond that ascertained
in the focus groups and interviews, and to discuss and debate some of the more contentious issues
around a future trial that could be captured in the trial design survey.
CONSENSUS AND TRIAL DESIGN MEETING
NIHR Journals Library www.journalslibrary.nihr.ac.uk
66
Chapter 6 Patient and public involvement
Aim
To gain meaningful PICU and NNU parents’ perspectives and input into a future GASTRIC trial.
Parent involvement objectives
Objective 1
l Obtain NNU and PICU parents’ views on the design of the study.
l Include input into the acceptability of the proposed trial.
l Address outcome measures.
l Review participant information and to discuss any potential barriers or opportunities to recruitment.
Objective 2
l To obtain feedback from parents regarding the results of the study. This was delivered via two
webinars, one aimed at NNU parents and one aimed at PICU parents. Feedback would be
incorporated into the consensus meetings.
Objective 3
l Parent involvement in NNU and PICU consensus meetings.
Prior to the study commencing, we consulted with parents from both neonatal intensive care (through
personal contacts and via the charity Bliss) and paediatric intensive care (through the PICANet
parents’ group and personal contacts). We also consulted with an ex-PICU patient (now aged 18 years).
All parents agreed that this topic was important to them and that the proposed feasibility study would
genuinely elicit parents’ views.
Methods
In the original application, we set out to form a parent advisory group made up of parents who had
experience of their child being in a NNU or a PICU, who would meet face to face at least twice during
the study. However, it proved difficult to recruit to such a group for face-to-face meetings for various
reasons, such as caring responsibilities, juggling work and geographical distance. Therefore, we sought
other virtual methods to engage with these parents.
Nine parents (five PICU parents, two NNU parents and two parents having had experience of both
NNUs and PICUs) took part in a virtual capacity (five in the study design phase and four in the
feedback webinar sessions). One parent became a member of the Study Management Group and two
parents attended the face-to-face consensus meetings. Parents were contacted through a variety of
channels, including parent support groups, social media and parent charity organisations (e.g. Bliss).
To compensate for the lack of face-to-face meetings, parents were offered support via a parent and
carers’ research forum (based at Alder Hey Children’s Hospital, co-ordinated by the patient and public
involvement manager, JP). The group offers ongoing support to parent members (with varied
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experiences of looking after a child with a chronic condition), through training, regular face-to-face
meetings (if family commitments allow), joining an online community (closed Facebook group), regular
contact with other parents and carers, and various opportunities to attend and present at conferences.
One parent is a member of this group and attends regular meetings, and three of the five parents
joined the closed Facebook group. The majority, however, preferred to communicate via e-mail or
telephone call, if necessary, if they had any questions.
Parent feedback on the design of the study
Five parents contributed to the design of the study. Study documentation, which included a lay
summary of the study, draft parent information, proposed outcome measures and the parent interview
guide, was shared with each parent. Guidance and prompts were shared with the documentation,
to include:
l Is the wording in the parent information sheet clear?
l Do you understand what the study team is trying to explain?
l Have the study team explained the list of possible outcomes well enough? Are they clear?
For the question guide for interviews:
l Do you think we have missed out any important questions?
l Are we asking the right questions to gauge parents’ views and opinions on a future trial like this?
l Do you have any other concerns?
Parent views on study documentation
Lay summary
Overall, parents felt that the lay summary was clear and easy to understand, although two parents
(PICU) highlighted their dislike of the phrase ‘sucking it out’ in reference to the withdrawing of
the fluid:
I understand it is wanting to not sound too medical but it just sounds a bit brutal when it really isn’t.
NNU parent
This raised a question from one parent, ‘when they suck out the child’s stomach contents do they put
it back?’. The parent suggested that maybe the response to this needs to be included in the parent
information sheet.
One parent did not like the mention of saving costs to justify the reason for undertaking the study:
I think it’s fine to say it saves time, etc., but no parents/patients ever want to hear costs being discussed
as we can’t put a price on our kids’ lives. Much better to phrase it that saving time for nurses leads to
better care, etc.
PICU parent
Parent feedback on the proposed GASTRIC RCT participant information sheet
All five parents highlighted the need to explain, in a little more detail, the potential benefits and risks
of the study:
It covers benefits well but when a child is on PICU a parent tends to think more about risks and
potentially negative outcomes to their own child rather than benefits to children in the future.
PICU parent
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Three parents (PICU, n = 2; NNU, n = 1) highlighted their dislike of the word ‘safe’, which appears
several times across all the documents (e.g. ‘To find out whether not routinely measuring GRV during is
safe and beneficial’). One parent stressed:
I would be inclined to remove the word ‘safe’ and instead talk about the ‘pros and cons’ of not measuring
GRV, premature parents make very good armchair medics, and the last thing NNU staff need is parents
questioning whether they are putting their baby at undue risk by measuring/not measuring GRV!
NNU parent
Another parent stressed:
We want to see whether it is safe – parents may have the understanding that the trial could potentially
be unsafe and could be putting their child at risk. Maybe change the wording in the information to – we
want to see whether the child is absorbing enough calories?
PICU parent
The parents felt that if the risks are explained enough then they thought that the study would be OK:
I suppose the main worry for any parent would be the risks associated with taking part, and as long as
these are fully discussed and reassurances made, I don’t see a problem.
NNU parent
Obtaining consent and the ability for parents to decide to participate in the study was a concern for
some parents. One parent felt that there was quite a lot of information to take in, and that verbally
discussing and explaining the study may be more useful to some parents:
There is a lot of text, but I’m not sure how else you could gain full consent without all the information
listed? My own experience was that I had pre-eclampsia and was really quite unwell for the first few days
my baby was in NNU. The unit was busy, we very rarely saw the same member of staff and some staff
were much better at communicating updates on my babies’ care than others. I am not even sure that
I would know the answers to a lot of these questions as I was either never given the information or
I was too ill to remember.
NNU parent
Another parent felt that the timing of the interview is crucial, especially for mothers of babies being tube fed:
It’s horrible when your baby is ill but actually, from my own memories, the tube feeding is soul destroying.
The most natural thing in the world is to feed your baby and so when that is taken away from you feel
completely useless as a mother. Parents need some time to adjust to that and really not questioned too
heavily on their thoughts on tube feeding and just asked the absolutely essential things for the study and
as concisely as possible.
PICU parent
The same parent was also not overly keen on the phrase ‘cannot eat normally’ because for her child,
and for many others, tube feeding is normal feeding: ‘Could this be changed to “cannot feed orally”
perhaps?’ (PICU parent).
One parent expressed the importance of producing a summary of the results to give to parents who
had participated:
There is no mention of follow up feedback or results? If I was consenting to the study I would like to
know I will receive some feedback at the end of the study.
PICU parent
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Overall, parents considered the draft PIS to be clear and felt that it explained the study well and was
written in a way people will find easy to interpret. A summary of what would benefit from further
clarification is provided in Box 4.
Parent feedback on the interview questions
The main feedback regarding the interview questions is that there were too many and could be
reduced. Parents felt that HCPs carrying out the study will have access to patients’ notes, either
electronically or on paper. Some of the questions can already be answered, for example ‘how long was
your child on a ventilator (differentiate between mechanical ventilation/ continuous positive airway
pressure/high flow)’. Some parents may understand this question, but others may not be able to
differentiate, and this information can be obtained beforehand.
One parent felt that some of the questions may be difficult for parents to answer precisely:
From my own experience, I would struggle to tell you exactly the amount of days/months we spent on
PICU and definitely struggle to recall the length of ventilation. I’m not sure if this is because we’ve been
there so many times or if it’s because I’ve tried to forget about it as it feels like a surreal situation being
on the unit. There are also a lot of questions to be asking parents whilst they are sat on PICU during a
stressful time. Could some of the information be obtained from the notes with consent?
PICU parent
General concerns about explaining risks and benefits were raised again:
In question 4 of the question guide, I would be inclined to expand the statement ‘we cannot guarantee
this will benefit your baby,’ to include an additional comment to the effect of, ‘However, we do guarantee
that it won’t cause harm, and won’t negatively affect their treatment’.
NNU parent
It might be worth adding a note to make it clear that the baby’s care will be provided by the same highly
qualified NNU/PICU doctors and nurses, irrespective of whether they participate in the study or not, and that
their decision about whether or not to participate will not, in any way, affect the care and treatment that
their child receives, other than the specific procedure of measuring GRV as outlined in the study notes.
NNU parent
Subtle word changes were also mentioned to avoid raising any further concern with parents:
I would advise changing ‘the babies reached their full levels of feeds and did not get ANY bowel infections
. . . ’ to ‘did not get AS MANY bowel infections . . .’ again, this subtle change in wording will avoid parents
questioning whether their child contracted NEC/needed bowel surgery as a result of what they now feel
(after reading about your study) might have been an unnecessary procedure.
NNU parent
BOX 4 Example suggestions for the improvement of the proposed GASTRIC trial PIS
NNU and PICU PIS
Additional information, suggested examples:
l When they suck out the child’s stomach contents do they put it back?
l Remove the word ‘safe’.
l Expansion on the proposed ‘risks’ and ‘benefits’.
l Feedback of the results to parents.
l Further detail on if parents will know if their child was allocated to the GRV group or the no GRV group.
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Parent feedback on outcome measures
Following a review of all previous research studies, looking at GRV measurement a list of proposed
outcomes for the GASTRIC trial was shared with the parents, to identify if there was anything missing.
The main outcomes parents wanted to add include:
l Were they able to take their baby home from the hospital?
l What setbacks did the family encounter during their baby’s stay in the hospital?
l Does the child have any lasting health issues?
l Was their child left with any long-term feeding issues as a result of their time on the PICU?
l Are they still tube fed or struggling to gain weight?
l Did they have any feeding or GI issues after the PICU stay?
One parent also suggested rephrasing the last point asking about survival, suggesting that this be
worded in less clinical, more compassionate terms.
Parent feedback on potential trial barriers to and opportunities for recruitment
Parents perceived that the main potential barrier to recruitment to any proposed study was the timing
of the approach.
Several suggestions were made on possible recruitment opportunities, which include:
l using social media would get attention but maybe not the responses
l a simple letter or e-mail to parents of the children asking if they would be interested in taking part
l asking parents whose child is having a planned admission to PICU beforehand
l involving organisations, such as Bliss, followed by Facebook groups specifically targeting parents of
preemies, such as the born-too-soon group on BabyCentre
(URL: www.babycentre.co.uk), as well as hospital support groups
l try to link with parent groups who have communities of > 100,000 mums.
Parent feedback webinars
Two evening webinars were held at a time agreed with the parents, one for PICU parents and one for
NNU parents. These webinars were used to thank parents for their contributions to date, feed back
the preliminary findings from the study so far and get parents’ feedback on this, which would inform
the preparation of the two planned consensus meetings. Despite the teams’ best efforts, only one
parent dialled into the NNU webinar (one mother) and four parents (one father and three mothers)
dialled into the PICU webinar.
Neonatal unit webinar
Following a short presentation of the results, the parents asked some questions:
l To clarify, what is meant by ‘surgical’ babies?
l Why did nurses prefer individual randomisation and parents prefer a cluster trial?
l Is it correct that feedback, so far, indicates that babies already showing signs of NEC should be
excluded from the study?
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In addition, the parent recalled the lack of recollection of GRV measurements being taken, and asked
whether or not all units in the UK measure GRV. The parent later followed this up in an e-mail
regarding the practice of the hospital in which her daughter was cared for:
Going back to the existing results, it would be interesting to see if the results are biased towards units
that do currently check GRV, and more specifically, what proportion of the 48% of units that didn’t
respond to your survey don’t check GRV (and, therefore, like my daughter’s hospital, felt as though they’d
have nothing useful to say on the subject)? Could it be that the checking of GRV isn’t quite as pervasive
as your findings suggest? Not sure how relevant this is to the study, but if it is important to know one way
or the other, it could be easily checked by running a simple ‘tick-box’ survey of units asking, say, ‘which of
the following are routinely practiced in your department . . .’ with a variety of different options, one being
the checking of GRV.
NNU parent
The parent also emphasised the point that parents’ experience of early stages of admission are hectic
and making decisions about feeds is not always their priority. It is also difficult to understand the
terminology in the early stages of admission.
Paediatric intensive care unit webinar
Similarly, a short presentation of the study results was given, then parents shared their experiences
and asked questions. Some parents had experience of both PICUs and NNUs and some were still home
tube feeding their child. The parents were all positive about the GASTRIC trial, and felt that it was
necessary and would benefit both the children and HCPs involved.
Questions and discussions included:
l Does checking aspirates help to identify issues or conditions such as NEC, bowel issues, etc.?
l Is the study team proposing measuring volumes at set times or at times of feeds or medication?
One parent discussed their experience of feeds being stopped because of large aspirates and agreed
with the suggestion that stopping feeds may not be the best for the child, and highlighted that calories
mean growth and growth helps the child get better. In addition, the same parents emphasised that it is
important to consider how parents are approached to take part in the trial, which was highlighted in
the feedback above and in the qualitative phase of the study.
Parental involvement in the neonatal unit and paediatric intensive care unit
consensus meetings
Two NNU parents joined the NNU meeting, but unfortunately the parent who expressed an interest
in attending the PICU meeting had to withdraw at the last minute due to her child being unwell. The
consensus meetings provided an opportunity for parents to hear the detailed findings from the study
and contribute to further discussions to inform the development of a future trial.
Summary of the patient and public input into the GASTRIC feasibility study
Despite using a variety of recruitment methods to involve as many parents with PICU and NNU
experience as possible, meeting face to face was extremely challenging for this group of parents. This
was more challenging if they are still caring for babies who may have complex care needs, as well as
looking after other members of the family, combining this with work and if meetings are geographically
distant from parents’ homes. The lack of face-to-face meetings meant that most activities were carried
out virtually. The offer of support to the parents via a parent and carers’ research forum was taken up
by four of the parents involved, but their preferred method of support was via e-mail or telephone.
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Despite these limitations, the information we gathered provided us with valuable insights into the
important issues for parents and carers for a future study exploring GRV measurement in UK PICUs
and NNUs. The study team acted on this, listened to feedback from parents and revised the lay
summary, PISs and interview questions, accordingly. The summary of the research findings will be
co-produced by parents in a visual abstract format and disseminated widely among the PICU and NNU
parent community.
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Chapter 7 Proposed trial designs
This chapter will summarise some of the findings and discuss a proposed trial design, control andintervention arms for a future trial in (1) PICUs and (2) NNUs.
Paediatric intensive care units
As trial design is influenced largely by the choice of primary outcome measure, the two suggested primary
outcome measures of VAP and the percentage of energy target achievement will now be discussed.
Ventilator-associated pneumonia
Work package 2 showed that VAP is the AE that most PICU clinicians fear about a full stomach,
leading to vomiting and subsequent pulmonary aspiration (resulting in VAP), and adult trials of no GRV
have powered their trials on this outcome. However, the incidence of VAP is much lower in paediatric
ICUs at 5.6 to 9.2 per 1000 ventilator days (compared with that reported in adult ICUs of 19–27% or
21.3 per 1000 ventilator days).29,41,42 Currently, few UK PICUs report having an active surveillance
programme for VAP (L Tume, University of Salford, 2019, personal communication) and one unit that
did, abandoned this altogether. Furthermore, the diagnostic criteria for VAP in paediatrics remains
subjective and problematic.43,44 Therefore, given the low incidence in PICUs, it is unlikely that a
non-inferiority trial would have sufficient statistical power on this outcome.
Time to achievement of predicted energy goals
The most commonly preferred primary outcome was time to achievement of predicted energy goals.
Published literature reports the achievement of mean energy targets over the first 3 days within the
PICU population to be quite variable, ranging from 31% to 82%.45–48 A study by Tume et al.31 is the only
study that looks at the effect of measuring GRV on the outcome in PICUs, but is a small retrospective
observational study comparing measuring GRV to not measuring GRV. This study found that by day 3,
the GRV group had achieved 82% (SD 40) of their prescribed feed, compared with 95% (SD 23) in
the ‘no GRV’ group. This indicates that there is potential for an improvement in feeding if GRV is not
measured, although a larger RCT would be needed to find a statistically significant difference. In adult
populations, percentage energy targets achieved seem to be much higher, ranging from 65% to 80%,29,49
and they also provide evidence to suggest that in these populations, measuring GRV has an adverse
effect on this outcome. A cohort study of adult ICUs49 showed that over 7 days ‘no GRV’ patients had an
average of 95% energy target reached compared with 83% in those ‘with GRV’. Current recommendations50
are to try to achieve no more than the estimated energy requirements using the Schofield equation
by 72 hours post PICU admission. All UK PICUs set some energy targets (almost all using the Schofield
equation with a variation). In Chapter 4 we present PICANet data for 2016 and 2017. These data show
that we can expect > 8000 children in the UK every year that satisfy our potential eligibility criteria
and, of these, > 5000 are likely to be intubated for ≥ 3 days (≥ 72 hours).
Sample size calculation
Table 27 below gives a range of possible calculations based on different effect sizes and SDs for the
following primary outcome:
Y = Average % energy achieved by day 3
=
1
3
× 100
×
Energy given on day 1 + Energy given on day 2 + Energy given on day 3
Schofield target set at baseline
 
.
(1)
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The calculations assume that the outcome is normally distributed and are based on the independent
samples t-test for testing for a difference between means. All the scenarios in Table 27 show that the
total numbers needed are feasible within the eligible population. We recommend that a future trial is
designed with an in-built pilot phase, to check that SDs are correct, given the variability of estimates of
these from the literature.
Trial design
In terms of ‘buy-in’ from PICUs for a future trial, 13 out of 29 PICUs attended the consensus meeting,
with all but one demonstrating commitment and interest in this future trial. Additionally, feedback was
that this energy target outcome would get significant ‘buy-in’ from the PICU dietitians, many of whom
could, and would like to, act as local principal investigators for this study.
There was support at the consensus meeting for utilising a cluster randomised approach with the same
outcome measures. Many clinicians favoured this approach, with triallists and statisticians not in favour.
With only 29 PICUs in the UK (and 19 of these research active and eliminating the two Scottish PICUs
who require individual consent for any trial), it is very unlikely that a cluster trial could be powered in
the ≤ 15 PICUs that had showed an interest. However, potential advantages with this method were
noted, that is, a whole unit-based education programme and ‘buy-in’ and potentially less risk of crossover
between control and intervention trial arms (if the nurse had two or more patients on different arms of
the trial). This anticipated problem would need to be investigated in the pilot phase of a future trial.
The most feasible trial design for PICU therefore appears to be an individual consent superiority trial
with an inbuilt pilot study, with clear progression targets on the primary outcome of achievement of
energy targets by 72 hours after PICU admission, combined with an underlying process evaluation.
Secondary outcomes should be those that gained ‘consensus in’ via the e-Delphi study and the final
voting at the consensus meeting.
TABLE 27 Sample size calculations for the outcome ‘mean % energy intake by day 3’, assuming type I error α = 0.05;
for different effect sizes, SDs and power
Effect size: mean difference in % energy target
achieved by day 3 for ‘no GRV’ vs. GRV SD
n required per arm
80% power 90% power
5% 20 251 337
30 564 757
40 1003 1345
10% 20 63 85
30 141 190
40 251 337
12% 20 44 59
30 98 132
40 175 234
15% 20 28 38
30 63 85
40 112 150
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Proposed paediatric intensive care unit GASTRIC trial control and intervention arms
The proposed PICU ‘control arm’ of GRV measurement is as follows:
l Standardised nutritional assessment: Paediatric Yorkhill Malnutrition Score risk
score +weight + length/height + z-score at admission.
l Energy targets should be calculated based on the Schofield equation, with an aim to achieve but not
exceed this target by 72 hours.
l If no contraindications, start gastric feeding within 6–12 hours of admission (continuous or bolus allowed).
l Feeding tube position should always be checked and pH tested – this is not GRV measurement and
requires only ≈0.3 ml of aspirate (do not aspirate the whole stomach).
l Routine GRV measurement at least 6-hourly, whether bolus or continuous feeding (always using a
50-ml syringe and aspirate slowly).
l GRV threshold for stopping enteral feeds: 5 ml/kg or < 250 ml for > 40 kg.
l If < 5 ml/kg, replace and continue to increase feeds (rate/volume) as per unit protocol.
l If GRV > 5 ml/kg, replace GRV (unless faecal, bloody or very bilious), withhold feeds for 2 hours and
reassess GRV.
l If two or more GRVs are > 5 ml/kg and fail to tolerate enteral nutrition (EN) consider post-pyloric
feeding, adding prokinetics (suggest oral erythromycin), changing feed formula and/or changing to
continuous feeding (if bolus fed).
l In patients requiring frequent fasting (e.g. larger burns) place nasojejunal tube early and commence
post-pyloric feeding.
See Appendix 1 for a flow chart.
A proposed no GRV ‘intervention arm’ for the PICU GASTRIC trial is as follows:
l Define daily nutritional goals according to patient status using the Schofield equation.
l Prescribe nutritional support according to these goals.
l Monitor tolerance (vomiting and other GI or systemic signs).
Discuss and agree ‘feed intolerance ‘and any feed withholding with senior colleague or team, and
actively search for other causes to treat:
l iatrogenic sedation withdrawal syndrome
l malpositioned gastric tube tip (i.e. tip in oesophagus)
l electrolyte imbalances (e.g. hypokalaemia and/or hypomagnesaemia)
l intracranial hypertension
l coughing
l patient agitation.
See Appendix 2 for a flow chart.
A previous single-centre UK PICU study48 examining PICU nurses’ decision-making around GRV found
that most nurses (84%) would be very concerned if they could not measure GRV routinely. However,
there was some confusion around what GRV measurement was and what was pH testing to confirm
tube position. Many nurses, when presented with some evidence, could understand the need for a trial
and would be happy to participate, so long as some education and clear guidance was provided about
how to monitor tolerance if not using GRV. The intervention arm would have to be supported by an
educational (e-learning) package, which presents the evidence and rationale for the trial, along with
clear guidance about pH testing compared with GRV measurement, and a simple flow chart to guide
their decision-making and what to do if they were concerned regarding feed intolerance.
The supporting nurse education package (with proposed educational content) is provided in Appendix 4.
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Neonatal unit
The two suggested primary outcome measures, incidence of NEC and the time from start of enteral
feeding to achieve full (150 ml/kg/day) enteral feeds, will now be discussed.
Incidence of necrotising enterocolitis
Work package 1 showed that NEC is the AE that many NNU clinicians (24/61, 39%) rated as the most
important for a primary outcome in a future trial. In Chapter 4 we presented national data on NEC
from 2017 and 2018. In those 2 years, the underlying incidence of NEC was 0.6% in NNUs and 5.2%
in infants born before 32 weeks’ gestation. Given that neonatal clinicians would not adopt no GRV
measurement if there was an appreciable increase in NEC, a non-inferiority analysis would be
appropriate for this outcome. If there is truly no difference between the standard and experimental
treatments (5.24% in both groups), then 17,018 patients are required to be 90% sure that the upper
limit of a one-sided 95% confidence interval (or equivalently a 90% two-sided confidence interval) will
exclude a difference in favour of the standard group of > 1%. This is a very large number and would
not be a feasible primary outcome measure The UK measures the incidence of NEC annually by NNU
for benchmarking, through the NNAP and using data held in the NNRD. Collection of NEC data would
therefore be feasible using existing, routinely recorded clinical data held in the NNRD, for a secondary
safety outcome in any planned trial.
Time required to achievement of full (150 ml/kg/day) milk feeds
The second most highly ranked outcome from the e-Delphi and consensus process was time to full milk
feeds (150 ml/kg/day). This is a very feasible outcome that has already been used for other neonatal
trials, including the Speed of Increasing Feeds Trial5 and the Abnormal Doppler Enteral Prescription
Trial (ADEPT).51 The data required for this outcome are routinely recorded using existing electronic
patient record systems and held in the NNRD, so the use of this outcome for a trial would be efficient
and feasible. In Chapter 4 we present NNRD data for 2017 and 2018. This shows that we can expect
> 7500 babies in the UK every year being admitted to a NNU, who are born at < 32 gestational weeks.
Many of these babies will be mechanically ventilated and require a nasogastric tube feed. However,
even babies who are not mechanically ventilated or who will not require a nasogastric tube feed at
these gestational ages, will need to establish milk feeds and could benefit or be harmed by GRV
monitoring. The median time it took for these babies to achieve a full feed was 12 (IQR 9–17) days and
the mean was 15.3 (SD 11.9) days. As the median is lower than the mean, and these statistics are
based on a sample size of 15,375 babies, we can assume that this measure is not normally distributed
and is skewed towards a shorter length of time.
Sample size calculation
Table 28 gives a range of possible sample size calculations based on different effect sizes and SDs for
the outcome ‘time required for achievement of full (150 ml/kg/day) enteral feeds’. These calculations
assume that the outcome has minimal censoring (almost all babies will reach full feed unless transferred
or death occurs), so the outcome does not need to be treated as a time-to-event and is positively
skewed (has a log-normal distribution). Calculations are based on the methodology given by O’Keefe
et al.,52 which uses medians and SDs to provide sample size calculations. We use the NNRD data to
provide estimates for the GRV arm (median 12 days, SD 11.9 days). All the scenarios in Table 28 show
that the total numbers needed are feasible within the eligible population. Given that 7500 babies are
born each year in the UK at this gestational age, and that the Speed of Increasing Feeds Trial5 recruited
2804 such babies in 25 months, these sample sizes all appear feasible.5 A total of 3736 infants would
give adequate power for most of the probable scenarios. If this was felt to be unfeasible, 1594 infants
would give adequate power to detect a 3-day difference.
Proposed neonatal unit ‘no GRV’ intervention arm based on Lyon neonatal unit protocol
A proposed NNU ‘no GRV’ intervention arm was developed and discussed at the consensus meeting.
This was based on the protocol in use in the Lyon NNU and is presented here for information. In addition,
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this would be used as a starting block for discussion and planning of a future trial. For medical babies,
this protocol included aspects that would be open to individual site practice variations in a pragmatic trial.
These were:
l enteral feeding from day 1 of life
l eight feeds per 24 hours
l oral feeds commenced at 29 weeks’ gestational age
l feeds increased across the eight daily feeds, according to the weight of the baby (Table 29).
Instead of using GRV, tolerance to feeding is assessed by bowel movements, softness of the abdomen
and the absence of erythema or tenderness (Figure 7). If there is emesis, erythema, distension or
tenderness, an assessment of severity is made and then feeds are held or reduced if the problems are
minor, or a radiograph is performed if NEC is suspected (see Figure 7).
Both proposed trial arms and their associated flow charts are provided in Appendix 2. The supporting
staff education package (with proposed educational content) is provided in Appendix 5.
TABLE 28 Sample size calculations for the outcome ‘time required for achievement of full (150 ml/kg/day) enteral feeds,
assuming type I error α = 0.05 and SDs of 11.9 for the GRV arm; and varying effect sizes and SDs for the intervention
group and the power required
Effect size: difference in median days
fed between GRVa and no GRV SD (GRV arm) SD (no GRV arm)
n required per arm
80% power 90% power
1 day 11.9 9.0 4695 6286
11.9 11.9 5510 7376
11.9 13.0 5799 7763
2 days 11.9 9.0 1129 1511
11.9 11.9 1326 1775
11.9 13.0 1395 1868
3 days 11.9 9.0 482 645
11.9 11.9 566 758
11.9 13.0 595 797
4 days 11.9 9.0 260 347
11.9 11.9 305 408
11.9 13.0 320 429
5 days 11.9 9.0 159 212
11.9 11.9 186 249
11.9 13.0 195 261
a Assumes that the GRV arm has a median primary outcome of 12 days.
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TABLE 29 Feed guidelines as per Lyon NNU protocol
Weight (g) Feed increase
< 800 8 × 0.5 ml extra for each feed
800–1000 8 × 1ml extra for each feed
1000–1200 8 × 2ml extra for each feed
1200–1500 8 × 3ml extra for each feed
1500–1750 8 × 4ml extra for each feed
1750–2000 8 × 5ml extra for each feed
2000–2500 7 × 10ml extra for each feed
> 2500 On demand
Maintain feeding
Feeding tolerance/2–4 hours
based on feeding times
± hold feed
± half volume
Minor
Yes
Major
Radiography
NEC
Emesis or abdominal
distension,
erythema tenderness
No
START HERE
Hold gastric feed
decompression management 
as NEC ± surgery consult
NEC
FIGURE 7 Proposed intervention arm protocol for no GRV measurement.
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Chapter 8 Discussion and conclusions
Summary of main findings
It was clear at the application stage that although paediatric and neonatal intensive care was ‘combined’
in the commissioning brief, these two specialties are different, with different staff and patients, and thus
two separate parallel feasibility studies were conducted: the GASTRIC PICU study and the GASTRIC
NNU study. The studies have been reported separately and cannot scientifically or feasibly be combined
into one trial.
Surveys of current practice
The survey of PICU practice showed that the regular and frequent measurement of GRV was usual
practice in all but one UK PICU. From this survey, we were able to construct a ‘most likely to be
accepted’ control arm of a future trial (see Appendix 1).
In NNUs, regular and frequent measurement of GRV was also common, but more mixed than in PICUs,
occurring in approximately 66% of responding NNUs in the UK (59/90). We were also able to construct
a ‘most likely to be accepted’ control arm of a future trial (see Appendix 2).
Qualitative study
The qualitative work with PICU parents and HCPs provided insight into issues about the information
provided and the acceptability of a definitive trial of no routine GRV measurement in UK PICUs. This
WP explored the views of 14 PICU parents and 26 PICU HCPs about a future trial. Overall, parents
were supportive of a trial but, like other trials in PICU, the timing and manner of the approach for
consent was identified as important. Concerns raised by parents related predominantly to delays in
identifying AEs or complications (such as vomiting with pulmonary aspiration, leading to pneumonia,
and NEC in infants) and unnecessary discomfort. We sought parents’ views about the most important
outcome measures to them. The parents prioritised seven key outcomes. These parent-generated
outcome measures were added into the e-Delphi survey for HCPs. Twenty-six PICU HCPs’ views from
two geographically dispersed PICUs were sought in focus groups. In addition, six telephone interviews
were conducted to target key individuals, such as surgeons. Staff were generally positive about a
future trial, with the biggest concern being about changing a long-standing and embedded practice
(that of routine GRV measurement to guide feeding). The least positive staff were junior nurses. Mixed
views existed about the benefit and utility of measuring GRV. Nurses were the most attached to this
historical practice, with many feeling that it was reassuring and provided them with a safety net.
Overall, the proposed GASTRIC paediatric intensive care unit trial was viewed as acceptable to most
PICU parents and staff, and is feasible to conduct.
For NNUs, the views of 17 parents and 16 HCPs were elicited regarding a future GASTRIC NNU trial.
These parents were also supportive of a trial and emphasised that the timing and manner of the approach
for consent were important. Similar to PICU parents, concerns were raised by NNU parents around delays
in identifying AEs, as well as unnecessary discomfort. Neonatal parents were particularly concerned about
NEC, but unlike the parents of PICU patients were not concerned about VAP. Neonatal parents prioritised
seven key outcomes and these were added into the e-Delphi survey for HCPs.
The views of 42 HCPs from two NNUs were gained in focus groups and five telephone interviews.
Staff, again, were generally positive about a future trial and the biggest concern raised was around
changing a historical and embedded practice. As in PICUs, the least positive staff were junior nurses,
who were the most attached to this historical practice.
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Overall, the proposed GASTRIC neonatal unit trial was also viewed as acceptable to most neonatal
parents and staff, and is practically feasible to conduct.
The trial design survey, including the e-Delphi study
The PICU e-Delphi study elicited views from 30 PICU HCPs, regarding who should be included and
who should be excluded in a future trial, their willingness to randomise a child into this study, trial
design and the ranking of the outcome measures for a future trial. Almost all (97%) staff were willing
to theoretically randomise a child in a definitive trial. Nearly three-quarters (73%) thought that all
children aged > 37 weeks to 17 years admitted to a PICU who were enterally fed should be included
in the definitive trial, not just mechanically ventilated children. Most believed that children expected to
stay < 24 hours or who are not expected to survive, would be excluded, along with children with a GI
pathology or a ‘surgical gut’ (who would not be enterally fed initially). Sixteen potential outcome
measures were rated in the first round of the e-Delphi study, including the seven parent-suggested
outcome measures. Six outcome measures were added from participants in rounds 1 and 2, resulting in
22 potential outcomes that were rated in round 2. Consensus was gained on four outcome measures:
(1) time to achieve target energy goals, (2) VAP, (3) the incidence of vomiting and (4) time feeds were
stopped in each 24-hour period. No items were voted ‘consensus out’, leaving 18 items to be discussed
and voted on at the consensus meeting. The two highest scoring primary outcome measures were
(1) time to achievement of predicted energy goals (full feeds) (36%) and (2) incidence of VAP (23%).
Seventy-six HCPs participated in the neonatal e-Delphi study, which sought to elicit views on inclusion
and exclusion criteria for a future trial, trial design, willingness to randomise a baby into a trial and
rating outcome measures for a future trial. Most (91%) staff were willing to theoretically randomise a
baby in a definitive trial. Nearly all (93%) HCPs indicated that preterm babies born before 32 weeks’
gestation should be included in the definitive trial, although there was support from many for more
mature infants too (e.g. 83% for babies born before 34 weeks). Most believed that babies with NEC or
with surgical problems should be excluded, but opinion was mixed on whether to include babies with
cardiac problems or those receiving therapeutic-treated hypothermia. Twenty-two potential outcome
measures were rated in the first round of the e-Delphi study, including the seven parent-suggested
outcome measures. Four outcome measures were added from participants in round 1, resulting in 26
outcomes being rated in round 2. Consensus was achieved on five outcome measures: (1) mortality,
(2) incidence of NEC, (3) days on parenteral nutrition, (4) time feeds stopped in each 24-hour period
and (5) time from start of enteral feeding to achieve full feeds (150 ml/kg/day). No items were voted
‘consensus out’, leaving 21 items to be discussed and voted on at the consensus meeting. The two
highest scoring primary outcome measures were (1) NEC (39%) and (2) time to achieve full feeds (30%).
Analysis of routinely collected national data sets: Paediatric Intensive Care Audit
Network and National Neonatal Research Database
Analysis of the national PICU data set (PICANet), based on the outcome of the e-Delphi study, showed
that if we included all mechanically ventilated children aged > 37 weeks’ gestational age to 17 years who
did not have a primary GI pathology at admission there were 16, 122 children in 2016 and 2017; 36%
of these had a surgical admission (n = 5813) and 64% a medical admission (n = 10,309); 84% of these
children stayed for > 72 hours (3 days), which would be realistic and enable time to achieve predicted
energy targets. This demonstrates that a superiority trial with individual consent is feasible in terms of
the number of eligible patients, even with a cautious consent rate of only 60%. This commissioned brief
did not allow us to randomise patients; thus, an inbuilt pilot phase, with clear stop/start and progression
to full trial, would still be required in a future trial.
Analysis of the NNRD, based on the outcome of the e-Delphi study, showed that in 2017 and 2018
there were 15,375 infants born before 32 weeks’ gestational age and admitted to a NNU in England,
Wales and Scotland. Mortality occurred in 1290 (8%) infants and NEC in 806 (5%) infants in this group
and their median duration for the time from start of enteral feeding to achieve full (150 ml/kg/day)
enteral feeds was 12 (IQR 9–17) days. This demonstrates that a superiority trial with individual
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consent is also feasible in terms of the number of eligible patients, again, with a cautious consent
rate of only 60%. This commissioned brief did not allow us to randomise patients; thus, an inbuilt
pilot phase, with clear stop/start and progression to full trial, would still be required in a future trial.
The available numbers of eligible patients and neonatal sites would also allow a cluster trial to be
undertaken in NNUs, given the necessary increase in required sample size. As described in Chapter 5,
there was support from many for this approach.
The consensus meetings
Twenty-two PICU HCPs (a mixture of physicians, nurses and dietitians), triallists and eight clinical
members of the study team attended the final stakeholder consensus meeting held on 2 April 2019; no
parents were able to attend on the day. After presentation of the findings and discussion, 30 participants
voted on 18 outcome measures that did not reach consensus in the e-Delphi study. Following this,
consensus (in or out) was reached on all but four items. At this meeting, the proposed intervention arm
(of no routine GRV measurement) was presented to the stakeholders by Dr Frederic Valla, a consultant
in a large PICU in Lyon, France, where GRV has not routinely been measured for around 20 years.
Overall, this was well accepted and participants felt that if the change (to not measuring GRV) was
protocolised as part of a trial, it would be easier to implement and nurses would be reassured that they
were not to blame if an AE occurred.
Seventeen neonatal HCPs (a mixture of physicians, nurses and dietitians), triallists and nine clinical
members of the study team attended the final stakeholder consensus meeting held on 1 April 2019;
two parents also attended the day. After presentation of the findings and discussion, 21 participants
voted on 21 outcome measures that did not reach consensus in the e-Delphi study. Following this,
consensus in or out was reached for four items each, respectively. At this meeting, the proposed
intervention arm (of no routine GRV measurement) was presented to the stakeholders by Dr Anne
Beissel, a consultant in a large NNU in Lyon, France, where GRV has not routinely been measured
for 5 years. Similar to the PICU meeting, this was well accepted and participants felt that if the change
(to not measuring GRV) was protocolised as part of a trial, it would be easier to implement and nurses
would be reassured that they were not to blame if an AE occurred.
Barriers to delivering the definitive GASTRIC paediatric intensive care unit trial
Synthesising the results from the multiple WPs in this study identifies several barriers to delivering
the definitive GASTRIC PICU trial, but has also informed us of how these barriers can be overcome.
However, three main barriers to delivering the definitive PICU trial were identified. As we were not
allowed to randomise patients and ‘test’ the protocol, these will need to be examined in an inbuilt pilot
phase of a future trial.
Parental non-consent is always a risk in trials of critically ill children, because of the parental stress and
anxiety associated with a child’s admission to the PICU. A deferred consent approach (which has been
used successfully in several trials in critically ill children53,54) allows trial randomisation and allocation,
followed by an approach to the parents for consent at a subsequent and, hopefully, less stressful time.
However, as enteral feeding is not an ‘urgent’ PICU intervention, and is usually commenced within
12 hours of admission, it would not meet the criteria for deferred consent.55 Additionally, parental feedback
on our information sheet was positive, but recommended some changes (which we have made) [see
project web page www.journalslibrary.nihr.ac.uk/programmes/hta/169402/#/documentation (accessed
13 February 2020)], to articulate the benefit of both arms of the trial and improve clarity. Finally,
parents articulated that although the written information was important, the verbal approach was even
more so, and this should be made in a caring and supportive manner by someone knowledgeable about
the trial. In UK PICUs this would normally be a PICU research nurse. Some parents suggested that
they did not want to read about risks in the PIS, as this was alarming. However, informed consent is
an essential ethics requirement for the conduct of research.56 The parental consent rate should be
assessed in the pilot phase of a future definitive trial.
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Lack of compliance with the trial protocol is another potential risk in a future trial; this may be more
pronounced in this case because it is existing practice to measure GRV routinely. The steps proposed
to mitigate this risk of non-compliance would be to focus first on developing an effective trial education
package (see Appendix 4) that is adapted and tailored locally to different professional groups. This has
been done based on the trial team’s experience and on data from the qualitative work with HCPs. This
addresses the rationale for a trial, evidence of the problem and includes simple, visually appealing and
easy to follow, one-page trial algorithms (flow charts). Education specifically directed at nurses needs to
address other ways to evaluate feed tolerance and to detect signs of AEs. This training should be able
to be adapted to each local site to improve site ‘buy-in’ and increase incorporation into existing local
processes. Sites should be provided with study materials that act as readily accessible ‘reminders’ of the
trial arm algorithms, and inclusion and exclusion criteria. This should be in the form of ‘cheat sheets’ to
attach to lanyards and pens with pull out text, along with other important marketing material, to enable
easy access to trial protocols. Gaining support and ‘buy-in’ from senior PICU staff is also vital to the
success of a trial, as consultants, in particular, are highly influential with all staff within a PICU. Nurses
are often reassured of the importance of a trial by PICU consultants and the senior ‘in charge’ nurses.
This should be done at the initial site visit and ongoing regular site visits. These site visits will both
support and monitor trial compliance. Trial adherence will be evaluated in the pilot phase of a future
trial, which we strongly recommend should also include a concurrent process evaluation to robustly
evaluate the issues underpinning trial delivery and this change in practice.
Deviation from protocol, specifically by nursing staff, warrants special mentioning as a further risk in a
future trial. Data from nurses both in the focus groups and in the e-Delphi process showed the most
concern about a future trial and not being able to measure GRV. This was most pronounced with junior
nurses. Much of this can be addressed by an effective education package targeted at bedside nurses, but
regular compliance monitoring will be essential and a process evaluation will also be invaluable to assess
these concerns. The inadvertent crossover between trial arms is a risk when nurses are allocated more
than one patient that are on different trial arms. Steps taken to mitigate this risk of inadvertent crossover
include visual reminders of the trial arm at each child’s bedside and small ‘cheat sheet’ reminders
attached to each nurse’s lanyard or by the bedside, alongside ongoing education and monitoring.
Barriers to delivering the GASTRIC neonatal unit definitive trial
Similarly, synthesising the results from the NNU WPs identified several barriers to delivering the
definitive GASTRIC NNU trial, but also informed us of how these barriers can be overcome.
Parental non-consent is also a risk in trials of newborn babies, because of the parental stress and
anxiety associated with a baby’s admission to a NNU. Like a PICU setting, a deferred consent approach
may improve recruitment rates by allowing more time for careful discussions outside an emergency
situation; however, this is unlikely to be acceptable in a trial of no GRV measurement, as feeding
decisions are usually not made urgently or as an emergency. Parental feedback on our information
sheet was positive. It did, however, recommended changes to articulate the potential benefits of both
trial arms and to improve clarity, which we have made [see project web page www.journalslibrary.nihr.ac.
uk/programmes/hta/169402/#/documentation (accessed 13 February 2020)]. Parents also articulated
that although written information was important, verbal communication was even more so and should
be made in a caring and supportive manner by someone knowledgeable about the trial. Several parents
suggested they did not want to read about risks in the PIS, as this was alarming. However, informed
consent is an essential ethics requirement for the conduct of research.56 We suggest that parental
consent rate should be assessed in an internal pilot phase of any future definitive trial.
In the same way as in PICUs, lack of compliance with the trial protocol is potentially a risk in a future
NNU trial, although the more varied practice suggests that this may not be as challenging. The steps
proposed to mitigate this risk of non-compliance would also be to focus on developing an effective trial
education package (see Appendix 5), adapted and tailored locally to different professional groups. This
should first address the rationale for a trial, provide evidence of the problem and include simple, visually
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appealing and easy to follow, one-page trial algorithms (flow charts). Education, specifically for nurses,
needs to address other ways to evaluate feed tolerance and to detect signs of AEs. This training should
be adaptable to each local site to improve site ‘buy-in’ and increase incorporation into existing local
processes. Sites should be provided with study materials that act as readily accessible ‘reminders’ of the
trial arm algorithms, and inclusion and exclusion criteria. This should be in the form of ‘cheat sheets’ to
attach to lanyards and pens with pull out text, along with other important marketing material, to enable
easy access to trial protocols. Gaining support and ‘buy-in’ from senior NNU staff is also vital to the
success of a trial: consultants carry a large amount of influence with all staff. Nurses are often reassured
of the importance of a trial from the influence of consultants and the senior ‘in charge’ nurses. Comments
collected from focus groups and the e-Delphi process also suggested that some neonatologists in individual
units may not all agree with both arms. This brings in the risk of failure to recruit, potential non-compliance
and crossover between the allocated groups. Steps taken to mitigate this will include those used for nurses,
but also additional leadership from the trial investigators and the local lead investigator. Monitoring of
recruitment and retention of participants will be undertaken during the inbuilt pilot phase and throughout
the trial.
Obtaining ‘buy-in’ should be the focus of the initial and ongoing regular site visits. These site visits will
both support and monitor trial compliance. Trial adherence will be evaluated in the pilot phase of a
future trial. For a future trial, we would strongly recommend a concurrent process evaluation to
robustly evaluate the issues underpinning trial delivery and this change in practice.
Proposed future trial design: GASTRIC paediatric intensive care unit trial
The most feasible trial design therefore appears to be an individual consent superiority trial, with
an inbuilt pilot study and with clear progression targets. The research question for a trial would be
as follows.
Population
In mechanically ventilated children aged 37 weeks (term) to 17 years, expected to stay > 24 hours and
who can be enterally fed.
Intervention
Does no regular (routine) measurement of GRV to guide enteral feeding.
Comparison
Compared with usual care, the regular 4- to 6-hour measurement of GRV to guide enteral feeding.
Outcomes
Impact on the achievement of predicted energy requirements (using the Schofield equation) by 72 hours
after PICU admission?
The trial should also have a concurrent process evaluation and a built-in non-inferiority analysis to
determine that not measuring GRV is safe and does not increase the incidence of VAP. This inbuilt pilot
phase must assess parental consent rates, clinician study protocol compliance and crossover, and
confirm the distribution of the primary outcome measure and feasibility of collection of secondary
outcome measures.
Proposed future trial design: GASTRIC neonatal unit trial
The most feasible trial design for NNUs is also an individually randomised superiority trial, with an
inbuilt pilot study and clear progression targets and a parallel process evaluation. This research
question would be as follows.
Population
In newborn infants born before 32 weeks’ gestation who are ready to start enteral feeds.
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Intervention
Does no regular (routine) measurement of GRV to guide enteral feeding.
Comparison
Compared with usual care, the regular 4- to 6-hour measurement of GRV to guide enteral feeding.
Outcomes
Impact of the time from start of enteral feeding to achieve full feeds (150 ml/kg/day)?
This trial should also have a concurrent process evaluation and a non-inferiority analysis built in on the
incidence of NEC.
Strengths and limitations of this feasibility study
The PICU survey was comprehensive and obtained a response from 24 (89%) of the 27 units in the
UK. Although a larger number of NNUs responded to the neonatal survey, it was less comprehensive
(95/184 NNUs, 52% response) owing to the higher number of NNUs in the UK and it may be less likely
to be representative of the whole country. The 95 responding NNUs provide a clear signal of mixed
practice and identify multiple potential sites for a future trial. In keeping with all surveys of practice,
both NNU and PICU surveys are limited by the theoretical, self-reported nature of any responses.
The qualitative work was limited by 74% of the parent sample being based in the north-west of
England. However, these participants drew on experience from 21 hospitals from across England and
Scotland. Another limitation is that, owing to the purposeful sampling of parents with PICU or NNU
experience, we had no ICU-naive parents’ views on the study information, which may be different. A
further limitation of WP 2 is its hypothetical, retrospective nature. As reflected in the findings related
to the importance placed on feeding, perceptions about measuring GRV and risk assessment of medical
factors (hospital-related infections, NEC) were substantially influenced by experiential knowledge.
The recruitment of HCPs in both groups was extensive, but targeted interviews drew on the wider
GASTRIC teams’ personal contacts, which may have influenced views.
The trial design survey and e-Delphi studies were limited in PICUs by the lower than expected response
rate (30/45, 67%) and in both surveys by not including parents and carers: we undertook parent and
carer involvement in other ways that we felt was more appropriate. The e-Delphi studies resulted in
numerous outcomes not achieving consensus in or out, but we were able to discuss and vote on these
at the final consensus meetings. In the PICU e-Delphi study, the wording of the outcome ‘time to
achievement of predicted energy goals (full feeds)’ could have been clearer. On further discussion at
the consensus meeting, a more appropriately worded outcome is ‘the achievement of a percentage of
the predicted goal achieved over time’. It may be that the clinicians completing this part of the study
understood what was meant here, and, in the context of the e-Delphi study, the important focus was
to gain consensus of whether this or the AE of VAP should be the primary outcome.
The analysis of the national routine data sets was limited by the data collected by these. Specifically,
PICANet (vs. the NNRD) collects a very minimal data set and nothing specific to nutrition or feeding.
However, the data about what items are collected are robust and reliable.
The consensus meetings were limited by their location (central London), potentially discouraging
parents and HCPs from further afield. However, we chose London because transport links meant this
was the easiest to reach for the majority. For the PICU meeting, despite our best efforts, no parents
were able to attend on the day.
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Conclusions and summary of key research recommendations
A definitive trial of no routine GRV measurement in PICUs is feasible to conduct, and this should
include an inbuilt pilot phase with clear stop/start progression criteria to full trial and a concurrent
process evaluation. Current practice, that is the consistent and frequent routine measurement of GRV,
will form the control arm. The intervention arm will be no routine measurement of GRV with an
associated education and training package (see Appendix 1 for proposed control and intervention arm
study protocol guidance and Appendix 4). This is a clear unmet need of evidence to determine the
clinical and cost-effectiveness of this practice.
A separate, definitive trial of no routine GRV measurement in NNU is feasible to conduct. Like the
PICU trial, such a trial should include an inbuilt pilot phase, with clear stop/start progression criteria
to full trial and a concurrent process evaluation. The frequent routine measurement of GRV, which is
current practice in many units, will form the control arm and the intervention arm will be no routine
measurement of GRV with an associated education and training package (see Appendix 2 for proposed
control and intervention arm study protocol guidance and Appendix 5). This is a clear unmet need for
evidence to determine the clinical and cost-effectiveness of this practice.
Further international research is needed to determine and get consensus on core outcome measures for
trials of nutritional interventions in critically ill children. Preliminary work is already under way on this (see
www.comet-initiative.org/Studies/Details/1106; accessed 22 April 2020), but a large international Delphi
study is required to gain consensus, involving families and important outcomes to families and parents.
In neonatal care, the Core Outcomes In Neonatology project has completed an international consensus
process to identify core outcomes for neonatal care in high-income settings.57 Any trials of nutritional
interventions in neonatal care should ensure that they measure and report these core outcomes. The
consensus processes reported in Chapters 3 and 5 of this report provide further evidence to inform
choice of additional outcomes more directly relevant to trials examining no measurement of GRV.
Implications for health-care practice
This is a feasibility study that did not recruit patients and therefore has no direct implications for
health-care practice at this stage.
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Appendix 1 Paediatric intensive care unit:
potential trial arms
PICU intervention arm: no routine GRV measurement to guide enteral feeding
Do nutritional assessment within 6 hours of PICU admission: weight, length and nutrition risk score. If no contraindications:
• Start enteral nutrition as soon as possible, at least within 6–12 hours of admission
• Feed as per your unit protocol, advancing feeds to achieve (but not exceed) energy targets by 72 hours post admission 
• Remember
    Test pH to
    confirm tube
    position but
    DO NOT
    aspirate the
    whole
    stomach
    contents
• Reduce
    opiates and
    sedatives as
    soon as
    possible
• Nurse head
    up 20–30 º  
Not tolerating feeds? 
• Agree this ONLY by discussion with senior
    team
• Stop feeds for 2 hours and reassess patient
    signs, restart feeds at previous rate/volume
Caution: if metabolic acidosis develops or
lactate increases markedly with no clear
cause, withhold feeds until cause established
Monitor for feed intolerance by:
• vomiting
• abdominal distension
• abdominal pain or distress 
Do not use GRV
Tolerating feeds?
• Increase feeds as per unit
    protocol to achieve target
Rule out and treat other causes of these common problems 
before stopping feeds
• Vomiting caused by coughing, suctioning, sedation withdrawal,
    intracranial hypertension
• Nasogastric tube in oesophagus          reposition nasogastric tube
• Treat ref lux, treat vomiting with antiemetics
• Abdominal distension due to air swallowing          aspirate air
    from nasogastric tube, replace GRV
• Diarrhoea due to gut infection (Clostridium difficile) or
• Sedation withdrawal          treatment cause
Still not tolerating feeds?
Consider other interventions to improve feed
tolerance:
• Change from bolus to continuous feeds and/or
    change feed formula (discuss with dietitian),
    consider placing post-pyloric tube, consider
    starting oral prokinetics (e.g. erythromycin);
• Starting parenteral nutrition should be the last
    option
  
                                          
                              
PICU control arm: routine GRV measurement
Do nutritional assessment at baseline within 6 hours of PICU admission: weight, length and nutrition risk score. If no
contraindications: 
• start feeds within 6–12 hours of PICU admission 
• feed as per unit protocol measuring GRV at least every 4–6 hours using a 50- ml syringe and aspirating slowly 
• increase feeds if GRV < 5 ml/kg or < 250 ml in a > 40 kg child 
• aim to achieve but not exceed energy targets by 72 hours after admission 
Not tolerating feeds?
• If GRV > 5 ml/kg (or 250 ml): replace GRV if not
    faecal, bloody or very bilious and withhold feeds
    for 2 hours then reassess GRV
Feed tolerance determined by GRV and other GI signs
Tolerating feeds?
• If GRV < 5 ml/kg (or 250 ml): increase feeds as per unit
    protocol to achieve energy targets
• If previous high GRV: restart feeds at previous
    rate/volume and reassess GRV after 4 hours
Still not tolerating feeds?
If GRV still > 5 ml/kg (or 250 ml), considerations to improve feed tolerance
• Change from bolus to continuous feeds and/or change feed formula (discuss with dietitian),
    consider starting oral prokinetics (e.g. erythromycin), consider placing post-pyloric tube
• Starting parenteral nutrition should be the last option unless specific concerns
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Appendix 2 Flow chart: neonatal unit
control and intervention arms
Neonatal unit intervention arm: no GRV to guide enteral feeding
If no contraindications:
• Start enteral nutrition as soon as 
    possible, preferably within first 
    24 hours of admission
• Feed as per your unit protocol
• Increase feeds as tolerated as 
    per unit protocol, with aim of
    reaching full feeds within 10 days
Monitor for feed intolerance:
• Vomiting
• Abdominal distension/
    tenderness/discolouration
• Bloody stool
• Abnormal abdominal radiograph
• Clinical deterioration
• Poor weight gain
Do not use GRV
Rule out and treat other causes of these
common problems before stopping feeds:
• Vomiting caused by coughing, suctioning,
    opiate withdrawal, intracranial hypertension
• Nasogastric tube/orogastric tube in 
    oesophagus         reposition feeding tube
• Treat ref lux, treat vomiting
• Abdominal distension due to air swallowing
            aspirate air from nasogastric tube, 
    replace GRV, keep orogastric tube open if 
    baby on non-invasive continuous positive 
    airway pressure
• Diarrhoea may be due to other causes 
    (e.g. opiate withdrawal)
If feed intolerance agreed on discussion
with senior team:
• Stop feeds for minimum of 2 hours (possibly
    longer) and reassess symptoms
• Restart feeds at previous rate/quantity
Remember
• Test pH to conf irm tube position
    but DO NOT aspirate the whole
    stomach contents
• Reduce opiates/sedatives as
    soon as possible
• Nurse head up 20–30 º
Neonatal unit control arm: routine GRV measurement
• Feed as per your unit protocol, but
    measure GRV every 4–6 hours using 
    a 10-ml syringe (aspirating slowly)
• Increase feeds if GRV < 5 ml/kg 
Feed tolerance determined by GRV
and other GI signs
• If GRV > 5 ml/kg, replace GRV if not
    faecal, bloody or bilious, withhold
    feeds for 2 hours and reassess GRV
If no contraindications: 
• Start enteral nutrition as soon as 
    possible, preferably within f irst 
    24 hours of admission
• Feed as per your unit protocol
• Increase feeds as tolerated as per unit
    protocol with aim of reaching full feeds
    within 10 days
• If GRV < 5 ml/kg, restart feeds at previous rate/volume
• If GRV still > 5 ml/kg, consider changing from bolus to continuous
    feeds and/or consider changing feed formula (discuss with dietitian)
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Appendix 3 Potential outcomes
Proposed outcomes of the GASTRIC trial: neonatal intensive care unit
l An outcome measure refers to ‘what’ should be measured in a research study to find out whether
or not an intervention is effective. In this study, we are interested in whether gastric residual
volume (GRV) measurement helps to make children better.
l Studies often have a number of outcome measures to determine whether or not an intervention
works. They could be measured during a child’s stay in hospital, at the end of their hospital stay or
when they have left hospital.
l Researchers or doctors often suggest what outcomes should be measured in a research study.
However, they do not always fully understand what it is like, either to be a sick child or to be the
parent or guardian of a sick child. This is why it is important that we ask parents and guardians
about the things that are important to them; the things we should measure from their perspective.
l For the GASTRIC study, we have reviewed all the previous research studies that have looked at
GRV measurement.
l Below is a list of outcomes that might be useful to measure. During the telephone interview, we will
ask you what you think about the outcome measures on this list.
l It is not a test! We just want to make sure we include outcomes that are important to parents
and children.
Outcomes that are already measured during a child’s stay in intensive care
l Time in the neonatal intensive care unit (NICU).
¢ The number of days your child was in NICU within a certain time period (usually period of
days/months).
l Time spent on the ventilator or on breathing support.
¢ The number of days your child was on breathing support within a certain time period.
l Duration of hospital stay.
¢ The time your child has spent in any particular hospital location (e.g. NICU, ward).
l Health-care-associated infections.
¢ An infection acquired in hospital, directly as a result of having a breathing tube or central line
(large drip) in your child.
l Occurence of necrotising enterocolitis (NEC).
¢ We look for any occurrence of a severe bowel infection (called NEC), defined in a specific and
consistent way in the infant’s NICU stay (while they are being tube fed).
l We look for the time taken to achieve full feeds.
¢ How many days it took to reach 150 ml/kg/day, the agreed definition of full feeds for a
preterm infant.
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l We measure the frequency of gut problems: vomiting, diarrhoea.
¢ How often the baby was recorded as vomiting and had episodes of diarrhoea per day during
their time being tube fed on intensive care.
l We count the number of days on total parenteral nutrition (TPN) (intravenous liquid food).
¢ How many days the baby received TPN.
l We count the number of days of central line access.
¢ The number of days the baby has a central line (a large drip into a big vein) in place.
Outcomes that are already measured at the end of care or after a child has left hospital
l Survival.
¢ Whether or not your child survived to a specific event (e.g. hospital discharge).
l Feeding issues.
¢ Whether or not your child has any ongoing feeding issues as a result of their time spent
on NICU.
¢ Whether or not your child is still requiring tube feeding at home.
¢ Whether or not your child has achieved their normal weight for age.
Proposed outcomes of the GASTRIC trial: paediatric intensive care unit
l An outcome measure refers to ‘what’ should be measured in a research study to find out whether
or not an intervention is effective. In this study, we are interested in whether or not the GRV
measurement helps to make children better.
l Studies often have a number of outcome measures to determine whether or not an intervention
works. They could be measured during a child’s stay in hospital, at the end of their hospital stay or
when they have left hospital.
l Researchers or doctors often suggest what outcomes should be measured in a research study.
However, they do not always fully understand what it is like, either to be a sick child or to be the
parent or guardian of a sick child. This is why it is important we ask parents and guardians about
the things that are important to them; the things we should measure from their perspective.
l For the GASTRIC study, we have reviewed all the previous research studies that have looked at
GRV measurement.
l Below is a list of outcomes that might be useful to measure. During the telephone interview, we will
ask you what you think about the outcome measures on this list.
l It is not a test! We just want to make sure we include outcomes that are important to parents
and children.
Outcomes that are already measured during a child’s stay in intensive care
l Time in the paediatric intensive care unit (PICU).
¢ The number of days your child was in PICU within a certain time period (usually period of
days/months).
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l Time spent on the ventilator or on breathing support.
¢ The number of days your child was on breathing support within a certain time period.
l Duration of hospital stay.
¢ The time your child spent in any particular hospital location (e.g. PICU, ward).
l Health-care-associated infections.
¢ An infection acquired in hospital, directly as a result of having a breathing tube or central line
(large drip) in your child.
l The proportion of patients with at least one episode of ventilator-associated pneumonia (VAP).
¢ We would measure the length of time your child has a breathing tube in place and if they
acquire a chest infection directly related to having this tube in place and being on a ventilator
(breathing machine).
l The actual achievement of predicted energy goals.
¢ When a child is admitted to the PICU a dietitian calculates how many calories they require each
day, so we would calculate how much (what percentage) of the amount that that child should
receive that they actually did get.
l The time taken to achieve full feeds.
¢ How many days it took to reach the number of calories that the dietitian predicted the
child needs.
l The frequency of gut problems: vomiting, diarrhoea.
¢ How often the child was recorded as vomiting and had episodes of diarrhoea per day during
their time being tube fed on intensive care.
l The weight changes from PICU admission to discharge.
¢ Any change in weight (in kilograms) from PICU admission weight to weight at PICU discharge.
Outcomes that are already measured at the end of care or after a child has left hospital
l Survival.
¢ Whether or not your child survived to a specific event (e.g. hospital discharge).
l Feeding issues.
¢ Whether or not your child has any ongoing feeding issues as a result of their time spent
on PICU.
¢ Whether or not your child still requires tube feeding at home.
¢ Whether or not they have achieved their normal weight for age.
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Appendix 4 Proposed education package
Proposed health-care professional education package to accompany future
GASTRIC trial
To address the concerns raised in staff focus groups and interviews, we have developed two separate
proposed educational packages to accompany the GASTRIC trial: one for PICU HCPs and one for
NICU HCPs.
There would be four separate short (< 10-minute) educational videos, filmed in the clinical area by a
clinician, discussing the topics below. These would be supported by PowerPoint® slide sets (Microsoft
Corporation, Redmond, WA, USA) for PICU and NICU champions to deliver in their units.
Paediatric intensive care unit module 1
Why a trial of GRV is needed, why GRV is not a valid marker, how achieving energy targets remains
a problem in critically ill children and how suboptimal energy achievement can have an impact on
clinical outcomes.
Neonatal intensive care unit module 1
Why a trial of GRV is needed, why GRV is not a valid way to assess feed tolerance, the lack of evidence
for GRV as a predictor of NEC, how delaying the time taken to reach full feeds increases the risk of
infection can have impacts on clinical outcomes.
Paediatric intensive care unit module 2
The ‘usual care’ arm of the trial in which GRV is routinely measured every 4–6 hours to guide enteral
feeding, discussing the technique to do this and actions to take when GRV is high for PICU.
Neonatal intensive care unit module 2
The ‘usual care’ arm of the trial where GRV is routinely measured every 4–6 hours to guide enteral
feeding, discussing the technique to do this and actions to take when GRV is high for NICU.
Paediatric intensive care unit module 3
The ‘intervention arm’ of not measuring GRV. How to assess feed tolerance without GRV using clinical
signs of vomiting, abdominal distension and abdominal pain or discomfort, or distress. Discuss ruling
out and treating of other likely causes of these signs and what to do if feed intolerance is identified in
the intervention arm in PICU. If metabolic acidosis develops and levels of lactate rise with no clear
cause and no other obvious signs, feeds may need to be withheld until the gut as a cause is ruled out.
Neonatal intensive care unit module 3
The ‘intervention arm’ of not measuring GRV. How to assess feed tolerance without GRV, using clinical
signs of vomiting, abdominal distension and abdominal pain or discomfort, or distress. Discuss the ruling
out and treating of other likely causes of these signs and what to do if feed intolerance is identified in the
intervention arm in NICU. If metabolic acidosis develops and levels of lactate rise with no clear cause and
no other obvious signs, feeds may need to be withheld until the gut as a cause is ruled out.
Paediatric intensive care unit module 4
Interventions to be considered if feed intolerance is a problem. Discuss changing from bolus to
continuous feeds, consulting with the dietitian to change to a different formula (e.g. semi-elemental),
using oral prokinetics or placing a post-pyloric tube, while minimising interventions that reduce gastric
motility (high-dose opioids and sedatives, correcting electrolyte abnormalities, etc.) for PICU patients.
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Neonatal intensive care unit module 4
Interventions to be considered if feed intolerance is a problem for NICU. Discuss changing feed volume,
the time between feeds and rate of increase of feeds. Discuss modifying medications, such as opiates
and sedatives, and correcting electrolyte imbalances for NICU patients.
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Appendix 5 Paediatric intensive care unit
Delphi outcomes
Name Help text Domain name
GI morbidity: diarrhoea The intervention may potentially have an impact on the
incidence of diarrhoea. Please indicate how important you
think it is that this outcome is measured in a future study
Physiological/clinical
(GI outcomes); AE
Incidence of GI morbidity:
vomiting
The intervention may potentially have an impact on the
incidence of vomiting. Please indicate how important you think
it is that this outcome is measured in a future study
Physiological/clinical
(GI outcomes); AE
Incidence of VAP The intervention may potentially have an impact on the
incidence of VAP. Please indicate how important you think it is
that this outcome is measured in a future study
Physiological/clinical
(infection outcomes);
AE
Length of stay: hospital The intervention may potentially have an impact on their
length of stay in hospital. Please indicate how important you
think it is that this outcome is measured in a future study.
Note, this outcome was prioritised by parents during the
qualitative interviews
Resource use (hospital)
Length of stay: PICU The intervention may potentially have an impact on their
length of stay in PICU. Please indicate how important you
think it is that this outcome is measured in a future study
Resource use (hospital)
Length of time: IV The intervention may potentially have an impact on the length
of time they spend on IV. Please indicate how important you
think it is that this outcome is measured in a future study
Physiological/clinical
(respiratory, thoracic
and mediastinal
outcomes)
Long-term feeding issues The intervention may potentially have a long-term impact on
feeding issues, this includes time spent on tube feedings at
home, reflux, colic, vomiting and appetite changes. Please
indicate how important you think it is that this outcome is
measured in a future study. Note, this outcome was identified
by parents as important and prioritised by parents during the
qualitative interviews
Life impact (perceived
health status)
Long-term outcomes
(after hospital discharge)
The intervention may potentially have a long-term impact on
health, this includes amputation, developmental issues, brain
damage and mobility. Please indicate how important you think
it is that this outcome is measured in a future study. Note, this
outcome was identified by parents as important and prioritised
by parents during the qualitative interviews
Life impact (physical
and cognitive
functioning)
Looking and/or behaving
like their normal self
The intervention may potentially have an impact on them
returning to their ‘normal’ self (e.g. improvement in mood,
increased communication, acting more like themselves,
increased alertness, starting to sit, starting to eat and drink).
Please indicate how important you think it is that this outcome
is measured in a future study. Note, this outcome was
identified by parents as important and prioritised by parents
during the qualitative interviews
Life impact (perceived
health status)
Mortality The intervention may potentially have an impact on mortality/
survival rates. Please indicate how important you think it is
that this outcome is measured in a future study. Note, this
outcome was prioritised by parents during the qualitative
interviews
Death (mortality/
survival)
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Name Help text Domain name
Nursing time spent
measuring GRV
The intervention may potentially have an impact on nursing
time taken to perform the procedure, which could otherwise
be spent on other things. Please indicate how important you
think it is that this outcome is measured in a future study
Resource use (hospital)
Time feed stopped per
24 hours
The intervention may potentially have an impact on the
amount of time the feed is stopped in the 24-hour period.
Please indicate how important you think it is that this outcome
is measured in a future study. Note, this outcome was
prioritised by parents during the qualitative interviews
Physiological/clinical
(metabolism and
nutrition outcomes)
Time to achievement of
predicted energy goals
(full feeds)
The intervention may potentially have an impact on the time
taken to achieve the child’s predicted energy goals. Please
indicate how important you think it is that this outcome is
measured in a future study
Physiological/clinical
(metabolism and
nutrition outcomes)
Total length of time on
respiratory support
(IV +NIV)
The intervention may potentially have an impact on the total
length of time on any respiratory support (both invasive and
non-invasive). Please indicate how important you think it is
that this outcome is measured in a future study. Note, this
outcome was prioritised by parents during the qualitative
interviews
Physiological/clinical
(respiratory, thoracic
and mediastinal
outcomes)
Change in weight (growth)
between PICU admission
and discharge
The intervention may potentially have an impact on the child’s
weight. Please indicate how important you think it is that this
outcome is measured in a future study. Note, this outcome was
prioritised by parents during the qualitative interviews
Physiological/clinical
(metabolism and
nutrition outcomes)
Change in length (growth)
between PICU admission
and discharge
The intervention may potentially have an impact on the child’s
growth. Please indicate how important you think it is that this
outcome is measured in a future study. Note, this outcome was
identified by parents as important and prioritised by parents
during the qualitative interviews
Physiological/clinical
(metabolism and
nutrition outcomes)
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Appendix 6 Paediatric intensive care unit
additional outcomes
Name Help text Domain name
Administration of parenteral
nutrition secondary to feed
intolerance
The intervention may potentially have an impact on
whether or not parenteral nutrition is administered. Please
indicate how important you think it is that this outcome is
measured in a future study
Physiological/clinical
(GI outcomes)
Post-pyloric feeding (placing a
post-pyloric tube) secondary to
feed intolerance
The intervention may potentially have an impact on
whether or not a post-pyloric feeding tube is placed. Please
indicate how important you think it is that this outcome is
measured in a future study
Physiological/clinical
(GI outcomes)
Parental satisfaction The intervention may potentially have an impact on how
satisfied the parent is with the delivery of care. Please
indicate how important you think it is that this outcome is
measured in a future study
Delivery of care
Change to feed formula type,
secondary to feed intolerance
The intervention may potentially have an impact on
whether or not there is a change to the type of feed
formula. Please indicate how important you think it is that
this outcome is measured in a future study
Physiological/clinical
(GI outcomes)
Administration of prokinetic
drugs, secondary to feed
intolerance
The intervention may potentially have an impact on
whether or not prokinetic drugs are administered. Please
indicate how important you think it is that this outcome is
measured in a future study
Physiological/clinical
(GI outcomes)
Incidence of NEC The intervention may potentially have an impact on the
incidence of NEC. Please indicate how important you think
it is that this outcome is measured in a future study
Physiological/clinical
(infection outcomes);
AE
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Appendix 7 Neonatal unit Delphi outcomes
Name Help text Domain name
Days of central venous line
access
The intervention may potentially have an impact on the
number of days of central venous line access. Please
indicate how important you think it is that this outcome is
measured in a future study
Resource use (need for
further intervention)
Days on parenteral nutrition The intervention arm may potentially have an impact on the
number of days on parenteral nutrition. Please indicate how
important you think it is that this outcome is measured in a
future study
Physiological/clinical
(metabolism and
nutrition outcomes)
GI morbidity: diarrhoea The intervention may potentially have an impact on the
incidence of diarrhoea. Please indicate how important you
think it is that this outcome is measured in a future study.
Note, this outcome was prioritised by parents during the
qualitative interviews
Physiological/clinical
(GI outcomes); AE
GI morbidity: vomiting The intervention may potentially have an impact on the
incidence of vomiting. Please indicate how important you
think it is that this outcome is measured in a future study.
Note, this outcome was prioritised by parents during the
qualitative interviews
Physiological/clinical
(GI outcomes); AE
Incidence of NEC The intervention may potentially have an impact on the
incidence of NEC. Please indicate how important you
think it is that this outcome is measured in a future study.
Note, this outcome was prioritised by parents during the
qualitative interviews
Physiological/clinical
(infection outcomes);
AE
Length of stay: hospital The intervention may potentially have an impact on their
length of stay in hospital. Please indicate how important you
think it is that this outcome is measured in a future study.
Note, this outcome was prioritised by parents during the
qualitative interviews
Resource use (hospital)
Length of stay: NNU The intervention may potentially have an impact on their
length of stay in the NNU. Please indicate how important
you think it is that this outcome is measured in a future
study
Resource use (hospital)
Length of time: IV The intervention may potentially have an impact on the
length of time they spend on IV. Please indicate how
important you think it is that this outcome is measured in a
future study
Physiological/clinical
(respiratory, thoracic
and mediastinal
outcomes)
Mortality The intervention may potentially have an impact on
mortality/survival rates. Please indicate how important
you think it is that this outcome is measured in a future
study. Note, this outcome was prioritised by parents during
the qualitative interviews
Death (mortality/
survival)
Nursing time spent
measuring GRV
The intervention may potentially have an impact on nursing
time taken to perform this task. Please indicate how
important you think it is that this outcome is measured in a
future study
Resource use (hospital)
Time feed stopped per
24 hours
The intervention may potentially have an impact on the
amount of time the feed is stopped in 24-hour period.
Please indicate how important you think it is that this
outcome is measured in a future study
Physiological/clinical
(metabolism and
nutrition outcomes)
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Name Help text Domain name
Time from start of enteral
feeding to achieve full
(150 ml/kg/day) enteral feeds
The intervention may potentially have an impact on the time
from start of enteral feeding to achieve full (150ml/kg/day)
enteral feeds. Please indicate how important you think it is
that this outcome is measured in a future study. Note, this
outcome was prioritised by parents during the qualitative
interviews
Physiological/clinical
(GI outcomes)
Time to nasogastric tube
removal
The intervention may potentially have an impact on the
time to nasogastric tube removal. Please indicate how
important you think it is that this outcome is measured in
a future study
Resource use (need for
further intervention)
Total length of time on
respiratory support
(IV +NIV)
The intervention may potentially have an impact on the
total length of time on respiratory support received
(includes both invasive and non-invasive). Please indicate
how important you think it is that this outcome is measured
in a future study. Note, this outcome was prioritised by
parents during the qualitative interviews
Physiological/clinical
(respiratory, thoracic
and mediastinal
outcomes)
Change in weight (growth)
between birth and NNU
discharge
The intervention may potentially have an impact on the
infant’s weight. Please indicate how important you think it is
that this outcome is measured in a future study. Note, this
outcome was prioritised by parents during the qualitative
interviews
Physiological/clinical
(metabolism and
nutrition outcomes)
Change in length (growth)
between birth and NNU
discharge
The intervention may potentially have an impact on the
infant’s growth. Please indicate how important you think it
is that this outcome is measured in a future study. Note,
this outcome was identified by parents as important and
prioritised by parents during the qualitative interviews
Physiological/clinical
(metabolism and
nutrition outcomes)
Long-term outcomes:
hearing loss
The intervention may potentially have a long-term impact
on the infant’s health. Please indicate how important you
think it is that this outcome is measured in a future study.
Note, this outcome was identified by parents as important
and prioritised by parents during the qualitative interviews
Life impact (physical
and cognitive
functioning)
Long-term outcomes:
problems with eye sight
The intervention may potentially have a long-term impact
on the infant’s health. Please indicate how important you
think it is that this outcome is measured in a future study.
Note, this outcome was identified by parents as important
and prioritised by parents during the qualitative interviews
Life impact (physical
and cognitive
functioning)
Long-term outcomes:
problems with cognition
The intervention may potentially have a long-term impact
on the infant’s health. Please indicate how important you
think it is that this outcome is measured in a future study.
Note, this outcome was identified by parents as important
and prioritised by parents during the qualitative interviews
Life impact (physical
and cognitive
functioning)
Long-term outcomes: brain
injury on imaging
The intervention may potentially have a long-term impact
on the infant’s health. Please indicate how important you
think it is that this outcome is measured in a future study.
Note, this outcome was identified by parents as important
and prioritised by parents during the qualitative interviews
Central nervous
system (physical and
cognitive functioning)
Long-term outcomes:
problems with mobility like
cerebral palsy
The intervention may potentially have a long-term impact
on the infant’s health. Please indicate how important you
think it is that this outcome is measured in a future study.
Note, this outcome was identified by parents as important
and prioritised by parents during the qualitative interviews
Life impact (physical
and cognitive
functioning)
Health-care-associated
infections
The intervention may potentially have an impact on the
incidence of NEC and other health-care-associated
infections. Please indicate how important you think it
is that this outcome is measured in a future study. Note,
this outcome was identified by parents as important and
prioritised by parents during the qualitative interviews
Physiological/clinical
(infection outcomes);
AE
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Appendix 8 Neonatal unit additional
Delphi outcomes
Name Help text Domain name
Change in head
circumference between
birth and NNU discharge
The intervention may potentially have an impact on the infant’s
head circumference. Please indicate how important you think it is
that this outcome is measured in a future study
Physiological/clinical
(respiratory, thoracic
and mediastinal
outcomes)
Incidence of pneumonia
due to milk aspiration
The intervention may potentially have an impact on the incidence of
pneumonia due to milk aspiration. Please indicate how important
you think it is that this outcome is measured in a future study
Physiological/clinical
(respiratory, thoracic
and mediastinal
outcomes)
Incidence of catheter-
associated bloodstream
infection
The intervention may potentially have an impact on the incidence
of catheter-associated bloodstream infection. Please indicate how
important you think it is that this outcome is measured in a future
study
Physiological/clinical
(infection outcomes);
AE
Time to oral feeding The intervention may potentially have an impact on the time
taken to start oral feeds. Please indicate how important you think
it is that this outcome is measured in a future study
Physiological/clinical
(GI outcomes)
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Appendix 9 Neonatal data items
extracted from the National Neonatal
Research Database for the GASTRIC study
- Aggregate annual data for England and Wales for 2017 and 2018, on the number of infants (data
separately for 1-3 below)
1. With a gestation at birth < 32 + 0 (weeks + days)
Defined as: Gestation Weeks < 32 weeks
1. Who received any mechanical ventilation
Defined as any of the following:
Respiratory support = ‘1 – Ventilation via endotracheal tube or tracheostomy’
OR
Ventilation mode equal to either:
‘1 – Conventional’
‘2 – High frequency oscillation’
OR
Added Oxygen = ‘11 – Oxygen given with ventilation’
2. Who are recorded as receiving any enteral feeds via nasogastric tube
Define as: Feeding Method = ‘4 – Nasogastric tube’
4. Aggregate annual data for number of infants that fulfil 1, 2, and 3 above
– All aggregate data (1–4 above) split by the following
a. Gestational age < 28 gestational weeks/≥ 28 gestational weeks at birth
b. Born in a NICU/born in a LNU/born in a SCBU
– The following number of cases recorded annually for 2017 and 2018 in each population group
(1–3 above) – total numbers unless stated otherwise:
a. Died prior to neonatal unit discharge
Defined as any of the following:
Discharge Destination = ‘3 – Died’
OR Final NNU Outcome = ‘3 –Died’
b. NEC (NNAP definition)
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Defined as:
NEC diagnosis = ‘1 =NEC diagnosed this episode’
AND
NEC DiagnosisBasedOn = (11– surgery
12 –post-mortem)
OR
NEC DiagnosisBasedON = ‘10 –clinical signs ‘AND at least one Clinical Features = (10- Bilious gastric
aspirate or emesis
11- Abdominal distension
12- Occult or gross blood in stool (no fissure)) AND at least on Radiographic Feature =
(10- Pneumatosis intestinalis
11- Hepato-biliary gas
12- Pneumoperitoneum)
c. Mean (SD) median (IQR) number of days receiving PN (please also note several babies that did not
receive any PN)
Defined as: Parenteral Nutrition = ‘1 – PN given’
d. Mean (SD) median (IQR) number of days before a baby is recorded as being fully enterally fed
(e.g. no PN or IV fluids for 2 consecutive days)
Defined as:
Parenteral Nutrition = ‘0 – No PN given’
AND
Glucose Electrolyte = ‘0 – None given’
AND
DayEnteralFeed =
1 - Suckling at the breast
2 - Mother’s fresh expressed breast milk
3 - Mother’s frozen expressed breast milk
4 - Donor expressed breast milk
5 - Breast milk fortifier
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6 - Formula
8 - Other)
e. Bloodstream infection (NNAP definition)
Defined as: SampleType = ‘BLOOD’
AND
Pathogen = pathogenic organisms (considered so from predefined list used for NNAP processing)
OR
Pathogen = skin commensal AND at least 3 clinical signs (including; tachypnoea or clinically relevant
increase in oxygen requirement or ventilatory support, clinically relevant increase in apnoea or
bradycardia episodes,
Hypotension, glucose intolerance, impaired peripheral perfusion (capillary refill time more than 3 sec,
pallor/mottling/core peripheral
temperature gap more than 2 °C), lethargy/irritability/poor handling,
temperature instability, feed intolerance, fall in urine output or metabolic acidosis (base deficit below
–10 mmol/l))
OR
Pathogen =mixed growth AND at least 3 clinical signs (as above)
AND
Sample taken time > 72 hours after birth
f. Mean (SD) median (IQR) number of days with a central line in (please also note several babies that
did not have a central line at all)
Defined as:
Lines in situ equal to any of the following:
B - Umbilical arterial line
C - Umbilical venous line
D - Percutaneous central venous line (long line)
E - Surgically inserted central venous line
These lines are considered central for the NNAP CLABSI item below
g. CLABSI (NNAP definition); please also note a number of babies that did not have a central line at
any point)
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Defined as: Bloodstream infection definition as above
AND
Line in situ equal to the above
h. Mean (SD) median (IQR) length of neonatal unit stay
Defined as the total number of days a baby received any level of care where location of care is set to
‘NNU’ (taken from Daily Care General Information - LOCATIONS OF HIGHEST LEVEL OF CARE)
i. Mean (SD) median (IQR) number of days receiving ventilation (also the number of babies not
ventilated at all)
Defined as any of the following:
Respiratory support = ‘1 – Ventilation via endotracheal tube or tracheostomy’
OR
Ventilation mode equal to any of the following:
‘1 – Conventional’
‘2 – High frequency oscillation’
OR
Added Oxygen = ‘11 – Oxygen given with ventilation’
j. Mean (SD) median (IQR) number of days receiving non-invasive ventilation (also the number of
babies not receiving non-invasive ventilation at all)
Defined as any of the following:
Respiratory support = ‘2 – Non-invasive support (inc CPAP)’
OR
Non-Invasive Respiratory Support equal to any of the following:
‘1 - nasal CPAP (prong or mask)’
‘2 - BIPAP/SIPAP’
‘4 - High flow O2/air device’
OR Added Oxygen equal to any of the following:
12 - Oxygen given with CPAP
13 - Oxygen given with nasal ventilation (as of 2012 this option was combined with option ‘12’ to give
Oxygen given with CPAP or nasal ventilation)
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14 - Headbox oxygen
15 - Nasal cannula oxygen up to 1 lpm
16 - Nasal cannula oxygen above 1 lpm
17 - High flow oxygen/air device used
18 - Oxygen therapy (unspecified)
Unit level aggregate annual numbers for NICU and LNU for 1–3
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Appendix 10 Study oversight committees
Study Steering Committee: independent members
Dr Pamela Cairns (chairperson), Consultant Neonatologist, NNU, St Michael’s Hospital, Bristol, UK.
Dr Linda Hunt, Statistician, National Joint Registry Office, Musculoskeletal Research Unit, Translational
Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Ms Nailah Brown, public member.
Professor Sharon Irving, Assistant Professor Paediatric Nursing, School of Nursing, University of
Pennsylvania, Philadelphia, PA, USA.
Dr Luise Marino, Clinical Academic PICU Dietitian, PICU, Southampton Children’s Hospital,
Southampton, UK.
Professor Nilesh Mehta, Associate Professor of Anaesthesia, Harvard Medical School, PICU, Boston
Children’s Hospital, Boston, MA, USA.
Professor Namasivayam Ambalavanan, Department of Paediatrics, Women & Infants Centre,
Birmingham, AL, USA.
Professor Leslie Parker, Associate Clinical Professor, University of Florida, Gainesville, FL, USA.
Study Management Group
Iza Andrzejewska, NICU nurse, Chelsea and Westminster Hospital, London, UK.
Barbara Arch, Statistician, Liverpool Clinical Trials Centre, University of Liverpool, Liverpool, UK (also a
member of the Liverpool Health Partners).
Anne Beissel, Neonatologist, Hospices Civils de Lyon, Lyon-Bron, France.
Ashley Jones, Senior Statistician, Clinical Trials Research Centre, University of Liverpool, Liverpool, UK
(also a member of the Liverpool Health Partners).
Beth Deja, Research Associate, Medical Research Centre North West Hub for Trials Methodology,
Research Institute of Psychology, Health and Society, Liverpool, Liverpool, UK.
Jon Dorling, Lead NICU Stream Neonatologist, IWK Health Centre, Halifax, NS, Canada.
Helen Eccleson, Study Co-ordinator, Clinical Trials Research Centre, University of Liverpool, Liverpool,
UK (also a member of the Liverpool Health Partners).
Chris Gale, Neonatologist and NNRD, Neonatal Medicine, Chelsea and Westminster Hospital, London, UK.
Helen Hickey, Senior Trials Manager, Clinical Trials Research Centre, University of Liverpool, a member
of the Liverpool Health Partners, UK.
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Clare Jackson, Senior Data Manager, Clinical Trials Research Centre, University of Liverpool, Liverpool,
UK (also a member of the Liverpool Health Partners).
Lynne Latten, PICU Dietitian, Nutrition and Dietetics, Alder Hey Children’s NHS Foundation Trust,
Liverpool, UK.
Roger Parslow, Senior Lecturer in Epidemiology, Leeds Institute of Cardiovascular and Metabolic
Medicine, School of Medicine, University of Leeds, Leeds, UK.
Nazima Pathan, University Lecturer and Honorary Consultant in Paediatric Critical Care University
Department of Paediatrics, Addenbrooke’s Hospital, Cambridge, UK.
Jenny Preston, patient and public involvement representative, Department of Women’s and Children’s
Health, Institute of Translational Medicine (Child Health), Alder Hey Children’s NHS Foundation Trust,
University of Liverpool, Liverpool, UK.
Louise Roper, Research Associate, Medical Research Council North West Hub for Trials Methodology,
Research Institute of Psychology, Health and Society, Liverpool, UK.
Lyvonne Tume, chief investigator/Associate Professor in Child Health, School of Health & Society,
University of Salford, Manchester, UK.
Frederic Valla, PICU Physician, Hospices Civils de Lyon, Lyon-Bron, France.
Kerry Woolfall, Department of Psychological Sciences, Medical Research Council North West Hub for
Trials Methodology, Research Institute of Psychology, Health and Society, Liverpool, UK.
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